
<html lang="en"     class="pb-page"  data-request-id="86686ab5-faa3-4fb8-a006-0f2044caf6e9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2014.57.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm500026w;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate" /></meta><meta name="dc.Creator" content="William N.  Washburn" /></meta><meta name="dc.Creator" content="Mark  Manfredi" /></meta><meta name="dc.Creator" content="Pratik  Devasthale" /></meta><meta name="dc.Creator" content="Guohua  Zhao" /></meta><meta name="dc.Creator" content="Saleem  Ahmad" /></meta><meta name="dc.Creator" content="Andres  Hernandez" /></meta><meta name="dc.Creator" content="Jeffrey A.  Robl" /></meta><meta name="dc.Creator" content="Wei  Wang" /></meta><meta name="dc.Creator" content="James  Mignone" /></meta><meta name="dc.Creator" content="Zhenghua  Wang" /></meta><meta name="dc.Creator" content="Khehyong  Ngu" /></meta><meta name="dc.Creator" content="Mary Ann  Pelleymounter" /></meta><meta name="dc.Creator" content="Daniel  Longhi" /></meta><meta name="dc.Creator" content="Rulin  Zhao" /></meta><meta name="dc.Creator" content="Bei  Wang" /></meta><meta name="dc.Creator" content="Ning  Huang" /></meta><meta name="dc.Creator" content="Neil  Flynn" /></meta><meta name="dc.Creator" content="Anthony V.  Azzara" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="Kenneth  Rohrbach" /></meta><meta name="dc.Creator" content="James J.  Devenny" /></meta><meta name="dc.Creator" content="Suzanne  Rooney" /></meta><meta name="dc.Creator" content="Michael  Thomas" /></meta><meta name="dc.Creator" content="Susan  Glick" /></meta><meta name="dc.Creator" content="Helen E.  Godonis" /></meta><meta name="dc.Creator" content="Susan J.  Harvey" /></meta><meta name="dc.Creator" content="Mary Jane  Cullen" /></meta><meta name="dc.Creator" content="Hongwei  Zhang" /></meta><meta name="dc.Creator" content="Christian  Caporuscio" /></meta><meta name="dc.Creator" content="Paul  Stetsko" /></meta><meta name="dc.Creator" content="Mary  Grubb" /></meta><meta name="dc.Creator" content="Brad D.  Maxwell" /></meta><meta name="dc.Creator" content="Hong  Yang" /></meta><meta name="dc.Creator" content="Atsu  Apedo" /></meta><meta name="dc.Creator" content="Brian  Gemzik" /></meta><meta name="dc.Creator" content="Evan B.  Janovitz" /></meta><meta name="dc.Creator" content="Christine  Huang" /></meta><meta name="dc.Creator" content="Lisa  Zhang" /></meta><meta name="dc.Creator" content="Chris  Freeden" /></meta><meta name="dc.Creator" content="Brian J.  Murphy" /></meta><meta name="dc.Description" content="Identification of MCHR1 antagonists with a preclinical safety profile to support clinical evaluation as antiobesity agents has been a challenge. Our finding that a basic moiety is not required for ..." /></meta><meta name="Description" content="Identification of MCHR1 antagonists with a preclinical safety profile to support clinical evaluation as antiobesity agents has been a challenge. Our finding that a basic moiety is not required for ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 9, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500026w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500026w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500026w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500026w" /></link>
        
    
    

<title>Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500026w" /></meta><meta property="og:title" content="Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0009.jpeg" /></meta><meta property="og:description" content="Identification of MCHR1 antagonists with a preclinical safety profile to support clinical evaluation as antiobesity agents has been a challenge. Our finding that a basic moiety is not required for MCHR1 antagonists to achieve high affinity allowed us to explore structures less prone to off-target activities such as hERG inhibition. We report the SAR evolution of hydroxylated thienopyrimidinone ethers culminating in the identification of 27 (BMS-819881), which entered obesity clinical trials as the phosphate ester prodrug 35 (BMS-830216)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500026w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500026w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500026w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500026w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500026w&amp;href=/doi/10.1021/jm500026w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7509-7522</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501175v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500192s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+N.++Washburn">William N. Washburn</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Manfredi">Mark Manfredi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pratik++Devasthale">Pratik Devasthale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guohua++Zhao">Guohua Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Saleem++Ahmad">Saleem Ahmad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andres++Hernandez">Andres Hernandez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Robl">Jeffrey A. Robl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Wang">Wei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Mignone">James Mignone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhenghua++Wang">Zhenghua Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Khehyong++Ngu">Khehyong Ngu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ann++Pelleymounter">Mary Ann Pelleymounter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Longhi">Daniel Longhi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rulin++Zhao">Rulin Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bei++Wang">Bei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Huang">Ning Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Flynn">Neil Flynn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+V.++Azzara">Anthony V. Azzara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Rohrbach">Kenneth Rohrbach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+J.++Devenny">James J. Devenny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne++Rooney">Suzanne Rooney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Thomas">Michael Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Glick">Susan Glick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helen+E.++Godonis">Helen E. Godonis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+J.++Harvey">Susan J. Harvey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Jane++Cullen">Mary Jane Cullen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongwei++Zhang">Hongwei Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Caporuscio">Christian Caporuscio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Stetsko">Paul Stetsko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Ã</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++Grubb">Mary Grubb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad+D.++Maxwell">Brad D. Maxwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Yang">Hong Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atsu++Apedo">Atsu Apedo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Gemzik">Brian Gemzik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Evan+B.++Janovitz">Evan B. Janovitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Huang">Christine Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Zhang">Lisa Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chris++Freeden">Chris Freeden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+J.++Murphy">Brian J. Murphy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>â </sup>Metabolic Diseases Chemistry, <sup>â¡</sup>Metabolic Diseases Biology, <sup>Â§</sup>Preclinical Candidate Optimization Metabolism and Pharmacokinetics, <sup>â¥</sup>Discovery Chemistry Synthesis, <sup>â¥</sup>Preclinical Candidate Optimization Discovery Toxicology, <sup>#</sup>Preclinical Candidate Optimization Discovery Bioanalytical Research, <sup>â</sup>Preclinical Candidate Optimization Biotransformation, <sup>Ã</sup>Preclinical Candidate Optimization Pharmaceutics, and <sup>â</sup>Preclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#0770697066746f6572756947606a666e6b2964686a"><span class="__cf_email__" data-cfemail="780f160f190b101a0d0a16381f15191114561b1715">[emailÂ protected]</span></a>. Phone: 609-737-7451.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500026w&amp;href=/doi/10.1021%2Fjm500026w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7509â7522</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 28, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 January 2014</li><li><span class="item_label"><b>Published</b> online</span>9 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 September 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500026w" title="DOI URL">https://doi.org/10.1021/jm500026w</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7509%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWilliam%2BN.%2BWashburn%252C%2BMark%2BManfredi%252C%2BPratik%2BDevasthale%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D18%26contentID%3Djm500026w%26title%3DIdentification%2Bof%2Ba%2BNonbasic%2BMelanin%2BHormone%2BReceptor%2B1%2BAntagonist%2Bas%2Ban%2BAntiobesity%2BClinical%2BCandidate%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7522%26publicationDate%3DSeptember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500026w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1875</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500026w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;N. Washburn&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Manfredi&quot;},{&quot;first_name&quot;:&quot;Pratik&quot;,&quot;last_name&quot;:&quot;Devasthale&quot;},{&quot;first_name&quot;:&quot;Guohua&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Saleem&quot;,&quot;last_name&quot;:&quot;Ahmad&quot;},{&quot;first_name&quot;:&quot;Andres&quot;,&quot;last_name&quot;:&quot;Hernandez&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Robl&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Mignone&quot;},{&quot;first_name&quot;:&quot;Zhenghua&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Khehyong&quot;,&quot;last_name&quot;:&quot;Ngu&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ann Pelleymounter&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Longhi&quot;},{&quot;first_name&quot;:&quot;Rulin&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Bei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Flynn&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;V. Azzara&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Rohrbach&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J. Devenny&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;Rooney&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Glick&quot;},{&quot;first_name&quot;:&quot;Helen&quot;,&quot;last_name&quot;:&quot;E. Godonis&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;J. Harvey&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Jane Cullen&quot;},{&quot;first_name&quot;:&quot;Hongwei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Caporuscio&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Stetsko&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Grubb&quot;},{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;D. Maxwell&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Atsu&quot;,&quot;last_name&quot;:&quot;Apedo&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Gemzik&quot;},{&quot;first_name&quot;:&quot;Evan&quot;,&quot;last_name&quot;:&quot;B. Janovitz&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;Freeden&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;J. Murphy&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;7509-7522&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500026w&quot;},&quot;abstract&quot;:&quot;Identification of MCHR1 antagonists with a preclinical safety profile to support clinical evaluation as antiobesity agents has been a challenge. Our finding that a basic moiety is not required for MCHR1 antagonists to achieve high affinity allowed us to explore structures less prone to off-target activities such as hERG inhibition. We report the SAR evolution of hydroxylated thienopyrimidinone ethers culminating in the identification of 27 (BMS-819881), which entered obesity clinical trials as the phosphate ester prodrug 35 (BMS-830216).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500026w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500026w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500026w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500026w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500026w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500026w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500026w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500026w&amp;href=/doi/10.1021/jm500026w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500026w" /></input><a href="/doi/pdf/10.1021/jm500026w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (597 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500026w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500026w%26sid%3Dliteratum%253Aachs%26pmid%3D25165888%26genre%3Darticle%26aulast%3DWashburn%26date%3D2014%26atitle%3DIdentification%2Bof%2Ba%2BNonbasic%2BMelanin%2BHormone%2BReceptor%2B1%2BAntagonist%2Bas%2Ban%2BAntiobesity%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D18%26spage%3D7509%26epage%3D7522%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jmcmar.2014.57.issue-18/20140925/jmcmar.2014.57.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Identification of MCHR1 antagonists with a preclinical safety profile to support clinical evaluation as antiobesity agents has been a challenge. Our finding that a basic moiety is not required for MCHR1 antagonists to achieve high affinity allowed us to explore structures less prone to off-target activities such as hERG inhibition. We report the SAR evolution of hydroxylated thienopyrimidinone ethers culminating in the identification of <b>27</b> (BMS-819881), which entered obesity clinical trials as the phosphate ester prodrug <b>35</b> (BMS-830216).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ever increasing worldwide incidence of obesity and the attendant health costs have prompted renewed efforts by the pharmaceutical industry to focus on antiobesity agents.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These efforts comprise three different approaches: anorectics typically requiring CNS targeting, metabolic enhancers directed toward peripheral targets, and nutrient absorption modulators associated with GI targets.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Each approach poses its own challenges. Agents that reduce absorption of specific nutrients achieve most of their effect by encouraging diet modification to minimize the probability of gastric disturbances.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Metabolic elevation of cardiovascularly compromised patients has proved difficult to achieve safely because of the increased cardiac output required to support the elevated cellular metabolism.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In principle, anorectic agents represent the most direct weight loss approach; however, modulation of certain CNS pathways controlling caloric intake may also activate brain circuits, resulting in unacceptable side effects as was most recently shown by the cannabanoid inverse agonists.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The melanin concentrating hormone (MCH) pathway is one of a variety of neurological circuits reported to modulate caloric consumption. The natural ligand is a 19 amino acid cyclic peptide conserved across all mammalian species.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Predominant MCH peptide expression is limited to magnocellular neurons in the lateral hypothalamus and zona incerta. These neurons project to many areas of the brain including cortex, amygdala, dorsal and ventral striatum, olfactory tubercle, nucleus accumbens, and nuclei located in the hindbrain.</div><div class="NLM_p">In humans and most other species, MCH binds to two class A GPCRs termed MCHR1 and MCHR2 for which the sequence identity is 38%. MCHR1 is primarily expressed in the brain at moderate levels in many areas including cortex, olfactory tubercle, hippocampus, outer shell of the nucleus accumbens, and amygdala. MCHR1 is also expressed in the arcuate and ventromedial portion of the hypothalamus, implicating a role for the receptor in feeding. The overall expression pattern of MCHR2 in the brain is similar to that of MCHR1. MCHR2 is expressed in higher mammals such as dog, monkey, and primates; however, it is not expressed in rodents such as mouse and rat. At present, the physiological role of MCHR2 in humans is not known.</div><div class="NLM_p">The in vivo and transgenic studies establishing that MCHR1 was a promising antiobesity target have been extensively reviewed; selected salient studies are briefly summarized herein.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> The presence of up-regulated MCH mRNA in the hypothalamus of the genetically obese, leptin-deficient ob/ob mouse provided the first evidence that MCH may be an orexigenic peptide exerting its effects at the level of the hypothalamus. Intracerebroventicular (icv) injection of MCH increased acute food intake of rats; furthermore, chronic infusion of MCH into the lateral ventricle of mice resulted in significantly increased food intake, body weight, and white adipose tissue mass. Nutritional status modulates MCH peptide mRNA levels; levels were up-regulated after food deprivation in lean rats and were elevated in the hypothalami of diet-induced obese (DIO) rats.</div><div class="NLM_p">Transgenic animals overexpressing MCH mRNA in the lateral hypothalamus were more susceptible to obesity when fed a high fat diet, whereas knockout mice lacking MCH peptide were hypophagic and lean compared to wild-type littermates. Since MCH knockout mice showed an increase in metabolism, weight loss observed in the MCH knockout mice is attributed to a combination of both hypophagia and increased metabolism. MCHR1 â/â mice are lean when fed either a normal chow or high fat diet when compared to wild-type littermates. In summary, all studies with MCH peptide and both the MCHR1 and MCH peptide knockout mice are consistent with MCH playing a role in energy homeostasis, thereby establishing the potential utility of a MCHR1 antagonist for use in obesity.</div><div class="NLM_p">Pharmaceutical pursuit of MCHR1 antagonists began in earnest around 2002 with the disclosure of T-226296 (<b>1</b>).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> These efforts have been guided by prior agonist SAR studies that revealed Arg 11 of the MCH peptide was essential for agonist activity due to presumed formation of a salt bridge with Asp123 of the MCHR1 receptor.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> By 2005, when BMS initiated a MCHR1 antagonist program, a number of patent applications had published disclosing a variety of high affinity MCHR1-selective competitive antagonists exemplified by <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> These disclosures spanning a diverse set of lipophilic amines have been summarized in a number of reviews.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> Perusal of these structures, best described as a set of hydrophobic modular assemblages each containing a basic site, suggests that the MCHR1 receptor possesses a very accommodative binding site(s). Since the structural features of these chemotypes are highly conducive to hERG inhibition, removal of hERG activity from these active pharmacophores proved to be a formidable medicinal chemistry challenge.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23">(19-23)</a> Despite the disclosures of >200 patents for potent MCHR1 antagonists, only a few candidates including entries from GSK (GW856464), Amgen (AMG-076), Neurogen (NGD-4715), AMRI-Technology (ALB-127158) have entered clinical trials, but none progressed beyond phase 1.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Identification of compounds that could be safely progressed to clinical trials continues to be exceedingly challenging.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> Herein we report a finding that enabled identification of MCHR1 antagonists with minimal hERG activity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative MCHR1 antagonists and amide counterparts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening the BMS chemical library revealed compound <b>5</b> (MCHR1 <i>K</i><sub>i</sub> = 27 nM). Surprisingly inhibition due to <b>5</b> was not irreversible as would be anticipated if conversion of <b>5</b> to a long-lived bis 2,6-di-<i>tert</i>-butylphenolic radical had promoted oxidative inactivation of MCHR1. Rather <b>5</b> appeared to be either a competitive or noncompetitive inhibitor despite the fact that <b>5</b> lacked the structural elements associated with MCHR1 antagonists. However, our interest in this lead diminished once SAR elucidation revealed that the bis-<i>tert</i>-butylphenol component, which was essential for in vitro activity, precluded adequate CNS exposure to achieve in vivo efficacy.</div><div class="NLM_p">Spurred by the finding of MCHR1 antagonist activity of <b>5</b>, we explicitly tested the assumption that the basic amine was an essential element for high affinity MCHR antagonists by ablating the basic amine of selected potent MCHR antagonists while maintaining all other structural elements intact. Preparation and characterization of the amide counterparts <b>6</b> and <b>7</b> of amine <b>2</b> revealed only a 3- to 4-fold decrease in affinity; moreover, <b>8</b> the amide counterpart of <b>3</b> exhibited only a 2 fold decrease in affinity, findings inconsistent with the consensus conception regarding formation of a critical salt bridge between the antagonist and the MCHR1 receptor. This structural change greatly reduced aqueous solubility and dramatically attenuated affinities for hERG as well as biogenic amine receptors. For example, the hERG electrophysiological IC<sub>50</sub> of <b>2</b> was <1 Î¼M, whereas <b>6</b> induced only 20% inhibition at 10 Î¼M. When screened against 30 biogenic amine receptors and ion channels, <b>2</b> exhibited >50% inhibition in seven assays at 1 Î¼M whereas an amide counterpart exhibited <50% activity at 10 Î¼M.</div><div class="NLM_p">Encouraged by these findings, we pursued MCHR antagonists lacking basic amines by replacing the pyrrolidine moiety of thienopyrimidinone <b>2</b> with a variety of nonbasic functionalities exemplified by examples <b>9</b>â<b>19</b>. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, all were potent MCHR1 antagonists; however, aqueous solubility was <1 Î¼g/mL. Following oral administration as a 1% methylcellulose/0.5% Tween 80 suspension to rats, three distinct groupings emerged based on AUC and brain/plasma ratio. Very low oral exposures were obtained with the urea <b>9</b>, tertiary carbamate <b>10</b>, amide <b>11</b>, or carboxamide <b>12</b>. Modest peripheral exposures were obtained with the sulfonamide <b>13</b> or secondary amide <b>14</b> as a polar group, whereas incorporation of a secondary carbamate <b>15</b> increased AUC values significantly. However, in all cases, essentially no CNS exposure was achieved with <b>9</b>â<b>15</b>. Although alkyl ethers exhibited favorable brain/plasma ratios, exposures were unacceptably low for nonhydroxylated ethers such as <b>16</b> and marginal at 10 mg/kg for hydroxylated ethers <b>17</b>â<b>19</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison of MCHR1 Affinities, PK Profile, and Tissue Distribution</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>Â Â±Â SEMÂ (nM);Â <i>n</i></th><th class="colsep0 rowsep0" align="center">plasma <i>C</i><sub>max</sub> (nM)</th><th class="colsep0 rowsep0" align="center">brain/plasma at 24Â h</th><th class="colsep0 rowsep0" align="center">AUC<sub>0â24h</sub> (Î¼molÂ·h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>-pyrrolidine</td><td class="colsep0 rowsep0" align="left">3.8 Â± 2.4; <i>n</i> = 15</td><td class="colsep0 rowsep0" align="left">585</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>-NH-CO-NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="left">11.9Â (6.7â21.3);Â <i>n</i>Â =Â 3</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.076</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>-NMe-CO-OMe</td><td class="colsep0 rowsep0" align="left">15.5 Â± 1.2; <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>)<sub>2</sub>-NEt-CO-Me</td><td class="colsep0 rowsep0" align="left">9.7 Â± 1.9; <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.025</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CONEt<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.1 Â± 2.7; <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>)<sub>2</sub>-NH-SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">9.3 Â± 1.6; <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">565</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>)<sub>2</sub>-NH-CO-Me</td><td class="colsep0 rowsep0" align="left">11.6 Â± 0.96; <i>n</i> = 4</td><td class="colsep0 rowsep0" align="left">1879</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">9.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>-NH-CO-OMe</td><td class="colsep0 rowsep0" align="left">10.7 Â± 2.6; <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">10500</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">63.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">25.4 Â± 7.8; <i>n</i> = 14</td><td class="colsep0 rowsep0" align="left">431</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">7.7 Â± 1.4; <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">644</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH<sub>2</sub>CH(Me)OH</td><td class="colsep0 rowsep0" align="left">9.5 Â± 1.4; <i>n</i> = 6</td><td class="colsep0 rowsep0" align="left">2240</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">13.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>C(Me)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">7.9 Â± 0.7; <i>n</i> = 7</td><td class="colsep0 rowsep0" align="left">2921</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">16.3</td></tr></tbody></table></div></div><div class="NLM_p">The challenge was to maintain the favorable CNS/plasma partitioning conferred by the hydroxylated ether moiety while increasing exposure in a dose dependent manner. Since the failure to significantly increase exposures with higher doses suggested that solubility limited absorption was the limiting factor, prodrugs of <b>18</b> and <b>19</b> were evaluated. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> summarizes the AUC<sub>0â24h</sub> of <b>18</b> and <b>19</b> achieved following oral administration to rats of 10 mg/kg suspensions of the parent alcohols and their corresponding amino acid (AA) esters, monoesters of dibasic acids, dibasic phosphate esters, or a glucoside. On the basis of the superior exposures achieved and given the ease of preparation and purification, the amino acid esters were selected as the prodrug for oral administration of these 3-(4-(2-hydroxyethoxy)aryl)thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-ones.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Variation in exposure of <b>18</b> and <b>19</b> due to prodrug employed for oral administration to rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although stable in plasma, hydrolysis of these AA esters readily occurred during transit to the GI wall and the liver. Since these AA esters were potent MCHR antagonists (<i>K</i><sub>i</sub> â 3â10 nM) as well as 1â3 nM inhibitors of hERG and cytochrome P450 (CYP) 2C9 and 2C19, it was essential that there be no peripheral exposure of the prodrug following oral administration to avoid potentially confounding results. The preferred prodrugs were the <span class="smallcaps smallerCapital">l</span>-valine ester for 1Â° and 2Â° alcohols and the glycine ester for 3Â° alcohols. PK studies established that no detectable amount of these esters survived the initial passage through the liver whereas measurable levels were observed for more sterically encumbered AA esters. When these esters were administered orally as a HCl salt as a 0.5% methyl cellulose (Methocel)/0.1% Tween 80 aqueous suspension, dose dependent alcohol exposures were obtained following oral administration of doses of 1â100 mg/kg. For each prodrugged alcohol, oral PK studies were run prior to efficacy evaluation to ascertain that the peripheral and CNS exposures of the alcohol were adequate and that the AA prodrug was not detectable. Following identification of a potential development candidate alcohol, our strategy entailed preparation and utilization of the corresponding phosphate prodrug for final studies prior to advancement of the phosphate prodrug into clinical development, thereby avoiding any potential off-target risks posed by these amino ester prodrugs.</div><div class="NLM_p">These MCHR1 antagonists were initially evaluated in a young growing rat model using 8-week-old SpragueâDawley (SD) rats that had been previously acclimated to a choice diet.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A critical determinant for efficacy was whether adequate 24 h drug coverage was maintained. If not, breakthrough food consumption would occur once plasma drug levels became too low to maintain the prerequisite receptor occupancy. This critical <i>C</i><sub>min</sub> value was compound dependent reflecting affinity, brain to plasma ratio, free fraction in the CNS, and kinetics pertaining to receptor occupancy. Since these 3-(4-(2-hydroxyethoxyaryl)thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-ones were uniformly highly bound to serum proteins, drug concentrations measured in plasma and brain vastly overestimated the concentrations available to bind to MCHR1. Typically the % free drug was <1% unless the structure contained a second polar functionality as in the case for <b>21</b> or <b>24</b>, whereupon the % free fraction increased to 2â7%.</div><div class="NLM_p">Body weights of rats administered <b>18</b> or <b>19</b> q.d. at 3 mg/kg as the valine or glycine ester prodrug, respectively, for 10 days as a Methocel/Tween 80 aqueous suspension were 2.3% and 10.3% less than their vehicle treated cohort, whereas for a 30 mg/kg dose this differential increased to 15.7% and 15.6%, respectively. Weight loss produced by these MCHR1 antagonists was gradual and continuous throughout the study course. Daily food and water consumption was measured. Although the daily decrease versus vehicle was rarely significant, the cumulative difference was. Separate studies established that taste aversion was not a confounding factor. Routine liver histopathology was performed to screen for overt hepatotoxicity. After 4 days obstructive and proliferative lesions of small caliber intrahepatic bile ducts were observed in all lean SD rats treated with <b>18</b> at 30 mg/kg but not in those treated with <b>19</b>. Subsequently a 28-day dose dependent response study using DIO rats revealed that <b>19</b> at 30 mg/kg/day produced identical bile duct lesions in 40% of the treated rats. Serum bilirubin and bile acid levels were only increased in those rats with the most severe and widespread bile duct lesions; biomarkers of toxicity, including transcripomic and metabolomic profiles, were descriptive rather than predictive.</div><div class="NLM_p">Rather than abandoning this chemotype, we elected to conduct mechanistic studies to ascertain whether the toxic agent was the amino acid prodrug, parent alcohol, or a metabolite. Incubation with hepatocytes revealed these thienopyrimidinones to be surprisingly resistant to metabolic oxidation. The methyl ether remained intact; rather the primary, if not exclusive, site subject to oxidation was the hydroxylated side chain. Metabolism of <b>18</b> occurred at two sites of the hydroxylated alkyl substituent to respectively generate phenol <b>20</b> and diol <b>21a</b> which was further transformed to the Î±-hydroxyacid <b>22a</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). An analogous transformation of <b>19</b> generated <b>20</b>, <b>21b</b>, and <b>22b</b>. Both <b>21a</b> and <b>21b</b> were potent brain penetrant MCHR1 antagonists (<i>K</i><sub>i</sub> = 7 and 10 nM, respectively) for which the brain/plasma was â¼1:2. In contrast, <b>22a</b> and <b>22b</b> were weak MCHR1 antagonists (<i>K</i><sub>i</sub> â 1 Î¼M) which were not brain penetrant.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo mechanistic studies utilized <b>18</b>, since lesions were formed much more quickly than with <b>19</b>. To resolve the role of the prodrug, rats were treated for 4 days q.d. with the valine ester <b>18a</b> (absorbed from GI tract and hydrolyzed in liver) and phosphate ester <b>18b</b> (not absorbed from GI, hydrolyzed at the intestinal brush border releasing <b>18</b> which was absorbed). Comparable plasma levels of <b>18</b> were generated following oral administration of either prodrug at 30 mg/kg. The appearance of lesions in all rats administered either the phosphate or valine ester of <b>18</b> excluded the prodrug as the causative agent. To ascertain if <b>18</b> was toxic, rats were administered <b>18a</b> daily for 4 days at 30 mg/kg with and without the nonspecific CYP inhibitor aminobenztriazole (ABT) at 10 mg/kg. The findings that <b>18a</b> alone produced lesions in all rats but coadministration of ABT with <b>18a</b> completely prevented lesion formation established that the toxic agent was a metabolite. The phenol <b>20</b> was excluded, since no lesions were detected when it was administered as the corresponding phenolic acetate. In contrast, administration of the bis valine ester of diol <b>21a</b> generated very severe lesions in all rats after 3 days whereas less severe lesions were detected in 60% of the rats if ABT was coadministered. These results are best explained by the Î±-hydroxy acid <b>22a</b> being the toxic agent, although these findings do not preclude diol <b>21a</b> being a minor contributor.</div><div class="NLM_p">Although these findings precluded advancement of <b>18</b> or <b>19</b>, the understanding that the toxicity arose because of formation of a toxic Î±-hydroxy acid dictated future target selection. We replaced the methylcarbinol moieties with functionality that would both disfavor formation of a 1,2-diol metabolite and preclude formation of an Î±-hydroxy acid metabolite by employing two approaches: cyclic alcohols and secondary alcohols not prone to hydroxylation. Most alcohols evaluated were prepared by alkylating nitroguiacol with an appropriate alkyl halide or epoxide. Following catalytic reduction, the resulting aniline was condensed with <b>33</b> either in ethanol at 80 Â°C or in a phenol melt at 130 Â°C. The preparation of <b>27</b> shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> illustrates this route.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, MeOH, 0 Â°C, 59%; (b) DMF, 80 Â°C, 90%; (c) NaBH<sub>4</sub>, EtOH, 96%; (d) chiral chromatography, 93%; (e) H<sub>2</sub>, Pd/C, 100%; (f) phenol, 130 Â°C, 74%; (g) (SEMO)<sub>2</sub>P(NiPr<sub>2</sub>); (h) H<sub>2</sub>O<sub>2</sub>, 95% (steps g and h combined yield); (i) TFA, 0 Â°C, 73%; (j) EtOH, 80 Â°C, 88%.</p></p></figure><div class="NLM_p">Compounds exhibiting <i>K</i><sub>i</sub> < 10 nM and acceptable 24 h PK profiles in SD rats when administered as the amino ester prodrug were evaluated as anorectic agents.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> PK studies with the secondary alcohols <b>23</b>â<b>28</b> eliminated <b>23</b> because of low exposure (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Histopathology examinations following initial efficacy studies with alcohols <b>24</b>â<b>28</b> revealed no evidence for formation of biliary lesions. We attributed the weak anorectic effect of the ethyl sulfone <b>24</b> to poor CNS exposure (brain/plasma ratio was â¼0.05). The trifluoromethyl <b>25</b> and trifluoroethyl <b>26</b> carbinols were not further pursued because the reduction in weight gain exhibited a nonlinear dose dependence and the drug accumulations of 3- to 5-fold by day 5 led to high brain and plasma levels. Encouraged by the promising <i>K</i><sub>i</sub>, AUC, and CNS exposure exhibited by a racemic cyclopropyl carbinol, the two enantiomers <b>27</b> and <b>28</b> were prepared. Although the <i>R</i> and <i>S</i> enantiomers were equally potent MCHR1 inhibitors, the <i>R</i> enantiomer <b>27</b> became the focus of the program because of a superior PK profile (AUC of <b>27</b> when administered as the valine prodrug was â¼3-fold higher than that of <b>28</b>). The absolute configuration of <b>27</b> was assigned following a chiral synthesis of <b>28</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Weight Loss and Exposures in SpragueâDawley Rats Observed after Oral q.d. Administration of Hydroxylated Thienopyrimidinone Ethers as Amino Acid (AA) Prodrug Esters for 4 Days</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0007.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0008.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">Comparable weight loss was observed with young growing SD rats following oral administration of <b>27</b> as either the valine ester prodrug <b>27a</b> or phosphate prodrug ester <b>35</b> as would be expected since both prodrugs were equally efficient noncirculating delivery vehicles. Note that neither prodrug was detected in plasma despite both being stable in plasma. In a 10-day doseâresponse study the reduced weight gain relative to vehicle cohort produced by daily administration of <b>35</b> at 1, 3, 10, and 30 mg/kg was 3.4%, 5.5%, 7.8%, and 10.6%, respectively. An equivalent dose response was obtained after a 28-day study with DIO SD rats. In both sets of studies, 5% reduced weight gain versus vehicle correlated with trough plasma levels equal to 1.2 Î¼M. Given that <b>27</b> is 99.8% bound to rat serum proteins and rat MCHR1 <i>K</i><sub>i</sub> is 7 nM, this finding suggests that trough free drug plasma levels must remain above 0.4 <i>K</i><sub>i</sub> to achieve 5% weight reduction. The anorectic effect appears to be solely MCHR1 mediated, as administration of <b>35</b> at 10 mg/kg for 12 days to WT mice resulted in a 7.6% reduction in body weight whereas MCHR1 KO mice gained 2.5%.</div><div class="NLM_p">FLIPR-based assays established that <b>27</b> was a potent and highly selective MCHR1 functional antagonist. <b>27</b> (<i>K</i><sub>b</sub> = 32 nM) effectively blocked MCH stimulated Ca<sup>2+</sup> mobilization in heterologous cells overexpressing MCHR1 but failed to inhibit MCH mediated Ca<sup>2+</sup> mobilization of cells expressing MCHR2 at 10 Î¼M. No activity was observed upon screening <b>27</b> at 10 Î¼M versus a panel of 20 GPCRs associated with feeding homeostasis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The percent of <b>27</b> bound to serum proteins was species dependent ranging from 99.8%, 99.6%, and 99.3%, respectively, for rat, dog, and monkey; for humans the value was 99.5%. Although <b>27</b> was a weak P-glycoprotein 1 substrate, the high permeability (>100 nm/s) dominated; consequently CNS exposure was adequate resulting in a brain/plasma ratio of 0.66. When screened for CYP activity, EC<sub>50</sub> values for 1A2, 2C9, 2C19, 2D6 were >40 Î¼M; however, the 3A4 EC<sub>50</sub> was 13 Î¼M.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In microsomal preparations <b>27</b> was oxidized by 3A4 to the corresponding cyclopropyl ketone <b>36</b> which was subsequently reduced to generate a mixture of <b>27</b> and <b>28</b>. Microsomal incubations revealed no propensity for conjugation to glutathione. <b>27</b>, <b>28</b>, <b>36</b>, and <b>35</b> exhibited no significant off-target activities; all four compounds exhibited <50% inhibition when evaluated against a panel of 38 receptors, ion channels, or enzymes at 10 Î¼M.</div><div class="NLM_p">Cardiovascular safety studies supported initiating clinical studies with <b>27</b> and <b>35</b>. In the absence of serum proteins, hERG inhibition of 48% and 64% was observed for <b>27</b> at 3 and 10 Î¼M whereas <b>35</b> at 10 Î¼M produced 12% inhibition. The inhibition of the human cardiac Na<sup>+</sup> channel and the L-type Ca<sup>2+</sup> channel produced by <b>27</b> at 10 Î¼M was 20% and 15%, respectively. Studies with purkinje fibers at 30 Î¼M revealed no drug induced effect on action potential duration or resting membrane potentials. In an anesthetized rabbit model, plasma levels of 38 Î¼M caused no drug induced effect on QT or QRS duration. For dogs, plasma levels reaching 7.6 Î¼M <b>27</b> produced no drug related changes in heart rate, blood pressure, or QT.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PK Profile of <b>27</b> in Rat, Dog, and Cynomologous Monkey</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">compound: doseÂ (mg/kg)</th><th class="colsep0 rowsep0" align="center">route of admin</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>Max</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUCÂ (INF) (Î¼molÂ·h)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">CL (mLÂ minâ1Â kg<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>SS</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left"><b>27</b>: 1</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left"><b>35</b>: 3</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">3.3Â Â±Â 1.2</td><td class="colsep0 rowsep0" align="left">26Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left"><b>27</b>: 1</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">17Â Â±Â 5.6</td><td class="colsep0 rowsep0" align="left">32Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">2.3Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="left">4.1Â Â±Â 1.1</td><td class="colsep0 rowsep0" align="left">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left"><b>35</b>: 10</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">1.3Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="left">65Â Â±Â 2.4</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cynomologous monkey</td><td class="colsep0 rowsep0" align="left"><b>27</b>: 1</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">11Â Â±Â 1.9</td><td class="colsep0 rowsep0" align="left">14Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">3.5Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="left">4.0Â Â±Â 1.1</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left"><b>35</b>:Â 10</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 11</td><td class="colsep0 rowsep0" align="left">21Â Â±Â 4.4</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr></tbody></table></div></div><div class="NLM_p last">PK studies using three species (rat, dog, and cynomologous monkey) were conducted with <b>27</b> administered iv at 1 mg/kg and as the phosphate ester prodrug <b>35</b> administered po at 10 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). For all three species no detectable plasma levels of <b>35</b> were observed. Clearance of <b>27</b> was low in all three species, giving rise to the same major metabolites: oxidation to generate the cyclopropyl ketone <b>36</b>, alcohol <b>28</b> from subsequent nonselective reduction of <b>36</b>, and the glucuronides of alcohols <b>27</b> and <b>28</b>. The projected human PK profile based on these findings supported advancement of <b>27</b> into clinical development as the phosphate ester <b>35</b> (BMS-830216). By use of these parameters, a 400 mg dose q.d. of <b>35</b> was projected to generate trough human plasma levels of 1.2 Î¼M <b>27</b> (BMS-819881) corresponding to the trough levels required to produce 5% weight loss in the rat models. Clinical trials were begun with BMS-830216; results will be disclosed in a subsequent publication.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reactions were carried out under a static atmosphere of argon or nitrogen and stirred magnetically unless otherwise noted. All reagents used were of commercial quality and were primarily obtained from Aldrich Chemical Co., Sigma Chemical Co., Lancaster Chemical Co., or Acros Chemical Co. Anhydrous solvents from Aldrich Chemical Co. or EM Science Chemical Co. unless otherwise noted were utilized. <sup>1</sup>H (400 MHz) and <sup>13</sup>C (100 MHz) NMR spectra were recorded on a JEOL GSX400 spectrometer using Me<sub>4</sub>Si as an internal standard unless otherwise noted. <sup>1</sup>H (500 MHz) and <sup>13</sup>C (125 MHz) NMR spectra were recorded on a JEOL JNM-ECP500 spectrometer. Chemical shifts are given in parts per million (ppm) downfield from internal reference Me<sub>4</sub>Si in Î´ units, and coupling constants (<i>J</i>) are given in hertz (Hz). All flash chromatographic separations were performed using E. Merck silica gel (particle size, 0.040â0.063 mm). Reactions were monitored by TLC using 0.25 mm E. Merck silica gel plates (60 F254) and were visualized with UV light or with 5% phosphomolybdic acid in 95% EtOH. LCMS data were recorded on a Shimadzu LC-10AT equipped with a SIL-10A injector and a SPD-10AV detector, normally operating at 220 nm and interfaced with a Micromass ZMD mass spectrometer. LCMS separations were obtained with a Phenomenex reverse phase C18 column 4.6 mm Ã 50 mm, 4 min gradient, 10% MeOH/90% H<sub>2</sub>O/0.1% TFA to 90% MeOH/10% H<sub>2</sub>O/0.1% TFA, 1 min hold, 4 mL/min, UV detection at 220 nm. Analytical HPLC separations typically employed a Phenomenex Luna S5 reverse phase C18 column 4.6 mm Ã 50 mm, 4 min gradient, 10% MeOH/90% H<sub>2</sub>O/0.2% H<sub>3</sub>PO<sub>4</sub> to 90% MeOH/10% H<sub>2</sub>O/0.2% H<sub>3</sub>PO<sub>4</sub>, 1 min hold, 4 mL/min, UV detection at 220 nm. Preparative HPLC purifications entailed gradient elution from a Phenomenex Luna AXIA column using an appropriate mixture of 10% MeOH/90% H<sub>2</sub>O/0.1% TFA to 90% MeOH/10% H<sub>2</sub>O/0.1% TFA. On occasion, mixtures of 10% MeCN/90% H<sub>2</sub>O/0.1% TFA and 90% MeCN/10% H<sub>2</sub>O/0.1% TFA were employed. If the molecule contained an acid sensitive component, the TFA was omitted. Purity for all compounds was greater than 95% as determined by LCMS analysis..</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Preparation of <b>18</b></h3><div class="NLM_p">To a solution of Ph<sub>3</sub>P (23.3 g, 88.7 mmol) in 450 mL of THF cooled to 0 Â°C was added a solution of di-<i>tert</i>-butyl azodicarboxylate (20.4 g, 88.7 mmol) in 50 mL of THF over 15 min. After the mixture was stirred at 0 Â°C for 10 min, 4-nitroguaiacol (10.0 g, 59.1 mmol) was added followed by (<i>S</i>)-glycidol (6.3 mL, 94.6 mmol) over 10 min. The mixture was allowed to warm to room temperature and was stirred for 2 h prior to removal of the volatiles under vacuum. The residue was dissolved in EtOAc, washed with H<sub>2</sub>O and brine, dried over anhydrous MgSO<sub>4</sub>, and filtered. After concentration under reduced pressure, the residue was purified by flash chromatography (silica gel, hexanes/EtOAc, 100:0 to 1:3 gradient). Impure fractions were concentrated under reduced pressure and further purified by flash chromatography (silica gel, hexanes/EtOAc, 100:0 to 0:100 gradient). Pure fractions from both columns were combined and concentrated under reduced pressure to afford 9.58 g (72%) of (<i>R</i>)-2-((2-methoxy-4-nitrophenoxy)methyl)oxirane as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 2.78â2.80 (m, 1H), 2.94â2.96 (m, 1H), 3.40â3.43 (m, 1H), 3.96 (s, 3H), 4.06â4.11 (m, 1H), 4.41â4.44 (m, 1H), 6.98 (d, <i>J</i> = 8.79 Hz, 1H), 7.75 (d, <i>J</i> = 2.20 Hz, 1H), 7.89 (dd, <i>J</i> = 8.79 Hz, 2.19 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 28.20, 44.57, 49.75, 56.28, 70.17, 106.80, 111.71, 117.50, 141.92, 149.20, 153.38. HPLC: 2.09 min retention time. LCMS (ES): <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>.</div><div class="NLM_p">To 160 mL of Et<sub>2</sub>O cooled to 0 Â°C was added LiClO<sub>4</sub> (80 g, 752 mmol) in portions over 20 min. The mixture was allowed to warm to room temperature prior to addition of (<i>R</i>)-2-((2-methoxy-4-nitrophenoxy)methyl)oxirane (9.55 g, 42.5 mmol). After the mixture was stirred for 10 min, BH<sub>3</sub>-NHMe<sub>2</sub> (3.40 g, 46.6 mmol) was added, and the suspension was stirred at room temperature for 2.5 h. The suspension was diluted with CH<sub>2</sub>Cl<sub>2</sub> and stirred in a beaker with H<sub>2</sub>O until gas evolution ceased. The organic layer was washed with H<sub>2</sub>O, dried over anhydrous MgSO<sub>4</sub>, and filtered prior to concentration under reduced pressure. The residue was triturated in CH<sub>2</sub>Cl<sub>2</sub>, filtered, and purified by flash chromatography (silica gel, hexanes/EtOAc, 100:0 to 100:0 gradient) to afford 6.83 g (70%) of (<i>R</i>)-1-(2-methoxy-4-nitrophenoxy)propan-2-ol as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.31 (d, <i>J</i> = 6.59 Hz, 3H), 2.77 (br s, 1H), 3.90â3.94 (m, 4H), 4.05â4.08 (m, 1H), 4.24â4.32 (m, 1H), 6.92 (d, <i>J</i> = 9.35 Hz, 1H), 7.74 (d, <i>J</i> = 2.75 Hz, 1H), 7.88 (dd, <i>J</i> = 8.79 Hz, 2.74 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 18.64, 56.18, 65.87, 74.85, 106.73, 111.66, 117.60, 141.76, 149.20, 153.63. HPLC: 2.17 min retention time. LCMS (ES): <i>m</i>/<i>z</i> 228 [M + H]<sup>+</sup>.</div><div class="NLM_p">A stirred EtOH suspension (100 mL) containing (<i>R</i>)-1-(2-methoxy-4-nitrophenoxy)propan-2-ol (6.0 g, 26.4 mmol) and 10% Pd/C (0.15 g) was hydrogenated under 60 psi of H<sub>2</sub> for 5 h. HPLC analysis revealed no starting nitrocatechol ether remained. After filtration through a pad of Celite under a blanket of N<sub>2</sub>, the resultant red solution was immediately concentrated using a rotary evaporator under vacuum to yield 6.4 of (<i>R</i>)-1-(2-methoxy-4-aminophenoxy)propan-2-ol as a dark oil which was used without further purification.</div><div class="NLM_p last">Following the literature procedure for preparation of the thienopyrimidinones,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (<i>R</i>)-1-(2-methoxy-4-aminophenoxy)propan-2-ol (26.4 mmol) was condensed with methyl 5-(4-chlorophenyl)-3-((dimethylamino)methyleneamino)thiophene-2-carboxylate <b>33</b> (8.8 g mg, 24 mmol) by heating an EtOH solution (36 mL) of the two components at reflux for 15 h. Upon cooling and filtration, <b>18</b> (8.2 g, 77%) was isolated as a white solid after washing with Et<sub>2</sub>O and air drying. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 1.16 (d, <i>J</i> = 6.05 Hz, 3H), 3.77â3.82, (m, 4H), 3.88â3.91 (m, 1H), 3.94â4.02 (m, 1H), 4.89 (d, <i>J</i> = 4.39 Hz, 1H), 7.03 (dd, <i>J</i> = 8.79 Hz, 1.64 Hz, 1H), 7.10 (d, <i>J</i> = 8.25 Hz, 1H), 7.18 (d, <i>J</i> = 1.65 Hz, 1H), 7.57 (d, <i>J</i> = 8.25 Hz, 2H), 7.92 (d, <i>J</i> = 8.25 Hz, 2H), 7.97 (s, 1H), 8.39 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 20.03, 55.58, 64.21, 73.88, 111.63, 112.68, 119.43, 121.56, 121.84, 127.66, 129.10, 129.57, 131.02, 134.09, 148.27, 148.80, 149.32, 149.60, 155.91, 157.23. [Î±]<sub>589</sub> = â10.1Â° at 23 Â°C for 12.3 mg in 1 mL CH<sub>2</sub>Cl<sub>2</sub>. HPLC: 3.64 min retention time, (100%). LCMS (ES): <i>m</i>/<i>z</i> 443 [M + H]<sup>+</sup>.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Preparation of <b>19</b></h3><div class="NLM_p">A steel bomb with â¼55 mL capacity, fitted with an internal thermocouple, pressure gauge, and safety release valve rated at 3000 psi, was charged with the potassium salt of 2-methoxy-4-nitrophenol (6g, 29 mmol), NaH<sub>2</sub>PO<sub>4</sub> (3.3 g, 27.7 mmol), isobutylene oxide (2.8 g, 35 mmol), and 30 mL of 15% H<sub>2</sub>O/MeCN. The sealed bomb was heated at 170 Â°C for 3 h. Following cooling, HPLC revealed all starting phenol had been converted to product. The biphasic solution was concentrated using a rotary evaporator before being partitioned between CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O. The aqueous phase was extracted 3Ã with CH<sub>2</sub>Cl<sub>2</sub>; the combined CH<sub>2</sub>Cl<sub>2</sub> fractions were washed 3Ã with aqueous KHCO<sub>3</sub>/K<sub>2</sub>CO<sub>3</sub> and once with H<sub>2</sub>O. After drying over Na<sub>2</sub>SO<sub>4</sub>, concentration under vacuum yielded 6.9 g of 1-(2-methoxy-4-nitrophenoxy)-2-methylpropan-2-ol as a tan solid. (Buffering with NaH<sub>2</sub>PO<sub>4</sub> is essential to prevent reversion of the product to starting phenol as the pH will increase during the reaction if unbuffered. Note that even for small scale reactions, temperatures greater than 180 Â°C should be avoided to minimize the probability of explosive decomposition, since the potassium salt of 2-chloro-4-nitrophenol rapidly decomposes at â¼210 Â°C producing gaseous products.) <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.42 (s, 6H), 2.5 (s, 1H), 3.91 (s, 3H), 3.94 (s, 3H), 6.90 (d, <i>J</i> = 9 Hz, 1H), 7.74 (d, <i>J</i> = 2 Hz, 1H), 7.87 (dd, <i>J</i> = 2 and 9 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 26.02, 56.18, 70.00, 77.42, 106.77, 111.74, 117.56, 141.73, 149.37, 153.95. HPLC: 3.26 min retention time (99% API). LCMS (ES): <i>m</i>/<i>z</i> 242.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">A stirred EtOH suspension (320 mL) containing 1-(2-methoxy-4-nitrophenoxy)-2-methylpropan-2-ol (13.6 g, 56.4 mmol) and 10% Pd/C (0.25 g) was hydrogenated under 60 psi of H<sub>2</sub> for 6 h. HPLC analysis revealed no starting nitroarene remained. After filtration through a fiberglass filter paper under a blanket of N<sub>2</sub>, the resultant clear wine colored solution was immediately concentrated using a rotary evaporator under vacuum to yield 12.4 g of desired 1-(2-methoxy-4-aminophenoxy)-2-methylpropan-2-ol as a dark orange oil which was used without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.29 (s, 6H), 3.40, (br s, 2H), 3.74 (s, 2H), 3.78 (s, 3H), 6.20 (dd, <i>J</i> = 8.35 Hz, 2.64 Hz, 1H), 6.28 (d, <i>J</i> = 2.64 Hz, 1H), 6.76 (d, <i>J</i> = 8.35 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 25.90, 55.67, 70.02, 80.30, 100.76, 106.81, 118.27, 141.55, 141.93, 150.99. HPLC: 0.88 min retention time. LCMS (ES): <i>m</i>/<i>z</i> 212.1 [M + H].</div><div class="NLM_p last">The above product (12g, 57 mmol) was condensed with <b>33</b> (21g, 65 mmol) by heating overnight in refluxing EtOH, as described for the preparation of <b>18</b>. Upon cooling, <b>19</b> was isolated as a white solid ((20.1 g, 80%) following filtration, washing with Et<sub>2</sub>O, and air drying. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.38 (s, 6H), 2.74, (s, 1H), 3.87 (s, 3H), 3.89 (s, 2H), 6.93 (dd, <i>J</i> = 8.25 Hz, 2.20 Hz, 1H), 6.96 (d, <i>J</i> = 2.20 Hz, 1H), 7.01 (d, <i>J</i> = 8.25 Hz, 1H), 7.44 (d, <i>J</i> = 8.79 Hz, 2H), 7.52 (s, 1H), 7.65 (d, <i>J</i> = 8.80 Hz, 2H), 8.14 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 26.02, 56.11, 70.08, 78.05, 111.19, 114.49, 119.20, 120.82, 123.19, 127.61, 129.43, 130.46, 131.50, 135.66, 148.16, 149.35, 150.30, 151.64, 155.77, 157.34. HPLC: 4.29 min retention time, (99% API). LCMS (ES): <i>m</i>/<i>z</i> 457 [M + H].</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Preparation of Amino Acid Ester Prodrugs of <b>18</b> and <b>19</b> and Analogs</h3><div class="NLM_p">The following procedure, illustrated by the conversion of <b>18</b> to the valine ester prodrug, was employed to prepare all amino ester prodrugs of all alcohols except for the glycine ester prodrug of tertiary alcohols. A mixture of the alcohol <b>18</b> (50 mg, 0.113 mmol), diisopropylcarbodiimide (21 Î¼L, 0.135 mmol), 4-dimethylaminopyridine (1 mg, 0.011 mmol), and <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valine (29 mg, 0.135 mmol) in 1 mL of CH<sub>2</sub>Cl<sub>2</sub> was stirred at room temperature for 1 h before additional diisopropylcarbodiimide (5 Î¼L, 0.032 mmol) and <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valine (5 mg, 0.023 mmol) were added. After stirring at room temperature for 3.5 h, the suspension was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 100:0 to 98:2 gradient) to afford the desired BOC protected valine ester (76 mg) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 0.90â0.95 (m, 3H), 0.97â1.02 (m, 3H), 1.40 (d, 3H), 1.45 (s, 9H), 2.15â2.19 (m, 1H), 3.86 (d, 3H), 4.05â4.27 (m, 3H), 5.05â5.08 (m, 1H), 5.35â5.41 (m, 1H), 6.92â6.96 (m, 2H), 7.00â7.05 (m, 1H), 7.45 (d, <i>J</i> = 8.79 Hz, 2H), 7.54 (s, 1H), 7.66 (d, <i>J</i> = 8.80 Hz, 2H), 8.15 (d, 1H). HPLC: 4.73 min retention time, (99%). LCMS (ES): <i>m</i>/<i>z</i> 642 [M + H].</div><div class="NLM_p last">The above BOC amine was dissolved in a 1:2 mixture of TFA/CH<sub>2</sub>Cl<sub>2</sub> (1 mL). By HPLC analysis after 1 h at 20 Â°C, the reaction was complete, whereupon the volatiles were removed under vacuum. The residue upon dissolution in CH<sub>2</sub>Cl<sub>2</sub> was washed 2Ã with aqueous NaHCO<sub>3</sub>/Na<sub>2</sub>CO<sub>3</sub> followed by brine prior to drying over Na<sub>2</sub>SO<sub>4</sub>. Upon concentration, 65 mg (94%) of the desired valine prodrug was obtained. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 0.97â1.01 (m, 6H), 1.34â1.36 (m, 3H), 2.11â2.18 (m, 1H), 3.75 (d, 3H), 3.94â3.97 (m, 1H), 4.09â4.21 (m, 2H), 5.29â5.37 (m, 1H), 7.04â7.07 (m, 1H), 7.12â7.16 (m, 1H), 7.20â7.23 (m, 1H), 7.58 (d, <i>J</i> = 8.25 Hz, 2H), 7.92 (d, <i>J</i> = 8.80 Hz, 2H), 7.98 (s, 1H), 8.34 (br s, 3H), 8.39 (s, 1H). HPLC: 3.07 min. MS (ES): <i>m</i>/<i>z</i> 542 [M + H]<sup>+</sup>.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Preparation of the Glycine Ester Prodrug of <b>19</b></h3><div class="NLM_p">To a solution of <b>19</b> (0.96 g, 2.11 mmol), 4-pyrrolidinopyridine (0.31 g, 2.11 mmol), and <i>N</i>-(<i>tert</i>-butoxycarbonyl)glycine (1.11 g, 6.33 mmol) in 20 mL of refluxing CH<sub>2</sub>Cl<sub>2</sub> was added diisopropylcarbodiimide (0.98 mL, 6.33 mmol) over 3 h via syringe pump. After heating the suspension at reflux for 1 h, additional <i>N</i>-(<i>tert</i>-butoxycarbonyl)glycine (0.55 g, 3.17 mmol) was added followed by diisopropylcarbodiimide (0.55 mL, 3.17 mmol) over 2 h via syringe pump. The suspension was heated at reflux for 1 h prior to cooling to room temperature. (Note: Acylation of the tertiary alcohol was accompanied by a second acylation to extensively convert the desired product to an imide which could be converted back to the desired prodrug by careful treatment with hydrazine.)</div><div class="NLM_p">Hydrazine monohydrate (0.34 mL, 7.01 mmol) was added and the suspension stirred at room temperature for 2 h. The suspension was cooled to 0 Â°C, filtered and the filtrate washed with cold 1 N HCl, cold dilute NaHCO<sub>3</sub> solution, dried over anhydrous MgSO<sub>4</sub>, and filtered. After concentrating the filtrate under reduced pressure, the residue was purified by flash chromatography (silica gel, EtOAc/hexanes, 0:100 to 1:1 gradient) to afford 1.37 g (100%) of the title compound as an off-white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.24 (t, 3H), 1.45 (s, 9H), 1.64 (s, 6H), 2.68â2.73 (m, 2H), 3.85 (d, <i>J</i> = 4.95 Hz, 2H), 4.18 (s, 2H), 4.98 (br s, 1H), 6.92 (d, <i>J</i> = 9.35 Hz, 1H), 7.20â7.22 (m, 2H), 7.44 (d, <i>J</i> = 8.79 Hz, 2H), 7.53 (s, 1H), 7.66 (d, <i>J</i> = 8.25 Hz, 2H), 8.13 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 13.68, 23.39, 23.67, 28.28, 42.87, 72.72, 79.86, 81.86, 111.48, 120.82, 123.25, 125.42, 127.62, 129.42, 129.67, 131.54, 134.25, 135.59, 148.29, 151.50, 155.58, 156.69, 156.92, 157.37, 169.47. HPLC: 4.80 min retention time. LCMS (ES): <i>m</i>/<i>z</i> 612 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Following the procedure described for the generalized preparation of prodrugs, the BOC group was cleaved and the glycine prodrug isolated as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.24 (t, 3H), 1.48 (br s, 2H), 1.64 (s, 6H), 2.68â2.74 (m, 2H), 3.38 (s, 2H), 4.19 (s, 2H), 6.93 (d, <i>J</i> = 9.34 Hz, 1H), 7.19â7.22 (m, 2H), 7.44 (d, <i>J</i> = 8.79 Hz, 2H), 7.52 (s, 1H), 7.66 (d, <i>J</i> = 8.80 Hz, 2H), 8.12 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 13.68, 23.42, 23.75, 44.54, 72.72, 81.02, 111.43, 120.82, 123.22, 125.45, 127.62, 129.42, 129.62, 131.54, 134.17, 135.59, 148.27, 151.50, 156.77, 156.92, 157.37, 173.56. HPLC: 3.27 min retention time, (100%). LCMS (ES): <i>m</i>/<i>z</i> 512 [M + H]<sup>+</sup>.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Preparation of Half Oxalate Ester Prodrugs</h3><div class="NLM_p">To oxalyl chloride (0.50 mL, 5.91 mmol) cooled to 0 Â°C was added <i>tert</i>-butanol (0.28 mL, 2.95 mmol) over 30 min. After warming the solution to room temperature and concentration under reduced pressure, the residue was dissolved in 1 mL of CH<sub>2</sub>Cl<sub>2</sub> whereupon <b>19</b> (100 mg, 0.219 mmol) and pyridine (42 Î¼L, 0.522 mmol) were added. After the suspension was stirred at room temperature for 1.5 h, the solution was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with 1 N HCl and brine, dried over anhydrous MgSO<sub>4</sub>, and filtered. The filtrate was concentrated under reduced pressure prior to purification of the residue by flash chromatography (silica gel, hexanes/EtOAc, 100:0 to 1:1 gradient) to afford 120 mg (94%) of the desired of <i>tert</i>-butyl 1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-yl oxalate as a white foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.55 (s, 9H), 1.70 (s, 6H), 3.87 (s, 3H), 4.24 (s, 2H), 6.92 (dd, <i>J</i> = 8.25 Hz, 2.20 Hz, 1H), 6.96 (d, <i>J</i> = 2.20 Hz, 1H), 7.04 (d, <i>J</i> = 8.24 Hz, 1H), 7.44 (d, <i>J</i> = 8.79 Hz, 2H), 7.53 (s, 1H), 7.65 (d, <i>J</i> = 8.79 Hz, 2H), 8.13 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 23.14, 27.74, 56.36, 74.39, 84.26, 84.51, 111.76, 115.30, 119.27, 120.84, 123.22, 127.65, 129.47, 130.78, 131.54, 135.67, 148.19, 149.25, 150.64, 151.63, 156.77, 157.22, 157.35, 157.60. HPLC: 4.40 min retention time, (100%). MS (ES): <i>m</i>/<i>z</i> 585 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-yloxalate (124 mg, 0.212 mmol) in 0.5 mL of TFA and 1 mL of CH<sub>2</sub>Cl<sub>2</sub> was stirred at room temperature for 1.5 h. The solution was concentrated under reduced pressure to afford 102 mg (91%) of the oxalate prodrug as a white foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.70 (s, 6H), 3.86 (s, 3H), 4.30 (s, 2H), 6.91â6.94 (m, 2H), 7.09 (d, <i>J</i> = 8.80 Hz, 1H), 7.45 (d, <i>J</i> = 8.79 Hz, 2H), 7.66â7.69 (m, 3H), 8.74 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 22.76, 56.26, 74.60, 85.93, 111.25, 116.62, 119.30, 122.64, 127.93, 129.47, 129.70, 130.35, 136.86, 148.88, 151.00, 151.55, 155.17, 155.98, 157.04, 158.59, 159.55, 159.95. HPLC: 4.13 min retention time, (99%). MS (ES): <i>m</i>/<i>z</i> 529 [M + H]<sup>+</sup>.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Preparation of Half Malonate Ester Prodrugs</h3><div class="NLM_p">A suspension of <b>19</b> (100 mg, 0.219 mmol), 3-<i>tert</i>-butoxy-3-oxopropanoic acid (83 Î¼L, 0.538 mmol), diisopropylcarbodiimide (83 Î¼L, 0.538 mmol), and 4-<i>N</i>,<i>N</i>-dimethylaminopyridine (27 mg, 0.219 mmol) in 1 mL of CH<sub>2</sub>Cl<sub>2</sub> was stirred at room temperature for 17 h. After additional 3-<i>tert</i>-butoxy-3-oxopropanoic acid (83 Î¼L, 0.538 mmol) and diisopropylcarbodiimide (83 Î¼L, 0.538 mmol) were added, the suspension was stirred at room temperature for 3 h. The suspension was diluted with CH<sub>2</sub>Cl<sub>2</sub> and filtered, whereupon the filtrate was washed with 1 N HCl, saturated aqueous NaHCO<sub>3</sub>, and brine, dried over anhydrous MgSO<sub>4</sub>, and filtered. The residue, obtained after concentration of the filtrate, was purified by flash chromatography (silica gel, hexanes/EtOAc, 100:0 to 1:1 gradient) to afford 104 mg (79%) of <i>tert</i>-butyl 1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-yl malonate as a beige foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.47 (s, 9H), 1.64 (s, 6H), 3.23 (s, 2H), 3.87 (s, 3H), 4.20 (s, 2H), 6.91 (dd, <i>J</i> = 8.24 Hz, 2.20 Hz, 1H), 6.95 (d, <i>J</i> = 2.20 Hz, 1H), 7.02 (d, <i>J</i> = 8.24 Hz, 1H), 7.44 (d, <i>J</i> = 8.24 Hz, 2H), 7.53 (s, 1H), 7.66 (d, <i>J</i> = 8.80 Hz, 2H), 8.13 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 23.37, 27.92, 44.04, 56.23, 74.44, 81.83, 82.01, 111.53, 114.75, 119.20, 120.87, 123.22, 127.65, 129.47, 130.51, 131.54, 135.67, 148.19, 149.30, 150.49, 151.63, 156.79, 157.40, 165.85, 166.20. HPLC: 4.46 min retention time, (97%). MS (ES): <i>m</i>/<i>z</i> 599 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Treatment with TFA employing previously described conditions yielded the malonate prodrug. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.65 (s, 6H), 3.23 (s, 2H), 3.89 (s, 3H), 4.32 (s, 2H), 6.91â6.94 (m, 2H), 7.09 (d, <i>J</i> = 8.80 Hz, 1H), 7.45 (d, <i>J</i> = 8.24 Hz, 2H), 7.55 (s, 1H), 7.65 (d, <i>J</i> = 8.79 Hz, 2H), 8.22 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 22.89, 42.14, 56.20, 75.00, 83.88, 111.58, 116.26, 119.60, 120.54, 122.82, 127.72, 129.52, 130.00, 131.32, 135.95, 148.09, 149.58, 150.82, 152.62, 157.40, 157.58, 166.43, 167.52. HPLC: 4.22 min retention time. MS (ES): <i>m</i>/<i>z</i> 529 [M + H]<sup>+</sup>.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Preparation of Half Succinate Ester Prodrugs</h3><div class="NLM_p last">To a mixture of <b>19</b> (140 mg, 0.306 mmol) and DMAP (56 mg, 0.459 mmol) in DMA (0.6 mL) at 140 Â°C was added succinic anhydride (183 mg, 1.83 mmol) over 5 h. The reaction mixture was stirred at 140 Â°C for an additional 2 h and was then cooled to room temperature. After dilution with CH<sub>2</sub>Cl<sub>2</sub>, the crude product was purified using silica gel chromatography. Elution with CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>/MeCN/HOAc (90:5:5) afforded partially purified product which was recrystallized from EtOH to yield pure succinate prodrug 4-(1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-yloxy)-4-oxobutanoic acid, (90 mg, 53% yield) as an off-white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ ppm 2.48â2.57 (m, 4 H), 3.90 (s, 3 H), 4.32 (s, 2 H), 6.89â6.96 (m, 2 H), 7.03 (d, <i>J</i> = 8.14 Hz, 1 H), 7.15â7.21 (m, 1 H), 7.45 (d, <i>J</i> = 8.65 Hz, 2 H), 7.54 (s, 1 H), 7.66 (d, <i>J</i> = 8.65 Hz, 2 H), 8.16 (s, 1 H). HPLC: 4.71 min retention time. MS (ES): <i>m</i>/<i>z</i> 557 [M + H]<sup>+</sup>.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Preparation of Half Glutarate Ester Prodrugs</h3><div class="NLM_p last">A solution of <b>18</b> (100 mg, 0.225 mmol) in DMF (1 mL) was added to a solution of sodium hydride (8.1 mg, 0.338 mmol) in DMF (2 mL). The mixture was stirred at room temperature for 30 min. Glutaric anhydride (129 mg, 1.128 mmol) was then added, and stirring was continued at room temperature for 18 h. The reaction mixture was poured into a solution of 1.0 N HCl (40 mL) and extracted with EtOAc (30 mL). The EtOAc layer was dried over sodium sulfate and concentrated. The crude product was purified by prep-HPLC (ODS, waterâMeOH_TFA 90:10:0.1 to 10:90:0.1 gradient) to yield the glutarate prodrug, (<i>R</i>)-5-(1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)propan-2-yloxy)-5-oxopentanoic acid (114 mg, white solid). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ ppm 1.81â1.92 (m, 2 H), 2.31 (q, 4 H), 3.89 (s, 3 H), 4.25 (s, 2 H), 6.88â6.96 (m, 2 H), 7.04 (d, <i>J</i> = 8.65 Hz, 1 H), 7.15â7.21 (m, 1 H), 7.45 (d, <i>J</i> = 8.65 Hz, 2 H), 7.54 (s, 1 H), 7.66 (d, <i>J</i> = 8.65 Hz, 2 H), 8.16 (s, 1 H). HPLC: 3.50 min retention time. MS (ES): <i>m</i>/<i>z</i> 557 [M + H]<sup>+</sup>.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Preparation of Glucoside Prodrugs</h3><div class="NLM_p">To a mixture of <b>18</b> (100 mg, 0.225 mmol), silver carbonate (311 mg, 1.12 mmol), and 4 Ã molecular sieves (500 mg) in chloroform (7 mL) was slowly added a solution of acetobromo-Î²-<span class="smallcaps smallerCapital">d</span>-glucose (232 mg, 0.564 mmol) in CHCl<sub>3</sub> (3 mL). The reaction mixture was stirred at reflux for 48 h. After removal of the precipitated material by filtration, the filtrate was concentrated and subjected to ISCO flash chromatography (silica gel/hexaneâEtOAc 100:0 to 0:100 gradient) to obtain the tetraacetate (139 mg, 80% yield) as a brown gum.</div><div class="NLM_p last">To a solution of the tetraacetate (60 mg, 0.077 mmol) in MeOH (1 mL) was added a NaOMe solution freshly prepared by reaction of Na metal (75 mg, 3.12 mmol) with MeOH (3 mL). After stirring at room temperature for 1.5 h, the mixture was concentrated, dissolved in H<sub>2</sub>O (10 mL), and loaded onto an ODS column (10 g). The column was initially eluted with H<sub>2</sub>O followed by a progressively increasing MeOH/H<sub>2</sub>O gradient to elute the glucoside prodrug, (<i>R</i>)-6-(4-chlorophenyl)-3-(3-methoxy-4-(2-((2<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yloxy)propoxy)phenyl)thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (39 mg, 83% yield) as a white solid. <sup>1</sup>H NMR (MeOD) Î´ ppm 1.20â1.32 (m, 3 H), 3.06â3.15 (m, 1 H), 3.24â3.32 (m, 1 H), 3.52â3.63 (m, 1 H), 3.68â3.82 (m, 5 H), 3.90â4.04 (m, 2 H), 4.11â4.30 (m, 2 H), 4.33â4.59 (m, 1 H), 6.88â6.95 (m, 1 H), 7.02â7.10 (m, 2 H), 7.39â7.45 (m, 2 H), 7.59â7.64 (m, 1 H), 7.69â7.76 (m, 2 H), 8.22â8.29 (m, 1 H). HPLC: 2.65 min retention time. MS (ES): <i>m</i>/<i>z</i> 605 [M + H]<sup>+</sup>.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Preparation of Phosphate Prodrugs</h3><div class="NLM_p">A suspension of <b>19</b> (3.00 g, 6.56 mmol), 1,2,4-triazole (1.36 g, 19.7 mmol), and dibenzyl <i>N</i>,<i>N</i>-diisopropylphosphoramidite (6.62 mL, 19.7 mmol) in 40 mL of CH<sub>2</sub>Cl<sub>2</sub> was heated at reflux for 16 h. The solution was cooled to room temperature, whereupon 30% H<sub>2</sub>O<sub>2</sub> in water (4.00 mL, 35.3 mmol) was added. After stirring at room temperature for 2.5 h, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with 1 M sodium metabisulfite, 1 N HCl, water, and brine, dried over anhydrous MgSO<sub>4</sub>, and filtered. After concentration of the filtrate under reduced pressure, the residue was purified by flash chromatography (silica gel, hexanes/EtOAc, 100:0 to 0:100 gradient) to afford 3.79 g (80%) of dibenzyl 1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-yl phosphate as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.65 (s, 6H), 3.75 (s, 3H), 4.07 (s, 2H), 5.04â5.06 (m, 4H), 6.87â6.96 (m, 3H), 7.29â7.35 (m, 10H), 7.44 (d, <i>J</i> = 8.24 Hz, 2H), 7.53 (s, 1H), 7.66 (d, <i>J</i> = 8.25 Hz, 2H), 8.10 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 22.56, 25.04, 56.08, 68.98, 69.03, 75.36, 82.87, 111.30, 113.91, 119.15, 120.87, 127.42, 127.67, 127.88, 128.33, 128.48, 129.47, 130.33, 131.54, 135.69, 136.07, 148.19, 149.10, 150.19, 151.63, 156.79, 157.37. HPLC: 4.85 min retention time, (100%). MS (ES): <i>m</i>/<i>z</i> 717 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of dibenzyl 1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-ylphosphate (166 mg, 0.231 mmol) in 2 mL of TFA and 0.11 mL of water was stirred at room temperature for 2 h. The solution was diluted with methanol and concentrated under reduced pressure. The residue was purified by prep-HPLC to afford 59 mg (48%) of the phosphate prodrug 1-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-2-methylpropan-2-yl dihydrogen phosphate as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 1.52 (s, 6H), 3.79 (s, 3H), 4.03 (s, 2H), 7.04â7.12 (m, 2H), 7.20 (s, 1H), 7.57 (d, <i>J</i> = 8.25 Hz, 2H), 7.91 (d, <i>J</i> = 8.80 Hz, 2H), 7.96 (s, 1H), 8.39 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 25.00, 56.42, 75.75, 79.18, 112.54, 113.80, 120.13, 122.12, 122.40, 128.25, 129.66, 130.47, 131.61, 134.67, 148.84, 149.52, 149.88, 150.18, 156.48, 157.82. HPLC: 3.73 min retention time, (98%). MS (ES): <i>m</i>/<i>z</i> 537 [M + H]<sup>+</sup>.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Preparation of <b>27</b></h3><div class="NLM_p">Following the procedure described by Calverley,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Br<sub>2</sub> (21.72 mL, 422 mmol) was added over 5 min to a solution of 1-cyclopropylethanone (35.44 g, 421 mmol) in MeOH (250 mL) at 0 Â°C. After removal of the ice bath, the mixture was stirred at 20 Â°C for another 0.5 h, whereupon 30 mL of water was added. After stirring an additional 15 min, 90 mL water was added prior to extraction of the resulting mixture with 200 mL of Et<sub>2</sub>O (4Ã). The combined organic layers were sequentially washed with 1 M Na<sub>2</sub>CO<sub>3</sub> (150 mL) and brine (100 mL) and dried over anhydrous MgSO<sub>4</sub>. After filtration, the filtrate was concentrated using a rotary evaporator prior to distillation at 13 mmHg to yield 40.9 g (59%) of <b>29</b>, 2-bromo-1-cyclopropylethanone, as a colorless oil, bp 58â62 Â°C. <sup>1</sup>H NMR (500 MHz, (CDCl<sub>3</sub>) Î´ 0.95â1.03 (m, 2H), 1.08â1.15 (m, 2H), 2.13â2.21 (m, 1H), 4.00 (s, 2H)</div><div id="sec3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-Cyclopropyl-2-(2-methoxy-4-nitrophenoxy)ethanone <b>30</b></h4><div class="NLM_p last">An orange suspension of 4-nitroguaiacol potassium salt hydrate (31.7 g, 153 mmol) and <b>29</b> (29.4 g, 180 mmol) in DMF (310 mL) was heated at 80 Â°C for 1 h. The resulting yellow reaction mixture was diluted with H<sub>2</sub>O (932 mL) and stirred for 4 h at 20 Â°C. Subsequent filtration yielded a yellow filter cake which after washing 3Ã with 150 mL of H<sub>2</sub>O and air drying yielded 34.6 g (90%) of 1-cyclopropyl-2-(2-methoxy-4-nitrophenoxy)ethanone as a light yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 0.95â1.03 (m, 2H), 1.13â1.18 (m, 2H), 2.15â2.23 (m, 1H), 3.95 (s, 3H), 4.86 (s, 2H), 6.73 (d, <i>J</i> = 8.7 Hz, 1H), 7.75 (d, <i>J</i> = 2.7 Hz, 1H), 7.82 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 205.2, 152.7, 149.1, 117.3, 111.6, 106.9, 73.5, 56.3, 17.1, 12.0. HPLC: 2.98 min retention time. LCMS: <i>m</i>/<i>e</i> 252.3 (M + H); 4 min gradient, 2.35 min retention.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>R</i>)-1-Cyclopropyl-2-(2-methoxy-4-nitrophenoxy)ethanol <b>31</b></h4><div class="NLM_p">To a yellow suspension of <b>30</b> (34.6 g, 138 mmol) in 356 mL of EtOH at 0 Â°C was added NaBH<sub>4</sub> (3.1 g, 82 mmol) over 15 min. After removal of the ice bath, the temperature was not allowed to exceed 20 Â°C while the mixture was stirred for an 35 additional min. The stirred mixture was cooled to â¼10 Â°C prior to cautious slow addition of HOAc (12 mL, 210 mmol). After stirring for 0.5 h once gas evolution had ceased, the yellow suspension was concentrated under vacuum to remove â¼300 mL of EtOH. The resulting precipitate was collected by filtration, washed with H<sub>2</sub>O, and air-dried to yield a light yellow solid (28.7 g). Filtration, after further concentration of the filtrate to remove most of the EtOH, yielded an additional 4.9 g of desired product. The two fractions were combined to yield 33.6 g (96%) of racemic 1-cyclopropyl-2-(2-methoxy-4-nitrophenoxy)ethanol.</div><div class="NLM_p last">Racemic 1-cyclopropyl-2-(2-methoxy-4-nitrophenoxy)ethanol (45.1 g, mmol) in 2/1 MeCN/<i>i</i>-PrOH (451 mL) was resolved by chiral chromatography resolution using a Chiralpak AD-H (3 cm Ã 25 cm, 5 Î¼m) column under the chiral-SFC conditions. The chromatographic conditions employed an 85/15 mixture of CO<sub>2</sub>/<i>i</i>-PrOH as the mobile solvent with a flow rate of 130 mL/min at 35 Â°C with the BPR pressure maintained at 100 bar and detector wavelength at 234 nm. Each 0.7 mL injection required a run time of 7 min. The chiral purity of the <i>R</i> enantiomer was determined using analytical SFC conditions to be greater than 99.9% at 234 nm based on SFC/UV area %. Concentration of the resultant eluant under vacuum followed by subsequent dissolution in 150 mL of EtOH and reconcentration yielded a yellow oil which solidified to form a light yellow solid (20.9 g, 93%) upon drying under high vacuum overnight. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 0.30â0.37 (m, 1H), 0.42â0.50 (m, 1H), 0.55â0.69 (m, 2H), 0.97â1.08 (m, 1H), 2.40â2.70 (bs, 1H), 3.41 (ddd, <i>J</i> = 8.3, 8.3, 2.7 Hz, 1H), 3.93 (s, 3H), 4.10 (dd, <i>J</i> = 9.3, 8.0 Hz, 1H), 4.23 (dd, <i>J</i> = 9.3, 2.7 Hz, 1H), 6.95 (d, <i>J</i> = 8.8 Hz, 1H), 7.74 (d, <i>J</i> = 2.2 Hz, 1H), 7.89 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H). <sup>13</sup>C NMR (125 MHz, <i>CDCl</i><sub>3</sub>) Î´ 153.7, 149.2, 141.7, 117.6, 111.5, 106.7, 74.4, 73.5, 56.2, 13.4, 2.7, 2.0. HPLC: 3.23 min retention time. LCMS: <i>m</i>/<i>e</i> = 254.3 (M + H).</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>R</i>)-2-(4-Amino-2-methoxyphenoxy)-1-cyclopropylethanol <b>32</b></h4><div class="NLM_p last">To a solution of <b>31</b> (20.90 g, 83 mmol) in EtOH (546 mL) was added 5% Pd/C (3.0 g, 0.705 mmol). The suspension was hydrogenated (1 atm of H<sub>2</sub>, balloon) at 20 Â°C for 2.5 h, whereupon LCMS analysis revealed the reaction to be complete. After filtration of the reaction mixture through Celite pad and subsequent washing of the cake with EtOH, the filtrate was concentrated under vacuum using a rotary evaporator to yield (<i>R</i>)-2-(4-amino-2-methoxyphenoxy)-1-cyclopropylethanol as a brownish solid. (18.34 g, 100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 0.18â0.27 (m, 1H), 0.38â0.43 (m, 1H), 0.45â0.61 (m, 2H), 0.82â0.92 (m, 1H), 3.21 (ddd, <i>J</i> = 8.8, 8.8, 2.6 Hz, 1H), 3.80 (s, 3H), 3.86 (dd, <i>J</i> = 10.1, 8.8 Hz, 1H), 4.09 (dd, <i>J</i> = 10.1, 2.6 Hz, 1H),), 6.21 (dd, <i>J</i> = 8.3, 2.7 Hz, 1H), 6.29 (d, <i>J</i> = 2.7 Hz, 1H), 6.78 (d, <i>J</i> = 8.3 Hz, 1H). <sup>13</sup>C NMR (125 MHz, <i>CDCl</i><sub>3</sub>) Î´ 151.2, 142.1, 140.8, 118.7, 106.9, 100.5, 76.5, 74.4, 55.7, 12.9, 2.5, 1.6. LCMS: <i>m</i>/<i>e</i> 224.5 (M + H).</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>E</i>)-Methyl 5-(4-Chlorophenyl)-3-(2-(dimethylamino)vinyl)thiophene-2-carboxylate <b>33</b></h4><div class="NLM_p last">To a mixture of commercially available methyl 3-amino-5-(4-chlorophenyl)thiophene-2-carboxylate (75 g, 279 mmol) in EtOH (450 mL) was added 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (56 mL, 420 mmol). The stirred reaction mixture was heated to reflux, whereupon within 30 min, the suspension became a clear solution. LCMS analysis revealed that the reaction was complete after 4 h. The mixture was cooled to room temperature and then concentrated under vacuum using a rotary evaporator to obtain a yellow-green oil. After addition of Et<sub>2</sub>O (100 mL), the mixture was stirred as seed crystals were added. Continuation of stirring resulted in a rapid formation of a precipitate which was collected by filtration. After drying overnight under vacuum, 74.9 g of a light yellow solid was obtained. Concentration of the filtrate yielded another 4.5 g, resulting in a combined yield of 79.4 g (88%) of methyl 5-(4-chlorophenyl)-3-(2-(dimethylamino)vinyl)thiophene-2-carboxylate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 3.06 (s, 3H), 3.08 (s, 3H), 3.81 (s, 3H), 6.98 (s, 1H), 7.33â7.38 (m, 2H), 7.51â7.56 (m, 2H), 7.68 (s, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 163.2, 159.1, 156.0, 145.7, 134.4, 132.2, 129.1, 126.9, 122.3, 112.4, 51.4, 40.2, 34.3. LCMS: <i>m</i>/<i>e</i> 323.3 (M + H).</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-6-(4-Chlorophenyl)-3-(4-(2-cyclopropyl-2-hydroxyethoxy)-3-methoxyphenyl)thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>27</b></h4><div class="NLM_p last">A mixture of <b>33</b> (85 g, 263 mmol), aniline <b>32</b> (52 g, 233 mmol), and phenol (230 g, 2444 mmol) was heated at 130 Â°C for 30 min. After cooling the black sticky syrup to room temperature, the resulting mixture was diluted with Et<sub>2</sub>O (300 mL), stirred at room temperature for 20 min, then filtered and washed with Et<sub>2</sub>O (600 mL). Dissolution of the filter cake in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) generated an orange solution which, upon being stirred after dilution with Et<sub>2</sub>O (400 mL), generated a precipitate. The resulting solid was collected by filtration and dried in oven to give the desired title compound as an off-white solid (81 g, 74.2% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.29â0.45 (m, 4 H), 0.91â1.01 (m, 1 H), 3.34â3.39 (m, 1 H), 3.79 (s, 3 H), 3.96â4.05 (m, 2 H), 7.04 (dd, 1 H), 7.13 (d, <i>J</i> = 8.2 Hz, 1 H), 7.19 (s, 1 H), 7.58 (d, <i>J</i> = 8.8 Hz, 2 H), 7.92 (d, <i>J</i> = 8.2 Hz, 2 H), 7.97 (s, 1 H), 8.40 (s, 1 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.33, 1.66, 14.11, 55.79, 71.16, 73.18, 111.86, 112.81, 119.61, 121.71, 122.04, 127.84, 129.27, 129.68, 131.22, 134.27, 148.61, 148.99, 149.48, 149.78, 156.09, 157.40. LCMS: <i>m</i>/<i>e</i> 469.3 (M + H).</div></div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Preparation of <b>35</b></h3><div id="sec3_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Bis(2-(trimethylsilyl)ethyl) Diisopropylphosphoramidite</h4><div class="NLM_p last">A solution of 2-(trimethylsilyl)ethanol (12.6 g, 106.55 mmol) and Et<sub>3</sub>N (15.4 g, 152.19 mmol) in Et<sub>2</sub>O (84 mL) was added dropwise over 30 min under N<sub>2</sub> to a stirred 0 to â2 Â°C solution of diisopropylphosphoramidous dichloride (10.8 g 50.78 mmol) in diethyl ether (53 mL). A mild exotherm (+1â2 Â°C) accompanied the formation of a thick white suspension. After stirring overnight at 20 Â°C, the mixture was filtered. The resultant cake was washed twice with 30 mL portions of Et<sub>2</sub>O. The combined filtrates were washed with 2 Ã 100 mL of saturated aqueous NaHCO<sub>3</sub> followed by 40 mL of brine. After drying over MgSO<sub>4</sub> and concentrating to dryness under vacuum at room temperature, bis(2-(trimethylsilyl)ethyl) diisopropylphosphoramidite (18.12 g, 49.6 mmol, 97.6% yield) was obtained as a clear colorless liquid. <sup>1</sup>H NMR Î´ (CDCl<sub>3</sub>): 3.90â3.78 (m, 4H), 3.77â3.68 (m, 2H), 1.31 (d, <i>J</i> = 6.6 Hz, 12H), 1.17â1.12 (m, 4H), 0.15 (s, 18H). <sup>13</sup>C NMR Î´ (CDCl<sub>3</sub>): 60.7 (2, d, <i>J</i><sub>CâP</sub> = 19.1 Hz, 2C), 42.7 (1, d, <i>J</i><sub>CâP</sub> = 12.7 Hz, 2C), 24.6 (3, d, <i>J</i><sub>CâP</sub> = 7.6 Hz, 4C), 20.1 (2, d, <i>J</i><sub>CâP</sub> = 7.6 Hz, 2C), â1.4 (3, 6C). <sup>31</sup>P NMR Î´ (CDCl<sub>3</sub>): 143.5 (s).</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-2-(4-(6-(4-Chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-1-cyclopropylethyl Bis(2-(trimethylsilyl)ethyl)phosphate <b>34</b></h4><div class="NLM_p last">Addition of 1<i>H</i>-1,2,4-triazole (1.89 g, 27.02 mmol) to a 250 mL three-neck round-bottom flask containing a stirred solution of <b>27</b> (6.33 g, 13.50 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (65 mL) at 20 Â°C under N<sub>2</sub> produced a thick white suspension. To the resulting thick white suspension was added bis(2-(trimethylsilyl)ethyl) diisopropylphosphoramidite (9.8 g, 26.80 mmol). After heating the stirred reaction mixture at reflux for 18 h, HPLC analysis revealed complete conversion. The reaction mixture was cooled to â3 to â4 Â°C prior to dropwise addition of H<sub>2</sub>O<sub>2</sub> (8.8 mL, 100.14 mmol) over 15 min. Note that the exotherm was most severe during addition of the first 1.3â1.5 mL of the H<sub>2</sub>O<sub>2</sub>. After the addition was complete, the mixture was stirred for 2 h at 0â5 Â°C, whereupon HPLC analysis revealed the oxidation to be have generated a new component (â¼92.9â93 AP). The reaction was quenched by dropwise addition of 60 mL of cold 1 N aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub> over 12â15 min. Note that a cooling bath was required, as the first 15â20 mL of the quench produced an exotherm resulting in the temperature rising to 17â18 Â°C; the remainder of the addition was endothermic. The mixture was stirred for 20 min at 10â15 Â°C prior to separating the phases. The organic layer was washed sequentially with 70 mL of 1 N HCl, 65 mL of H<sub>2</sub>O, and 50 mL of brine prior to drying over MgSO<sub>4</sub>. After filtration, the filtrate was concentrated to approximately 30 mL using a rotary evaporator. The residue was redissolved in 65 mL of methyl <i>tert</i>-butyl ether (MTBE); reconcentration to â¼30â35 mL produced a slightly hazy residue. Dilution with an additional 35 mL of MTBE and 45 mL of hexanes induced formation of a solid. Concentration of the residue to dryness yielded 24.5 g of a white solid which upon trituation with 40 mL of hexanes produced a suspension that after further dilution with 40 mL of hexanes + 5 mL of MTBE was collected by filtration. The cake was washed twice with 21 mL each of 95:5 hexanes/MTBE and air-dried for 1 h on the filter with vacuum suction. After drying over the weekend at 20 Â°C under vacuum, (<i>R</i>)-2-(4-(6-(4-chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-1-cyclopropylethyl bis(2-(trimethylsilyl)ethyl)phosphate (9.64 g, 12.86 mmoles, 95.30% yield) was obtained as a white crystalline product with 96.6% purity. <sup>1</sup>H NMR Î´ (500 MHz, CDCl<sub>3</sub>): 8.10 (s, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 2H), 7.51 (s, 1H), 7.42 (d, <i>J</i> = 8.8 Hz, 2H), 7.05 (d, <i>J</i> = 8.8 Hz, 1H), 6.94 (d, <i>J</i> = 2.7 Hz, 1H), 6.90 (dd, <i>J</i> = 8.8, 2.7 Hz, 1H), 4.31â4.20 (m, 2H), 4.21â4.80 (m, 4H), 4.80â4.00 (m, 1H), 3.85 (s, 3H), 1.30â1.18 (m, 1H), 1.13â1.04 (m, 4H), 0.70â0.60 (m, 3H), 0.47â0.38 (m, 1H), 0.02 (s, 18 H). <sup>13</sup>C NMR Î´ (125 MHz, CDCl<sub>3</sub>): 157.4, 156.8, 151.7, 150.3, 149.1, 148.2, 135.7, 131.6, 130.5, 129.5, 127.7, 123.2, 120.1, 119.2, 114.3, 111.4, 81.1 (d, <i>J</i><sub>CâP</sub> = 5.1 Hz), 71.8 (d, <i>J</i><sub>CâP</sub> = 5.1 Hz), 66.1 (d, <i>J</i><sub>CâP</sub> = 6.4 Hz, 2C), 56.2, 19.6 (d, <i>J</i><sub>CâP</sub> = 6.4 Hz), 13.1 (d, <i>J</i><sub>CâP</sub> = 5.1 Hz), 3.6, 3.0, â1.5. <sup>31</sup>P NMR Î´ (CDCl<sub>3</sub>): â1.11 (m, <i>J</i><sub>PâH</sub> = 7.4 Hz). MS (electrospray, +ions) <i>m</i>/<i>z</i> 749, 751.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>R</i>)-2-(4-(6-(4-Chlorophenyl)-4-oxothieno[3,2-<i>d</i>]pyrimidin-3(4<i>H</i>)-yl)-2-methoxyphenoxy)-1-cyclopropylethyl Dihydrogen Phosphate <b>35</b></h4><div class="NLM_p last">A mixture of <b>34</b> (35.27 g, 47.06 mmol) and anhydrous CH<sub>2</sub>Cl<sub>2</sub> (315 mL) in a 500 mL Chemglass jacketed reactor was stirred at 20 Â°C until dissolution was complete, whereupon the internal temperature was reduced to â2 Â°C. Once the temperature had stabilized, TFA (30.2 mL, 399.40 mmol) was added dropwise to the stirred solution, taking care to maintain the internal reaction temperature between â0.5 and 1 Â°C since higher temperatures will promote solvolytic decomposition. Aliquots were periodically withdrawn to monitor the reaction progress by HPLC analysis. Immediately following completion of the TFA addition, HPLC analysis revealed the composition to be 9.29% starting <b>34</b>, 44.78% monodeprotection, 42.2% <b>35</b>, 1.21% <b>27</b>, and 1.25% of the main side product. After 35 min, the composition was 0.05% starting <b>34</b>, 5.34% monodeprotection, 90.47% <b>35</b>, 1.35% <b>27</b>, and 1.99% of main side product. After 64 min, the composition was 0.0% starting <b>34</b>, 0.62% monodeprotection, 94.36% <b>35</b>, 1.52% <b>27</b>, and 2.69% of main side product. After 95 min, the reaction was terminated by reduction of the reaction temperature to â3 Â°C prior to the addition of MeOH (28.5 mL) over 5 min. After stirring for 30 min between â1 and 0 Â°C, the volume was reduced under vacuum at 15 Â°C to â¼134 mL. After warming to 19 Â°C, slow addition of 120 mL of MTBE over 12 min produced a white precipitate which was stirred for 2 h at 19â20 Â°C prior to collection of the solid by filtration. The filter cake was washed twice with 120 mL of MTBE/CH<sub>2</sub>Cl<sub>2</sub> 2.5:1 v/v and air-dried for 15 min with vacuum suction before drying overnight in a vacuum oven at 45 Â°C. The crude product was recrystallized by heating to 55â57 Â°C in 200 mL of THF and 16 mL of water with stirring to achieve complete dissolution. The solution was heated at 60 Â°C for an additional 15 min, cooled to 45 Â°C over 10 min, whereupon 50 mL of acetone was added over â¼5 min while maintaining the temperature above 44 Â°C throughout the addition. Once seeding with <b>35</b> induced crystallization, acetone (245 mL) was added over 30 min while maintaining the temperature above 42.5 Â°C. The resultant thick slurry was cooled to 22 Â°C over â¼60 min and stirred for 90 min at 20â21 Â°C before collecting the solid by filtration. Both the reactor and the filter cake were washed first with 120 mL of acetone/THF 3:1 v/v and then with acetone (110 mL). After air-drying for 40 min with vacuum suction, the solid was dried in a vacuum oven at 50 Â°C for 18 h to yield 18.96 g of <b>35</b> (99.4% purity in 73.40% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.41 (m, 2H), 0.52 (m, 2H), 1.26 (m, 1H), 3.82 (m, 1H), 4.20 (d, 2H, <i>J</i> = 4.29 Hz), 3.80 (s, 3H),7.06 (dd, 1H, <i>J</i> = 8,57, <i>J</i> = 2.34 Hz), 7.15 (d, 1H, <i>J</i> = 8.57 Hz), 7.22 (d, 1H, <i>J</i> = 2.34 Hz), 7.58 (d, 2H, <i>J</i> = 8.57 Hz), 7.93 (2H, <i>J</i> = 8.57 Hz), 7.98 (s, 1H), 8.40 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.4, 3.1, 13.1, 56.0, 71.0, 77.9, 112.2, 113.1, 119.8, 121.9, 122.1, 128.0, 129.4, 130.1, 131.3, 134.4, 148.4, 149.1, 149.6, 149.9, 156.2, 157.5. <sup>31</sup>P NMR Î´ (162 MHz, DMSO-<i>d</i><sub>6</sub>)): â0.75. HPLC: 95.4% API. LCMS: <i>m</i>/<i>e</i> 549.1 (M + H). High resolution mass: C<sub>24</sub>H<sub>23</sub>O<sub>7</sub>N<sub>2</sub>ClPS calcd 549.065â22; exptl 549.065â31.</div></div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Spectral Characterization of Examples <b>6</b>â<b>17</b>, <b>21</b>â<b>23</b>, <b>25</b>, and <b>26</b></h3><div class="NLM_p"><b>6</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 2.02â2.08 (m, 2H), 2.39â2.42 (m, 2H), 3.65â3.68 (m, 2H), 3.74â3.76 (m, 2H), 3.89 (s, 3H), 4.21â4.23 (m, 2H), 6.93 (dd, <i>J</i> = 8.25 Hz, 2.20 Hz, 1H), 6.97 (d, <i>J</i> = 2.20 Hz, 1H), 6.99 (d, <i>J</i> = 8.25 Hz, 1H), 7.44 (d, <i>J</i> = 8.24 Hz, 2H), 7.53 (s, 1H), 7.66 (d, <i>J</i> = 8.25 Hz, 2H), 8.14 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) Î´ 18.20, 30.77, 42.22, 48.99, 56.11, 67.92, 111.03, 113.22, 119.18, 120.84, 123.17, 127.63, 129.43, 130.28, 131.50, 135.66, 148.12, 148.72, 149.90, 151.66, 156.79, 157.38, 175.36. LCMS: <i>m</i>/<i>z</i> 496 [M + H]<sup>+</sup>.</div><div class="NLM_p"><b>7</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.84â1.91 (m, 2H), 1.96â2.03 (m, 2H), 3.52â3.59 (m, 4H), 3.91 (s, 3H), 4.76 (s, 2H), 6.91 (dd, <i>J</i> = 8.35 Hz, 2.63 Hz, 1H), 6.98 (d, <i>J</i> = 2.20 Hz, 1H), 7.08 (d, <i>J</i> = 8.79 Hz, 1H), 7.45 (d, <i>J</i> = 8.35 Hz, 2H), 7.53 (s, 1H), 7.66 (d, <i>J</i> = 8.79 Hz, 2H), 8.13 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 496 [M + H].</div><div class="NLM_p"><b>9</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.15 (t, 6H, <i>J</i> = 7.4 Hz), 3.28 (q, 4H, <i>J</i> = 7.4 Hz), 3.7 (m, 2H), 3.89 (s, 3H), 4.18 (t, 2H, <i>J</i> = 4.8 Hz), 4.97 (m, 1H), 6.93 (dd, 1H, <i>J</i> = 8.4 Hz, <i>J</i> = 2.2 Hz), 6.97 (d, 1H, <i>J</i> = 2.2 Hz), 7.05 (d, 1H, <i>J</i> = 8.4 Hz), 7.44 (d, 2H, J<sub>AB</sub> = 8.3 Hz), 7.54 (s, 1H), 7.66 (d, 2H, <i>J</i><sub>AB</sub> = 8.3 Hz), 8.14 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 527 [M + H].</div><div class="NLM_p"><b>10</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 3.07 (s, 3H), 3.71 (br s, 5H), 3.88 (s, 3H), 4.17â4.27 (m, 2H), 6.92â7.04 (m, 3H), 7.44 (d, <i>J</i> = 8.25 Hz, 2H), 7.55 (s, 1H), 7.66 (d, <i>J</i> = 7.70 Hz, 2H), 8.19 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 500 [M + H].</div><div class="NLM_p"><b>11</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.16 (t, 0.75H, <i>J</i> = 7 Hz), 1.24 (t, 2.25H, <i>J</i> = 7 Hz), 2.13 (s, 2.25H), 2.24(s, 0.75H), 2.25 (s, 0.75H), 3.49 (q, 2 H, <i>J</i> = 7 Hz), 3.76 (t, 2H, <i>J</i> = 5.7 Hz), 3.87 (s, 0.75H), 3.885 (s, 2.25H), 4.16 (t, 0.5 5H, <i>J</i> = 5.7 Hz), 4.26 (t, 1.5H, <i>J</i> = 5.7 Hz), 6.95 (m, 2H), 7.06 (d, 1H, 9 Hz), 7.44 (d, 2H, J<sub>AB</sub> = 8.7 Hz), 7.53 (s, 1H), 7.66 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 8.14 (s, 1H). (Rotamers coalesce upon heating.) LCMS: <i>m</i>/<i>z</i>: 498 [M + H].</div><div class="NLM_p"><b>12</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.14 (t, 3H), 1.22 (t, 3H), 3.38â3.43 (m, 4H), 3.89 (s, 3H), 4.80 (s, 2H), 6.89 (dd, <i>J</i> = 8.80 Hz, 2.20 Hz, 1H), 6.97 (d, <i>J</i> = 2.20 Hz, 1H), 7.05 (d, <i>J</i> = 8.25 Hz, 1H), 7.43 (d, <i>J</i> = 8.24 Hz, 2H), 7.51 (s, 1H), 7.64 (d, <i>J</i> = 8.25 Hz, 2H), 8.12 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 498 [M + H].</div><div class="NLM_p"><b>13</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 3.06 (s, 3H), 3.60 (m, 2H), 3.89 (s, 3H), 4.20 (t, 2H, <i>J</i> = 4.8 Hz), 4.99 (m, 1H), 6.95 (dd, 1H, <i>J</i> = 8.8 Hz, <i>J</i> = 2.2 Hz), 6.98 (d, 1H, <i>J</i> = 2.2 Hz), 7.03 (d, 1H, <i>J</i> = 8.8 Hz), 7.45 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 7.54 (s, 1H), 7.66 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 8.14 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 506 [M + H].</div><div class="NLM_p"><b>14</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 2.03 (s, 3H), 3.72 (m, 2H), 3.91 (s, 3H), 4.16 (t, 2H, <i>J</i> = 4.8 Hz), 6.13 (m, 1H), 6.94 (dd, 1H, J= 8.4 Hz, <i>J</i> = 2.2 Hz), 6.98 (d, 1H, <i>J</i> = 2.2 Hz), 7.02 (d, 1H, <i>J</i> = 8.4 Hz), 7.45 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 7.54 (s, 1H), 7.66 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 8.14 (s, 1H). LCMS <i>m</i>/<i>z</i>: 498 [M + H].</div><div class="NLM_p"><b>15</b>: <sup>1</sup>H NMR (CDCl3) Î´ 3.65 (m, 2H), 3.70 (s, 3H), 3.89 (s, 3H), 4.14 (t, 2H, <i>J</i> = 4.8 Hz), 4.97 (m, 1H), 6.93 (dd, 1H, <i>J</i> = 8.4 Hz, <i>J</i> = 2.2 Hz), 6.97 (d, 1H, <i>J</i> = 2.2 Hz), 7.02 (d, 1H, <i>J</i> = 8.4 Hz), 7.44 (d, 2H, <i>J</i><sub>AB</sub> = 8.3 Hz), 7.54 (s, 1H), 7.66 (d, 2H, <i>J</i><sub>AB</sub> = 8.3 Hz), 8.14 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 486 [M + H].</div><div class="NLM_p"><b>16</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 3.89 (s, 3H), 3.93 (s, 3H), 6.9â7.0 (m, 3H), 7.43 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 7.51 (s, 1H), 7.63 (d, 2H, <i>J</i><sub>AB</sub> = 8.7 Hz), 8.12 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 399 [M + H].</div><div class="NLM_p"><b>17</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 3.72â3.75 (m, 2H), 3.77 (s, 3H), 4.03 (t, 2H), 4.91 (t, 1H), 7.03 (dd, <i>J</i> = 8.80 Hz, 2.20 Hz, 1H), 7.10 (d, <i>J</i> = 8.80 Hz, 1H), 7.18 (d, <i>J</i> = 2.75 Hz, 1H), 7.56 (d, <i>J</i> = 8.79 Hz, 2H), 7.91 (d, <i>J</i> = 8.80 Hz, 2H), 7.97 (s, 1H), 8.39 (s, 1H). LCMS <i>m</i>/<i>z</i>: 429 [M + H].</div><div class="NLM_p"><b>21a</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 3.43â3.50 (m, 2H), 3.77 (s, 3H), 3.77â3.85 (m, 1H), 3.90â3.94 (m, 1H), 4.02â4.05 (m, 1H), 4.68 (t, 1H), 4.98 (d, <i>J</i> = 4.83 Hz, 1H), 7.03 (dd, <i>J</i> = 8.35 Hz, 2.20 Hz, 1H), 7.10 (d, <i>J</i> = 8.79 Hz, 1H), 7.18 (d, <i>J</i> = 2.20 Hz, 1H), 7.57 (d, <i>J</i> = 8.35 Hz, 2H), 7.92 (d, <i>J</i> = 8.35 Hz, 2H), 7.97 (s, 1H), 8.39 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 459 [M + H].</div><div class="NLM_p"><b>21b</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 1.15 (s, 3H), 3.32â3.43 (m, 2H), 3.78â3.90 (m, 5H), 4.53 (s, 1H), 4.65 (t, 1H), 7.02 (dd, <i>J</i> = 8.25 Hz, 2.20 Hz, 1H), 7.10 (d, <i>J</i> = 8.24 Hz, 1H), 7.17 (d, <i>J</i> = 2.75 Hz, 1H), 7.57 (d, <i>J</i> = 8.80 Hz, 2H), 7.91 (d, <i>J</i> = 8.25 Hz, 2H), 7.96 (s, 1H), 8.38 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 473 [M + H].</div><div class="NLM_p"><b>22a</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 3.77 (s, 3H), 3.92â3.97 (m, 2H), 4.24â4.29 (m, 1H), 6.73â6.76 (m, 1H), 7.01 (dd, <i>J</i> = 8.79 Hz, 2.64 Hz, 1H), 7.08â7.16 (m, 3H), 7.57 (d, <i>J</i> = 8.79 Hz, 2H), 7.92 (d, <i>J</i> = 8.79 Hz, 2H), 7.97 (s, 1H), 8.40 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 473 [M + H].</div><div class="NLM_p"><b>22b</b>: <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 1.52 (s, 3H), 3.90 (s, 3H), 4.09 (d, <i>J</i> = 9.67 Hz, 1H), 4.34 (d, <i>J</i> = 9.66 Hz, 1H), 7.00 (dd, <i>J</i> = 8.35 Hz, 2.19 Hz, 1H), 7.09 (d, <i>J</i> = 2.63 Hz, 1H), 7.13 (d, <i>J</i> = 8.35 Hz, 1H), 7.48 (d, <i>J</i> = 8.79 Hz, 2H), 7.63 (s, 1H), 7.75 (d, <i>J</i> = 8.35 Hz, 2H), 8.29 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 487 [M + H].</div><div class="NLM_p"><b>23</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 1.46 (t, 3H), 3.16â3.38 (m, 5H), 3.89 (s, 3H), 4.14â4.15 (m, 2H), 4.63â4.69 (m, 1H), 6.95 (dd, <i>J</i> = 8.35 Hz, 2.63 Hz, 1H), 6.99 (d, <i>J</i> = 2.20 Hz, 1H), 7.06 (d, <i>J</i> = 8.35 Hz, 1H), 7.45 (d, <i>J</i> = 8.35 Hz, 2H), 7.54 (s, 1H), 7.66 (d, <i>J</i> = 8.35 Hz, 2H), 8.14 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 535 [M + H].</div><div class="NLM_p"><b>25</b>: <sup>1</sup>H NMR (DMSO-d<sup>6</sup>) Î´ 3.78 (s, 3H), 4.10â4.13 (m, 1H), 4.22â4.25 (m, 1H), 4.40â4.45 (m, 1H), 6.71 (d, <i>J</i> = 6.59 Hz, 1H), 7.06 (dd, <i>J</i> = 8.25 Hz, 2.20 Hz, 1H), 7.18 (d, <i>J</i> = 8.80 Hz, 1H), 7.23 (d, <i>J</i> = 2.20 Hz, 1H), 7.57 (d, <i>J</i> = 8.80 Hz, 2H), 7.91 (d, <i>J</i> = 8.80 Hz, 2H), 7.97 (s, 1H), 8.39 (s, 1H). LCMS: <i>m</i>/<i>z</i>: 497 [M + H].</div><div class="NLM_p last"><b>26</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 2.28â2.56 (m, 2H), 3.68 (s, 3H), 3.82â3.93 (m, 2H), 4.04â4.05 (m, 1H), 5.37 (d, <i>J</i> = 6.05 Hz, 1H), 6.95 (dd, <i>J</i> = 8.25 Hz, 2.20 Hz, 1H), 7.02 (d, <i>J</i> = 8.79 Hz, 1H), 7.11 (d, <i>J</i> = 2.20 Hz, 1H), 7.46 (d, <i>J</i> = 8.79 Hz, 2H), 7.81 (d, <i>J</i> = 8.79 Hz, 2H), 7.86 (s, 1H), 8.29 (s, 1H). LCMS <i>m</i>/<i>z</i>: 511 [M + H].</div></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Biological Assays</h3><div id="sec4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Determination of Binding Affinity (<i>K</i><sub>i</sub>)</h4><div class="NLM_p last">Membranes from stably transfected HEK-293 cells expressing a mutated (E4Q, A5T) hMCHR1 receptor were prepared by Dounce homogenization and differential centrifugation. Binding experiments were carried out with 0.5â1.0 Î¼g of membrane protein incubated in a total of 0.2 mL in 25 mM HEPES (pH 7.4) with 10 mM MgCl<sub>2</sub>, 2 mM EGTA, and 0.1% BSA (binding buffer) for 90 min. For competition binding assays, reactions were carried out in the presence of 0.06â0.1 nM [Phe<sup>13</sup>, [<sup>125</sup>I]Tyr<sup>19</sup>]MCH and increasing concentrations of unlabeled test molecules. Reactions were terminated by rapid vacuum filtration over 96-well GFC Unifilter plates precoated with 0.075 mL of binding buffer containing 1% BSA and washed 3 times with 0.4 mL of phospho-buffered saline (pH 7.4) containing 0.01% TX-100. Filters were dried, 0.05 mL of MicroScint 20 was added to each well, and radioactivity was subsequently quantified by scintillation counting on a TopCount microplate scintillation counter (Packard). Inhibitory constants were determined by nonlinear least-squares analysis using a four-parameter logistic equation.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Determination of MCHR Functional Activity</h4><div class="NLM_p">Stable HEK-293 cells expressing human MCHR1 or MCHR2 receptor were plated at a density of 50â000 cells/well in 96-well polylysine coated plates (BD no. 35-6640) and cultured overnight in DMEM (high glucose (4.5 g/mL), 25 mM HEPES, pH 7.4, 10% fetal bovine serum, 1 mM Na Cl) at 37 Â°C, 5% CO<sub>2</sub> conditions. For assay, the medium was replaced with 90 mL per well dye solution consisting of 3.8 mM Fluo4 AM (Invitrogen no. F14201), 0.04% Pluronic F-127 (Invitrogen no. P3000MP), and 2.5 mM Probencid (Sigma no. P8761) in base buffer (Hankâs balanced salt solution, 25 mM HEPES, 0.1% BSA). Dye solution was allowed to âloadâ for 1 h at room temperature in subdued light. Dye was subsequently removed and replaced with 75 mL of base buffer and 75 mL of diluted test compound and incubated for an additional 15 min. Test compound dilution plates were prepared by serial diluting test and reference compounds from 100% DMSO stocks first 1:50 in base buffer and then serially (1:3.26) in base buffer containing 2% DMSO to generate 12 half log test concentrations.</div><div class="NLM_p last">Serially diluted test compounds were assessed for their ability to inhibit MCH-stimulated calcium flux initiated by a fixed concentration of MCH (20â90% of full agonism). Agonist source plates also contained a reference MCH 12-point concentration response curve (CRC). An amount of 50 mL of agonist from agonist source plate was injected into the cell plates, and then fluorescence over a 150 s window (excitation, 488 nm; emission, 515â570 nm) was measured in a FLIPR instrument (Molecular Devices). The ÎRFU data for each concentration response curve were analyzed by nonlinear regression analysis using a four-parameter logistic equation in Excel Fit (eq 205) to determine IC<sub>50</sub> or EC<sub>50</sub>, Hill slope, and the maximum and minimum RFU for each CRC. <i>K</i><sub>b</sub> values were calculated using the modified ChengâPrusoff correction from the IC<sub>50</sub> values using the EC<sub>50</sub>, Hill slope, and concentration of the agonist peptide.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Protocol for Efficacy Studies Using Young Growing Rat Model</h4><div class="NLM_p">Male SpragueâDawley rats were obtained from Charles River Laboratories at 8 weeks of age. The rats were maintained on a 12:12 light/dark cycle in the BMS vivarium. Animals were acclimated to the facility for 10 days prior to use. Five days prior to the start of testing, rats were acclimated to the choice diet regime which entailed ad libitum access to two different diets: Harlan rat chow (standard chow, 5% fat, 3.5 kcal/g) and Research Diets D12327 (a highly palatable 40% fat diet, 4.59 kcal/g). Rats typically display â¼85% (by kcal) preference for the Research Diets chow.</div><div class="NLM_p last">At the start of the study rats were randomized and grouped based upon body weight, daily kcal intake, and diet preference. Rats were dosed orally with vehicle (0.5% Methocel/0.1% Tween 80/99.4% distilled H<sub>2</sub>O) or compounds dissolved in vehicle, at a volume of 5 mL/kg. Test compounds were administered orally 1 h before the onset of the dark cycle. Body weight and food consumption were measured daily at the time of drug administration. Upon completion of the study total caloric consumption, diet preference, and change in body weight were tabulated. Drug effects on body weight were analyzed using body weights converted to percent change from baseline and evaluated across treatment groups using a one-way ANOVA. Post hoc day by day group comparisons were evaluated using Fisherâs PLSD test. Drug effects on daily caloric consumption were similarly evaluated. In addition, cumulative caloric consumption for each animal over the entire treatment period was calculated and the results were analyzed using one-way ANOVA followed by Fisherâs PLSD.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm500026w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William N. Washburn</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bdcad3cadcced5dfc8cfd3fddad0dcd4d193ded2d0"><span class="__cf_email__" data-cfemail="f88f968f998b909a8d8a96b89f95999194d69b9795">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Manfredi</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pratik Devasthale</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guohua Zhao</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saleem Ahmad</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andres Hernandez</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Robl</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Mignone</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenghua Wang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khehyong Ngu</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ann Pelleymounter</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Longhi</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rulin Zhao</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bei Wang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Huang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Flynn</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony V. Azzara</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Rohrbach</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J. Devenny</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne Rooney</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Thomas</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Glick</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helen E. Godonis</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan J. Harvey</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Jane Cullen</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongwei Zhang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Caporuscio</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Stetsko</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Grubb</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad D. Maxwell</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Yang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atsu Apedo</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Gemzik</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Evan B. Janovitz</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Huang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Zhang</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris Freeden</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian J. Murphy</span> - <span class="hlFld-Affiliation affiliation">â Metabolic Diseases Chemistry, â¡Metabolic Diseases Biology, Â§Preclinical Candidate
Optimization
Metabolism and Pharmacokinetics, â¥Discovery Chemistry Synthesis, â¥Preclinical Candidate
Optimization Discovery Toxicology, #Preclinical Candidate Optimization Discovery Bioanalytical
Research, âPreclinical Candidate Optimization Biotransformation, ÃPreclinical Candidate
Optimization Pharmaceutics, and âPreclinical Candidate Optimization DAS SPS, Research and Development, Bristol-Myers Squibb Co., Princeton, New Jersey 08543-5400, United States </span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>World Health Organization Global Health Observatory (GHO) Web site. <a href="http://www.who.int/gho/ncd/risk_factors/obesity_text/en/" class="extLink">http://www.who.int/gho/ncd/risk_factors/obesity_text/en/</a> (accessed Oct 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+Global+Health+Observatory+%28GHO%29+Web+site.+http%3A%2F%2Fwww.who.int%2Fgho%2Fncd%2Frisk_factors%2Fobesity_text%2Fen%2F+%28accessed+Oct+18%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Holes-Lewis, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeil, P. M.</span><span> </span><span class="NLM_article-title">Pharmacotherapy of obesity: clinical treatments and considerations</span> <span class="citation_source-journal">Am. J. Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=284-288&author=K.+A.+Holes-Lewisauthor=R.+Malcolmauthor=P.+M.+O%E2%80%99Neil&title=Pharmacotherapy+of+obesity%3A+clinical+treatments+and+considerations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoles-Lewis%26aufirst%3DK.%2BA.%26aulast%3DMalcolm%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DP.%2BM.%26atitle%3DPharmacotherapy%2520of%2520obesity%253A%2520clinical%2520treatments%2520and%2520considerations%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D2013%26volume%3D345%26spage%3D284%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schwartz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, J. P.</span><span> </span><span class="NLM_article-title">Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">â</span> <span class="NLM_lpage">629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1038%2Foby.2007.96" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=18239553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVOquro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=623-629&author=S.+M.+Schwartzauthor=V.+P.+Bansalauthor=C.+Haleauthor=M.+Rossiauthor=J.+P.+Engle&title=Compliance%2C+behavior+change%2C+and+weight+loss+with+orlistat+in+an+over-the-counter+setting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting</span></div><div class="casAuthors">Schwartz, Susan M.; Bansal, Vidhu P.; Hale, Cecilia; Rossi, Maureen; Engle, Janet P.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">623-629</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Objective: The study was conducted to provide information on how consumers would use orlistat 60 mg, esp. in terms of product dosing, in a setting without physician supervision.  Methods and Procedures: A 3-mo, open-label, naturalistic study was conducted in an over-the-counter (OTC) setting in 18 pharmacies.  Consumers â¥18 years were allowed to purchase orlistat packages contg. a bottle of orlistat 60 mg plus educational materials, which provided lifestyle information and tools to encourage successful wt. loss.  Data were collected at pharmacy visits and during telephone interviews at 14, 30, 60, and 90 days after enrollment.  Results: A total of 237 subjects purchased and used the product, and completed at least one interview.  Most subjects followed the dosing directions and took two to three capsules per day with meals throughout the study.  The majority of subjects took a daily multivitamin, as directed.  Approx., 80% of subjects used the educational materials and found them useful or very useful.  Over the study duration, most subjects reported following a diet and 51% of subjects reported more frequent or longer exercise than at enrollment.  Approx., 80% of subjects indicated they were satisfied or very satisfied with the wt. loss achieved; measured and self-reported relative median wt. loss was â¼5% after â¥60 days of using orlistat.  Most common adverse events were gastrointestinal (GI), and majority of subjects did not interrupt or discontinue orlistat due to these GI events.  Discussion: These results demonstrate that orlistat 60 mg can be used appropriately and safely and with high consumer satisfaction without physician supervision or dietary counseling.  Collectively, results indicate that orlistat 60 mg is an appropriate wt. loss therapy in the OTC environment.  Obesity (2008) 16 3, 623-629. doi:10.1038/oby.2007.96.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8S5zUdEeRq7Vg90H21EOLACvtfcHk0lif3yc4z_zgsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVOquro%253D&md5=921dc36a02aaa16c9fcf9c3722515d87</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Foby.2007.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2007.96%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DS.%2BM.%26aulast%3DBansal%26aufirst%3DV.%2BP.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DEngle%26aufirst%3DJ.%2BP.%26atitle%3DCompliance%252C%2520behavior%2520change%252C%2520and%2520weight%2520loss%2520with%2520orlistat%2520in%2520an%2520over-the-counter%2520setting%26jtitle%3DObesity%26date%3D2008%26volume%3D16%26spage%3D623%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Larsen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toubro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Baak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saris, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astrup, A.</span><span> </span><span class="NLM_article-title">Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">â</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=12324291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1eqsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2002&pages=780-788&author=T.+M.+Larsenauthor=S.+Toubroauthor=M.+A.+van+Baakauthor=K.+M.+Gottesdienerauthor=P.+Larsonauthor=W.+H.+Sarisauthor=A.+Astrup&title=Effect+of+a+28-d+treatment+with+L-796568%2C+a+novel+beta%283%29-adrenergic+receptor+agonist%2C+on+energy+expenditure+and+body+composition+in+obese+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a 28-d treatment with L-796568, a novel Î²3-adrenergic receptor agonist, on energy expenditure and body composition in obese men</span></div><div class="casAuthors">Larsen, Thomas M.; Toubro, Soren; van Baak, Marleen A.; Gottesdiener, Keith M.; Larson, Patrick; Saris, Wim H. M.; Astrup, Arne</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">780-788</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Nutrition</span>)
        </div><div class="casAbstract">Stimulation of energy expenditure (EE) with selective thermogenic Î²-adrenergic agonists may be a promising approach for treating obesity.  We analyzed the effects of the highly selective human Î²3-adrenergic agonist L-796568 on 24-h EE, substrate oxidn., and body compn. in obese, wt.-stable men.  In this 2-center, double-blind, randomized, parallel-group study, we measured 24-h EE before and after 28 d of treatment with L-796568 (375 mg/d) or placebo during wt. maintenance (ie, without dietary intervention) in nondiabetic, nonsmoking men aged 25-49 yr with body mass index (in kg/m2) of 28-35 (n = 10 subjects per treatment group).  The mean change in 24-h EE from before to after treatment did not differ significantly between groups (92Â±586 and 86Â±512 kJ/24 h for the L-796568 and placebo groups, resp.).  The change in 24-h nonprotein RQ from before to after treatment did not differ significantly between groups (0.009Â±0.021 and 0.009Â±0.029, resp.).  No changes in glucose tolerance were obsd., but triacylglycerol concns. decreased significantly with L-796568 treatment compared with placebo (-0.76Â±0.76 and 0.42Â±0.31 mmol/L, resp.; P < 0.002).  Overall, treatment-related changes in body compn. were not obsd., but higher plasma L-796568 concns. in the L-796568 group were assocd. with greater decreases in fat mass (r = -0.69, P < 0.03).  Treatment with L-796568 for 28 d had no major lipolytic or thermogenic effect but it lowered triacylglycerol concns.  This lack of chronic effect on energy balance is likely explained by insufficient recruitment of Î²3-responsive tissues in humans, down-regulation of the Î²3-adrenergic receptor-mediated effects with chronic dosing, or both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogKuqIefRBVbVg90H21EOLACvtfcHk0lj7iukR2_FVww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1eqsLg%253D&md5=a1437ac79c034a5eb3ea710bb556b356</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DT.%2BM.%26aulast%3DToubro%26aufirst%3DS.%26aulast%3Dvan%2BBaak%26aufirst%3DM.%2BA.%26aulast%3DGottesdiener%26aufirst%3DK.%2BM.%26aulast%3DLarson%26aufirst%3DP.%26aulast%3DSaris%26aufirst%3DW.%2BH.%26aulast%3DAstrup%26aufirst%3DA.%26atitle%3DEffect%2520of%2520a%252028-d%2520treatment%2520with%2520L-796568%252C%2520a%2520novel%2520beta%25283%2529-adrenergic%2520receptor%2520agonist%252C%2520on%2520energy%2520expenditure%2520and%2520body%2520composition%2520in%2520obese%2520men%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2002%26volume%3D76%26spage%3D780%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Redman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenway, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravussin, E.</span><span> </span><span class="NLM_article-title">Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">â</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1210%2Fjc.2006-1740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=17118998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVaksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2007&pages=527-531&author=L.+M.+Redmanauthor=L.+de+Jongeauthor=X.+Fangauthor=B.+Gamlinauthor=D.+Reckerauthor=F.+L.+Greenwayauthor=S.+R.+Smithauthor=E.+Ravussin&title=Lack+of+an+effect+of+a+novel+beta3-adrenoceptor+agonist%2C+TAK-677%2C+on+energy+metabolism+in+obese+individuals%3A+a+double-blind%2C+placebo-controlled+randomized+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of an effect of a novel Î²3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study</span></div><div class="casAuthors">Redman, Leanne M.; de Jonge, Lilian; Fang, Xiaobing; Gamlin, Betsy; Recker, David; Greenway, Frank L.; Smith, Steven R.; Ravussin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">527-531</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Our objective was to test the safety and metabolic effects of a novel Î²3-adrenoreceptor agonist (TAK-677) in humans.  Design, Setting, and Participants: Sixty-five obese (body mass index = 33.9Â±2.1 kg/m2, mean Â± SE) men and women (31.4Â±0.9 yr) participated in a double-blind placebo-controlled study at an institutional research center.  Participants were randomized to 0.1 mg TAK-677 twice daily (BID) (n = 21), 0.5 mg TAK-677 BID (n = 22), or placebo BID (n = 22) for 29 days.  Drug safety, 24-h RQ (RQ), 24-h energy expenditure (EE), body compn., fat distribution, and fasting plasma concn. of substrates and hormones were assessed.  An acute-response study was also conducted.  The drug was well tolerated by all participants; however, heart rate was elevated (9Â±2 beats per min) with the 0.5-mg BID dose.  After 28 d of treatment and when compared with placebo, there was no change in 24-h RQ with either 0.1-mg BID (P = 0.1) or 0.5-mg BID (P = 1.0) doses of TAK-677.  However, TAK, 0.5 mg BID, resulted in a small increase in 24-h EE that was significantly different from placebo [change from baseline, 13 Â± 17 (0.5 mg BID) vs. -39 Â± 18 (placebo) kcal/d, P < 0.05].  Changes in wt., fat-free mass, and abdominal fat depots (visceral or s.c.) were not different between the three groups, nor were changes in fasting insulin, free fatty acid, or glucose concns.  TAK-677 has no effect on 24-h RQ or fat oxidn. but does slightly increase 24-h EE at the highest dose (0.5 mg BID).  The acute studies showed large interindividual variability in plasma concns. of TAK-677 indicating some possible problems with bioavailability and therefore efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObsRY4t2dobVg90H21EOLACvtfcHk0lj--WYuUw5a2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVaksb4%253D&md5=903a6913c9f14fd88a967714a198a341</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1210%2Fjc.2006-1740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2006-1740%26sid%3Dliteratum%253Aachs%26aulast%3DRedman%26aufirst%3DL.%2BM.%26aulast%3Dde%2BJonge%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DGamlin%26aufirst%3DB.%26aulast%3DRecker%26aufirst%3DD.%26aulast%3DGreenway%26aufirst%3DF.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BR.%26aulast%3DRavussin%26aufirst%3DE.%26atitle%3DLack%2520of%2520an%2520effect%2520of%2520a%2520novel%2520beta3-adrenoceptor%2520agonist%252C%2520TAK-677%252C%2520on%2520energy%2520metabolism%2520in%2520obese%2520individuals%253A%2520a%2520double-blind%252C%2520placebo-controlled%2520randomized%2520study%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D92%26spage%3D527%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Christensen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartels, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliddal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astrup, A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x"> (</span><span class="NLM_issue">9600</span><span class="NLM_x">) </span> <span class="NLM_fpage">1706</span><span class="NLM_x">â</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1016%2FS0140-6736%2807%2961721-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=18022033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWrsb7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=1706-1713&issue=9600&author=R.+Christensenauthor=P.+K.+Kristensenauthor=E.+M.+Bartelsauthor=H.+Bliddalauthor=A.+Astrup&title=Efficacy+and+safety+of+the+weight-loss+drug+rimonabant%3A+a+meta-analysis+of+randomised+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomized trials</span></div><div class="casAuthors">Christensen, Robin; Kristensen, Pernelle Kruse; Bartels, Else Marie; Bliddal, Henning; Astrup, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">9600</span>),
    <span class="NLM_cas:pages">1706-1713</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Since the prevalence of obesity continues to increase, there is a demand for effective and safe anti-obesity agents that can produce and maintain wt. loss and improve comorbidity.  We did a meta-anal. of all published randomized controlled trials to assess the efficacy and safety of the newly approved anti-obesity agent rimonabant.  We searched The Cochrane database and Controlled Trials Register, Medline via Pubmed, Embase via WebSpirs, Web of Science, Scopus, and ref. lists up to July, 2007.  We collected data from four double-blind, randomized controlled trials (including 4105 participants) that compared 20 mg per day rimonabant with placebo.  Patients given rimonabant had a 4.7 kg (95% CI 4.1-5.3 kg; p < 0.0001) greater wt. redn. after 1 yr than did those given placebo.  Rimonabant caused significantly more adverse events than did placebo (OR = 1.4; p = 0.0007; no. needed to harm = 25 individuals [95% CI 17-58]), and 1.4 times more serious adverse events (OR = 1.4; p = 0.03; no. needed to harm = 59 [27-830]).  Patients given rimonabant were 2.5 times more likely to discontinue the treatment because of depressive mood disorders than were those given placebo (OR=2.5; p = 0.01; no. needed to harm = 49 [19-316]).  Furthermore, anxiety caused more patients to discontinue treatment in rimonabant groups than in placebo groups (OR = 3.0; p = 0.03; no. needed to harm = 166 [47-3716]).  The findings suggest that 20 mg per day rimonabant increases the risk of psychiatric adverse events-ie, depressed mood disorders and anxiety-despite depressed mood being an exclusion criterion in these trials.  Taken together with the recent US Food and Drug Administration finding of increased risk of suicide during treatment with rimonabant, we recommend increased alertness by physicians to these potentially severe psychiatric adverse reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH4_5WdwCLbbVg90H21EOLACvtfcHk0lhUOF2yGUjnBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWrsb7E&md5=58bb31ac3b77690a60f1257462cf62f5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2961721-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252961721-8%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DR.%26aulast%3DKristensen%26aufirst%3DP.%2BK.%26aulast%3DBartels%26aufirst%3DE.%2BM.%26aulast%3DBliddal%26aufirst%3DH.%26aulast%3DAstrup%26aufirst%3DA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520the%2520weight-loss%2520drug%2520rimonabant%253A%2520a%2520meta-analysis%2520of%2520randomised%2520trials%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26issue%3D9600%26spage%3D1706%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pissios, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maratos-Flier, E.</span><span> </span><span class="NLM_article-title">Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological parameters</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">â</span> <span class="NLM_lpage">620</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1210%2Fer.2006-0021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=16788162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2gs7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=606-620&author=P.+Pissiosauthor=R.+L.+Bradleyauthor=E.+Maratos-Flier&title=Expanding+the+scales%3A+the+multiple+roles+of+MCH+in+regulating+energy+balance+and+other+biological+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions</span></div><div class="casAuthors">Pissios, Pavlos; Bradley, Richard L.; Maratos-Flier, Eleftheria</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">606-620</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Melanin-concg. hormone (MCH) is a cyclic peptide originally identified as a 17-amino-acid circulating hormone in teleost fish, where it is secreted by the pituitary in response to stress and environmental stimuli.  In fish, MCH lightens skin color by stimulating aggregation of melanosomes, pigment-contg. granules in melanophores, cells of neuroectodermal origin found in fish scales.  Although the peptide structure between fish and mammals is highly conserved, in mammals, MCH has no demonstrable effects on pigmentation; instead, based on a series of pharmacol. and genetic expts., MCH has emerged as a crit. hypothalamic regulator of energy homeostasis, having effects on both feeding behavior and energy expenditure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozEpay1iCpCrVg90H21EOLACvtfcHk0lhIe48SV-GlZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2gs7nK&md5=6e2445fe0bc9ad8709d717284dead386</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fer.2006-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2006-0021%26sid%3Dliteratum%253Aachs%26aulast%3DPissios%26aufirst%3DP.%26aulast%3DBradley%26aufirst%3DR.%2BL.%26aulast%3DMaratos-Flier%26aufirst%3DE.%26atitle%3DExpanding%2520the%2520scales%253A%2520the%2520multiple%2520roles%2520of%2520MCH%2520in%2520regulating%2520energy%2520balance%2520and%2520other%2520biological%2520parameters%26jtitle%3DEndocr.%2520Rev.%26date%3D2006%26volume%3D27%26spage%3D606%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Luthin, D. R.</span><span> </span><span class="NLM_article-title">Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">â</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=421-440&author=D.+R.+Luthin&title=Anti-obesity+effects+of+small+molecule+melanin-concentrating+hormone+receptor+1+%28MCHR1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuthin%26aufirst%3DD.%2BR.%26atitle%3DAnti-obesity%2520effects%2520of%2520small%2520molecule%2520melanin-concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonists%26jtitle%3DLife%2520Sci.%26date%3D2007%26volume%3D81%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Forray, C.</span><span> </span><span class="NLM_article-title">The MCH receptor family: feeding brain disorders?</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1016%2FS1471-4892%2802%2900013-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=12550747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=85-89&author=C.+Forray&title=The+MCH+receptor+family%3A+feeding+brain+disorders%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The MCH receptor family: feeding brain disorders?</span></div><div class="casAuthors">Forray, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of melanin concg. hormone (MCH) in the control of energy balance has been confirmed by findings of lean phenotypes of mice with targeted deletion of the melanin concg. hormone receptor 1 (MCH1-R).  The recent publications of anorectic and antiobesity effects of the first two selective MCH1-R antagonists have confirmed the notion that pharmacol. blockade of MCH1-R is a viable therapeutic approach for obesity.  In addn., MCH1-R antagonists have been found to have antidepressant and anxiolytic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUyIV7QZhsrVg90H21EOLACvtfcHk0lj4KXxuU3NZsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtA%253D%253D&md5=1a06cc3f443091732ee8780c2c9e577d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2802%2900013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252802%252900013-9%26sid%3Dliteratum%253Aachs%26aulast%3DForray%26aufirst%3DC.%26atitle%3DThe%2520MCH%2520receptor%2520family%253A%2520feeding%2520brain%2520disorders%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1016%2FS0014-2999%2802%2901314-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=11909603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWktb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2002&pages=129-35&author=S.+Takekawaauthor=A.+Asamiauthor=Y.+Ishiharaauthor=J.+Terauchiauthor=K.+Katoauthor=Y.+Shimomuraauthor=M.+Moriauthor=H.+Murakoshiauthor=K.+Katoauthor=N.+Suzukiauthor=O.+Nishimuraauthor=M.+Fujino&title=T-226296%3A+a+novel%2C+orally+active+and+selective+melanin-concentrating+hormone+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist</span></div><div class="casAuthors">Takekawa, Shiro; Asami, Asano; Ishihara, Yuji; Terauchi, Jun; Kato, Kaneyoshi; Shimomura, Yukio; Mori, Masaaki; Murakoshi, Hitomi; Kato, Koki; Suzuki, Nobuhiro; Nishimura, Osamu; Fujino, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Screening of a chem. compd. library found a novel melanin-concg. hormone (MCH) receptor antagonist, T-226296, a (-) enantiomer of N-[6-(dimethylamino)methyl]-5,6,7,8-tetrahydro-2-naphthalenyl-4'-fluoro[1,1'-biphenyl]-4-carboxamide.  T-226296 exhibited high affinity for cloned human and rat MCH receptors (SLC-1) in receptor-binding assays (IC50 5.5 nM for human SLC-1; 8.6 nM for rat SLC-1).  T-226296 had high selectivity over other receptors, including the 2nd subtype of the MCH receptor, SLT (MCH2), transporters and ion channels.  In Chinese hamster ovary cells expressing human SLC-1, T-226296 reversed the MCH-mediated inhibition of forskolin-stimulated cAMP accumulation, inhibited MCH-induced intracellular Ca2+ increase, and also inhibited MCH-stimulated arachidonic acid release.  In rats, oral administration of T-226296 (30 mg/kg) almost completely suppressed the increase in food intake induced by intracerebroventricular injection of MCH.  These results indicate that T-226296 is a novel, orally active and selective MCH receptor antagonist that will be promising for further exploring the physiol. and pathophysiol. of MCH-SLC-1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqciwFzh1_XK7Vg90H21EOLACvtfcHk0liR1_Q0kc7HzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWktb4%253D&md5=5867fd50dbbc869b259fe669e5d064d5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901314-6%26sid%3Dliteratum%253Aachs%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DAsami%26aufirst%3DA.%26aulast%3DIshihara%26aufirst%3DY.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DShimomura%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DMurakoshi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DNishimura%26aufirst%3DO.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DT-226296%253A%2520a%2520novel%252C%2520orally%2520active%2520and%2520selective%2520melanin-concentrating%2520hormone%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D438%26spage%3D129%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, A. G.</span><span> </span><span class="NLM_article-title">A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3962</span><span class="NLM_x">â</span> <span class="NLM_lpage">3971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040762v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3962-3971&author=D.+E.+Clarkauthor=C.+Higgsauthor=S.+P.+Wrenauthor=H.+J.+Dykeauthor=M.+Wongauthor=D.+Normanauthor=P.+M.+Lockeyauthor=A.+G.+Roach&title=A+virtual+screening+approach+to+finding+novel+and+potent+antagonists+at+the+melanin-concentrating+hormone+1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm040762v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040762v%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DHiggs%26aufirst%3DC.%26aulast%3DWren%26aufirst%3DS.%2BP.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DNorman%26aufirst%3DD.%26aulast%3DLockey%26aufirst%3DP.%2BM.%26aulast%3DRoach%26aufirst%3DA.%2BG.%26atitle%3DA%2520virtual%2520screening%2520approach%2520to%2520finding%2520novel%2520and%2520potent%2520antagonists%2520at%2520the%2520melanin-concentrating%2520hormone%25201%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3962%26epage%3D3971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">McBriar, M. D.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of melanin-concentrating hormone receptor antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">â</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=496-508&author=M.+D.+McBriar&title=Recent+advances+in+the+discovery+of+melanin-concentrating+hormone+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcBriar%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520melanin-concentrating%2520hormone%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D496%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hertzog, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Barazanji, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigham, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizzle, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handlon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span> </span><span class="NLM_article-title">The discovery and optimization of pyrimidinone-containing MCH R1 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4723</span><span class="NLM_x">â</span> <span class="NLM_lpage">4727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4723-4727&author=D.+L.+Hertzogauthor=K.+A.+Al-Barazanjiauthor=E.+C.+Bighamauthor=M.+J.+Bishopauthor=C.+S.+Brittauthor=D.+L.+Carltonauthor=J.+P.+Cooperauthor=A.+J.+Danielsauthor=D.+M.+Garridoauthor=A.+S.+Goetzauthor=M.+K.+Grizzleauthor=Y.+C.+Guoauthor=A.+L.+Handlonauthor=D.+M.+Ignarauthor=R.+O.+Morganauthor=A.+J.+Peatauthor=F.+X.+Tavaresauthor=H.+Zhou&title=The+discovery+and+optimization+of+pyrimidinone-containing+MCH+R1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHertzog%26aufirst%3DD.%2BL.%26aulast%3DAl-Barazanji%26aufirst%3DK.%2BA.%26aulast%3DBigham%26aufirst%3DE.%2BC.%26aulast%3DBishop%26aufirst%3DM.%2BJ.%26aulast%3DBritt%26aufirst%3DC.%2BS.%26aulast%3DCarlton%26aufirst%3DD.%2BL.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DDaniels%26aufirst%3DA.%2BJ.%26aulast%3DGarrido%26aufirst%3DD.%2BM.%26aulast%3DGoetz%26aufirst%3DA.%2BS.%26aulast%3DGrizzle%26aufirst%3DM.%2BK.%26aulast%3DGuo%26aufirst%3DY.%2BC.%26aulast%3DHandlon%26aufirst%3DA.%2BL.%26aulast%3DIgnar%26aufirst%3DD.%2BM.%26aulast%3DMorgan%26aufirst%3DR.%2BO.%26aulast%3DPeat%26aufirst%3DA.%2BJ.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520and%2520optimization%2520of%2520pyrimidinone-containing%2520MCH%2520R1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4723%26epage%3D4727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ulven, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Receveur, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rist, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NÃ¸rregaard, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ¶gberg, T.</span><span> </span><span class="NLM_article-title">6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structureâactivity relationship, and investigation of binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5684</span><span class="NLM_x">â</span> <span class="NLM_lpage">5697</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050103y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5684-5697&author=T.+Ulvenauthor=T.+M.+Frimurerauthor=J.+M.+Receveurauthor=P.+B.+Littleauthor=O.+Ristauthor=P.+K.+N%C3%B8rregaardauthor=T.+H%C3%B6gberg&title=6-Acylamino-2-aminoquinolines+as+potent+melanin-concentrating+hormone+1+receptor+antagonists.+Identification%2C+structure%E2%80%93activity+relationship%2C+and+investigation+of+binding+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm050103y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050103y%26sid%3Dliteratum%253Aachs%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DReceveur%26aufirst%3DJ.%2BM.%26aulast%3DLittle%26aufirst%3DP.%2BB.%26aulast%3DRist%26aufirst%3DO.%26aulast%3DN%25C3%25B8rregaard%26aufirst%3DP.%2BK.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DT.%26atitle%3D6-Acylamino-2-aminoquinolines%2520as%2520potent%2520melanin-concentrating%2520hormone%25201%2520receptor%2520antagonists.%2520Identification%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520investigation%2520of%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5684%26epage%3D5697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhern, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodjian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kym, P. R.</span><span> </span><span class="NLM_article-title">Identification of 2-(4-benzyloxyphenyl)-<i>N</i>-[1-(2-pyrrolidin-1-yl-ethyl)-1<i>H</i>-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1318</span><span class="NLM_x">â</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0490890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1318-1321&author=A.+J.+Souersauthor=J.+Gaoauthor=M.+Bruneauthor=E.+Bushauthor=D.+Wodkaauthor=A.+Vasudevanauthor=A.+S.+Juddauthor=M.+Mulhernauthor=S.+Brodjianauthor=B.+Daytonauthor=R.+Shapiroauthor=L.+E.+Hernandezauthor=K.+C.+Marshauthor=H.+L.+Shamauthor=C.+A.+Collinsauthor=P.+R.+Kym&title=Identification+of+2-%284-benzyloxyphenyl%29-N-%5B1-%282-pyrrolidin-1-yl-ethyl%29-1H-indazol-6-yl%5Dacetamide%2C+an+orally+efficacious+melanin-concentrating+hormone+receptor+1+antagonist+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0490890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0490890%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBrune%26aufirst%3DM.%26aulast%3DBush%26aufirst%3DE.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DJudd%26aufirst%3DA.%2BS.%26aulast%3DMulhern%26aufirst%3DM.%26aulast%3DBrodjian%26aufirst%3DS.%26aulast%3DDayton%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DR.%26aulast%3DHernandez%26aufirst%3DL.%2BE.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DKym%26aufirst%3DP.%2BR.%26atitle%3DIdentification%2520of%25202-%25284-benzyloxyphenyl%2529-N-%255B1-%25282-pyrrolidin-1-yl-ethyl%2529-1H-indazol-6-yl%255Dacetamide%252C%2520an%2520orally%2520efficacious%2520melanin-concentrating%2520hormone%2520receptor%25201%2520antagonist%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1318%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Johansson, A.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists</span> <span class="citation_source-journal">Curr. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">â</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1517%2F13543776.2011.575063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmt1ymurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=905-925&author=A.+Johansson&title=Recent+progress+in+the+discovery+of+melanin-concentrating+hormone+1-receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists</span></div><div class="casAuthors">Johansson, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">905-925</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The appetite stimulating effects of melanin-concg. hormone (MCH) continues to be of high interest, and there is substantial support to investigate the use of MCH 1-receptor antagonists for the treatment of obesity.  Other areas of potential use for MCH 1-receptor antagonists include depression and anxiety.  There are, to date, no clin. proof of concept data, and efforts are ongoing for the discovery of novel MCH 1-receptor antagonists, as evidenced by the no. of patent applications published over the last 5 years.  Areas covered: This review covers the patent literature on MCH 1-receptor antagonists from Jan. 2006 to Nov. 2010.  The emphasis is on disclosed biol. data, esp. in vivo data, of exemplified compds.  Wherever possible, selectivity towards undesired pharmacol. is analyzed.  Expert opinion: Over the years, different approaches have been taken to overcome the undesired effects of MCH 1-receptor antagonists, such as interactions with the hERG channel.  Many programs have faced difficulties and, to date, only a few compds. have progressed into humans.  From this point of view, the MCH 1-receptor is regarded as a difficult target, and whether newer programs will be successful depends, to a large extent, on their selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2AqNTXpEOkbVg90H21EOLACvtfcHk0lggPuUYyctYAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmt1ymurY%253D&md5=7df352cf7d1e33d0e245d09672c647fc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.575063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.575063%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520melanin-concentrating%2520hormone%25201-receptor%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D905%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rokosz, L. L.</span><span> </span><span class="NLM_article-title">Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">â</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1301-1327&author=L.+L.+Rokosz&title=Discovery+and+development+of+melanin-concentrating+hormone+receptor+1+antagonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRokosz%26aufirst%3DL.%2BL.%26atitle%3DDiscovery%2520and%2520development%2520of%2520melanin-concentrating%2520hormone%2520receptor%25201%2520antagonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D1301%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kowalski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=311-321&author=T.+J.+Kowalskiauthor=T.+Sasikumar&title=Melanin-concentrating+hormone+receptor-1+antagonists+as+antiobesity+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DT.%2BJ.%26aulast%3DSasikumar%26aufirst%3DT.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor-1%2520antagonists%2520as%2520antiobesity%2520therapeutics%26jtitle%3DBioDrugs%26date%3D2007%26volume%3D21%26spage%3D311%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Handlon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor-1 antagonists for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4017</span><span class="NLM_x">â</span> <span class="NLM_lpage">4022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058239j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4017-4022&author=A.+L.+Handlonauthor=H.+Zhou&title=Melanin-concentrating+hormone+receptor-1+antagonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm058239j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058239j%26sid%3Dliteratum%253Aachs%26aulast%3DHandlon%26aufirst%3DA.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor-1%2520antagonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4017%26epage%3D4022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mendez-Andino, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wos, J. A.</span><span> </span><span class="NLM_article-title">MCH-R1 antagonists: What is keeping most research programs away from the clinic?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">972</span><span class="NLM_x">â</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=972-979&author=J.+L.+Mendez-Andinoauthor=J.+A.+Wos&title=MCH-R1+antagonists%3A+What+is+keeping+most+research+programs+away+from+the+clinic%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendez-Andino%26aufirst%3DJ.%2BL.%26aulast%3DWos%26aufirst%3DJ.%2BA.%26atitle%3DMCH-R1%2520antagonists%253A%2520What%2520is%2520keeping%2520most%2520research%2520programs%2520away%2520from%2520the%2520clinic%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D972%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kamata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagisa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor-1 antagonists. Synthesis and structureâactivity relationships of novel 3-(aminomethyl)quinolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2353</span><span class="NLM_x">â</span> <span class="NLM_lpage">2366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201596h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2353-2366&author=M.+Kamataauthor=T.+Yamashitaauthor=T.+Imaedaauthor=S.+Masadaauthor=M.+Kamauraauthor=S.+Kasaiauthor=R.+Haraauthor=S.+Sasakiauthor=S.+Takekawaauthor=A.+Asamiauthor=T.+Kaishoauthor=N.+Suzukiauthor=S.+Ashinaauthor=H.+Oginoauthor=Y.+Nakanoauthor=Y.+Nagisaauthor=K.+Katoauthor=K.+Katoauthor=Y.+Ishihara&title=Melanin-concentrating+hormone+receptor-1+antagonists.+Synthesis+and+structure%E2%80%93activity+relationships+of+novel+3-%28aminomethyl%29quinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm201596h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201596h%26sid%3Dliteratum%253Aachs%26aulast%3DKamata%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DT.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DR.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DAsami%26aufirst%3DA.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DAshina%26aufirst%3DS.%26aulast%3DOgino%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DNagisa%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DY.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor-1%2520antagonists.%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%25203-%2528aminomethyl%2529quinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2353%26epage%3D2366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lim, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, K. Y.</span><span> </span><span class="NLM_article-title">Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2309</span><span class="NLM_x">â</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2309-2312&author=C.+J.+Limauthor=N.+Kimauthor=E.+K.+Leeauthor=B.+H.+Leeauthor=K.+S.+Ohauthor=S.+E.+Yooauthor=K.+Y.+Yi&title=Synthesis+and+SAR+investigations+of+novel+2-arylbenzimidazole+derivatives+as+melanin-concentrating+hormone+receptor+1+%28MCH-R1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DC.%2BJ.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DOh%26aufirst%3DK.%2BS.%26aulast%3DYoo%26aufirst%3DS.%2BE.%26aulast%3DYi%26aufirst%3DK.%2BY.%26atitle%3DSynthesis%2520and%2520SAR%2520investigations%2520of%2520novel%25202-arylbenzimidazole%2520derivatives%2520as%2520melanin-concentrating%2520hormone%2520receptor%25201%2520%2528MCH-R1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2309%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Berglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span> </span><span class="NLM_article-title">Discovery of 1,3-disubstituted-1<i>H</i>-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4859</span><span class="NLM_x">â</span> <span class="NLM_lpage">4863</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4859-4863&author=S.+Berglundauthor=B.+J.+Egnerauthor=H.+Gradenauthor=J.+Gradenauthor=D.+G.+Morganauthor=T.+Inghardtauthor=F.+Giordanetto&title=Discovery+of+1%2C3-disubstituted-1H-pyrrole+derivatives+as+potent+melanin-concentrating+hormone+receptor+1+%28MCH-R1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerglund%26aufirst%3DS.%26aulast%3DEgner%26aufirst%3DB.%2BJ.%26aulast%3DGraden%26aufirst%3DH.%26aulast%3DGraden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DInghardt%26aufirst%3DT.%26aulast%3DGiordanetto%26aufirst%3DF.%26atitle%3DDiscovery%2520of%25201%252C3-disubstituted-1H-pyrrole%2520derivatives%2520as%2520potent%2520melanin-concentrating%2520hormone%2520receptor%25201%2520%2528MCH-R1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4859%26epage%3D4863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kasai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagisa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor 1 antagonists: structureâactivity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1<i>H</i>-benzaxepine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6261</span><span class="NLM_x">â</span> <span class="NLM_lpage">6273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6261-6273&author=S.+Kasaiauthor=M.+Kamauraauthor=M.+Kamataauthor=K.+Asoauthor=H.+Oginoauthor=Y.+Nakanoauthor=K.+Watanabeauthor=T.+Kaishoauthor=M.+Tawadaauthor=Y.+Nagisaauthor=S.+Takekawaauthor=K.+Katoauthor=N.+Suzukiauthor=Y.+Ishihara&title=Melanin-concentrating+hormone+receptor+1+antagonists%3A+structure%E2%80%93activity+relationship%2C+docking+studies%2C+and+biological+evaluation+of+2%2C3%2C4%2C5-tetrahydro-1H-benzaxepine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DKamata%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DK.%26aulast%3DOgino%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DNagisa%26aufirst%3DY.%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIshihara%26aufirst%3DY.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor%25201%2520antagonists%253A%2520structure%25E2%2580%2593activity%2520relationship%252C%2520docking%2520studies%252C%2520and%2520biological%2520evaluation%2520of%25202%252C3%252C4%252C5-tetrahydro-1H-benzaxepine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6261%26epage%3D6273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kasai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagisa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span> </span><span class="NLM_article-title">Synthesis, structureâactivity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether a-go-go-related gene (hERG) associated liabilities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4336</span><span class="NLM_x">â</span> <span class="NLM_lpage">4351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300167z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4336-4351&author=S.+Kasaiauthor=M.+Kamauraauthor=S.+Masadaauthor=J.+Kunitomoauthor=M.+Kamauraauthor=T.+Okawaauthor=K.+Takamiauthor=H.+Oginoauthor=Y.+Nakanoauthor=S.+Ashinaauthor=K.+Watanabeauthor=T.+Kaishoauthor=Y.+N.+Imaiauthor=S.+Ryuauthor=M.+Nakayamaauthor=Y.+Nagisaauthor=S.+Takekawaauthor=K.+Katoauthor=T.+Murataauthor=N.+Suzukiauthor=Y.+Ishihara&title=Synthesis%2C+structure%E2%80%93activity+relationship%2C+and+pharmacological+studies+of+novel+melanin-concentrating+hormone+receptor+1+antagonists+3-aminomethylquinolines%3A+reducing+human+ether+a-go-go-related+gene+%28hERG%29+associated+liabilities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm300167z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300167z%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DOkawa%26aufirst%3DT.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOgino%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DAshina%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%2BN.%26aulast%3DRyu%26aufirst%3DS.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DNagisa%26aufirst%3DY.%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIshihara%26aufirst%3DY.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520pharmacological%2520studies%2520of%2520novel%2520melanin-concentrating%2520hormone%2520receptor%25201%2520antagonists%25203-aminomethylquinolines%253A%2520reducing%2520human%2520ether%2520a-go-go-related%2520gene%2520%2528hERG%2529%2520associated%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4336%26epage%3D4351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sasmal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasmal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbineni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roshaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suresh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shashikuma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimure, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rist, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ¶gberg, T.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: focus to detune hERG inhibition</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">â</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=285-289&author=P.+K.+Sasmalauthor=S.+Sasmalauthor=C.+Abbineniauthor=B.+Venkateshamauthor=P.+T.+Raoauthor=M.+Roshaiahauthor=I.+Khannaauthor=V.+J.+Sebastianauthor=J.+Sureshauthor=M.+P.+Singhauthor=R.+Talwarauthor=D.+Shashikumaauthor=K.+H.+Reddyauthor=T.+M.+Frimureauthor=O.+Ristauthor=L.+Elsterauthor=T.+H%C3%B6gberg&title=Synthesis+and+SAR+studies+of+benzimidazole+derivatives+as+melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonists%3A+focus+to+detune+hERG+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasmal%26aufirst%3DP.%2BK.%26aulast%3DSasmal%26aufirst%3DS.%26aulast%3DAbbineni%26aufirst%3DC.%26aulast%3DVenkatesham%26aufirst%3DB.%26aulast%3DRao%26aufirst%3DP.%2BT.%26aulast%3DRoshaiah%26aufirst%3DM.%26aulast%3DKhanna%26aufirst%3DI.%26aulast%3DSebastian%26aufirst%3DV.%2BJ.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DM.%2BP.%26aulast%3DTalwar%26aufirst%3DR.%26aulast%3DShashikuma%26aufirst%3DD.%26aulast%3DReddy%26aufirst%3DK.%2BH.%26aulast%3DFrimure%26aufirst%3DT.%2BM.%26aulast%3DRist%26aufirst%3DO.%26aulast%3DElster%26aufirst%3DL.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520benzimidazole%2520derivatives%2520as%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonists%253A%2520focus%2520to%2520detune%2520hERG%2520inhibition%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D285%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hadden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deering, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khmelnitsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viggers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, P. R.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-aryl-(1-indazol-5-yl)pyridine-2(1<i>H</i>)ones as MCH-1 antagonists for the treatment of obesity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7020</span><span class="NLM_x">â</span> <span class="NLM_lpage">7023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7020-7023&author=M.+Haddenauthor=D.+M.+Deeringauthor=A.+J.+Hendersonauthor=M.+D.+Surmanauthor=M.+Lucheauthor=Y.+Khmelnitskyauthor=S.+Vickersauthor=J.+Viggersauthor=S.+Cheethamauthor=P.+R.+Guzzo&title=Synthesis+and+SAR+of+4-aryl-%281-indazol-5-yl%29pyridine-2%281H%29ones+as+MCH-1+antagonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadden%26aufirst%3DM.%26aulast%3DDeering%26aufirst%3DD.%2BM.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26aulast%3DSurman%26aufirst%3DM.%2BD.%26aulast%3DLuche%26aufirst%3DM.%26aulast%3DKhmelnitsky%26aufirst%3DY.%26aulast%3DVickers%26aufirst%3DS.%26aulast%3DViggers%26aufirst%3DJ.%26aulast%3DCheetham%26aufirst%3DS.%26aulast%3DGuzzo%26aufirst%3DP.%2BR.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-aryl-%25281-indazol-5-yl%2529pyridine-2%25281H%2529ones%2520as%2520MCH-1%2520antagonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7020%26epage%3D7023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mihalic, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">â</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3781-3785&author=J.+T.+Mihalicauthor=P.+Fanauthor=X.+Chenauthor=X.+Chenauthor=Y.+Fuauthor=A.+Motaniauthor=L.+Liangauthor=M.+Lindstromauthor=L.+Tangauthor=J.+L.+Chenauthor=J.+Jaenauthor=K.+Daiauthor=L.+Li&title=Discovery+of+a+novel+melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonist+with+reduced+hERG+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalic%26aufirst%3DJ.%2BT.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DMotani%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DJaen%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonist%2520with%2520reduced%2520hERG%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3781%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Devenny, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godonis, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelleymounter, M. A.</span><span> </span><span class="NLM_article-title">Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">â</span> <span class="NLM_lpage">45â1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1038%2Foby.2012.59" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=16-45%E2%80%931652&author=J.+J.+Devennyauthor=H.+E.+Godonisauthor=S.+J.+Harveyauthor=S.+Rooneyauthor=M.+J.+Cullenauthor=M.+A.+Pelleymounter&title=Weight+loss+induced+by+chronic+dapagliflozin+treatment+is+attenuated+by+compensatory+hyperphagia+in+diet-induced+obese+%28DIO%29+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Foby.2012.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2012.59%26sid%3Dliteratum%253Aachs%26aulast%3DDevenny%26aufirst%3DJ.%2BJ.%26aulast%3DGodonis%26aufirst%3DH.%2BE.%26aulast%3DHarvey%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DS.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DPelleymounter%26aufirst%3DM.%2BA.%26atitle%3DWeight%2520loss%2520induced%2520by%2520chronic%2520dapagliflozin%2520treatment%2520is%2520attenuated%2520by%2520compensatory%2520hyperphagia%2520in%2520diet-induced%2520obese%2520%2528DIO%2529%2520rats%26jtitle%3DObesity%26date%3D2012%26volume%3D20%26spage%3D16%26epage%3D45%25E2%2580%25931652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Rat MCHR1 <i>K</i><sub>i</sub> values were also determined for all compounds prior to evaluation for in vivo efficacy. In all instances the rat MCHR1 <i>K</i><sub>i</sub> value was within a factor of 2 of the human MCHR1 <i>K</i><sub>i</sub> value.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">The chirality of <b>28</b> was assigned based on the coincident retention time of <b>28</b> using a chiral column with that of the product generated by alkylation of phenol <b>20</b> with the cyclopropanated product obtained by treatment of commercial (<i>S</i>)-2-hydroxybut-3-enyl 4-methylbenzenesulfonate with Et<sub>2</sub>Zn/CH<sub>2</sub>I<sub>2</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">Angiotensin, APJ, calcitonin gene related peptide, cholecystokinin A, cholecystokinin B, G-protein-coupled receptor 8, galanin 1, galanin 2, histamine H3, leptin, melanocortin 3, melanocortin 4, melatonin 1, melatonin 2, neuromedin U1, neuromedin U2, neurotensin 1, neurotensin nonselective, somatostatin, urotensin II.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">Despite aqueous solubility of <b>27</b> and related thienopyrimidinones analogs being <1 mg/mL, nephelometry studies confirmed that stable 40 Î¼M solutions required for in vitro profiling could be prepared by addition of a DMSO stock solution to aqueous buffer.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Calverley, M. J.</span><span> </span><span class="NLM_article-title">Synthesis of MC 903, a biologically active vitamin D metabolite analogue</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4609</span><span class="NLM_x">â</span> <span class="NLM_lpage">4619</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=4609-4619&author=M.+J.+Calverley&title=Synthesis+of+MC+903%2C+a+biologically+active+vitamin+D+metabolite+analogue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalverley%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520of%2520MC%2520903%252C%2520a%2520biologically%2520active%2520vitamin%2520D%2520metabolite%2520analogue%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D4609%26epage%3D4619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Leff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougall, I. G.</span><span> </span><span class="NLM_article-title">Further concerns over ChengâPrusoff analysis</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">â</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1993&pages=110-112&author=P.+Leffauthor=I.+G.+Dougall&title=Further+concerns+over+Cheng%E2%80%93Prusoff+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DDougall%26aufirst%3DI.%2BG.%26atitle%3DFurther%2520concerns%2520over%2520Cheng%25E2%2580%2593Prusoff%2520analysis%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1993%26volume%3D14%26spage%3D110%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':[],'ref31':[],'ref32':[],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saleem  Ahmad</span>, <span class="hlFld-ContribAuthor ">William N.  Washburn</span>, <span class="hlFld-ContribAuthor ">Andres S.  Hernandez</span>, <span class="hlFld-ContribAuthor ">Sharon  Bisaha</span>, <span class="hlFld-ContribAuthor ">Khehyong  Ngu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Pelleymounter</span>, <span class="hlFld-ContribAuthor ">Daniel  Longhi</span>, <span class="hlFld-ContribAuthor ">Neil  Flynn</span>, <span class="hlFld-ContribAuthor ">Anthony V.  Azzara</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rohrbach</span>, <span class="hlFld-ContribAuthor ">James  Devenny</span>, <span class="hlFld-ContribAuthor ">Suzanne  Rooney</span>, <span class="hlFld-ContribAuthor ">Michael  Thomas</span>, <span class="hlFld-ContribAuthor ">Susan  Glick</span>, <span class="hlFld-ContribAuthor ">Helen  Godonis</span>, <span class="hlFld-ContribAuthor ">Susan  Harvey</span>, <span class="hlFld-ContribAuthor ">Hongwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Brian  Gemzik</span>, <span class="hlFld-ContribAuthor ">Evan B.  Janovitz</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa  Zhang</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, and <span class="hlFld-ContribAuthor ">Brian J.  Murphy</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8848-8858. <a href="https://doi.org/10.1021/acs.jmedchem.6b00676" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00676%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAntiobesity%252BProperties%252Bof%252B6-%2525284-Chlorophenyl%252529-3-%2525284-%252528%2525283%25252C3-difluoro-1-hydroxycyclobutyl%252529methoxy%252529-3-methoxyphenyl%252529thieno%25255B3%25252C2-d%25255Dpyrimidin-4%2525283H%252529-one%252B%252528BMS-814580%252529%25253A%252BA%252BHighly%252BEfficacious%252BMelanin%252BConcentrating%252BHormone%252BReceptor%252B1%252B%252528MCHR1%252529%252BInhibitor%26aulast%3DAhmad%26aufirst%3DSaleem%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03052016%26date%3D15092016%26date%3D13102016%26date%3D26082016%26volume%3D59%26issue%3D19%26spage%3D8848%26epage%3D8858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Johansson</span>, <span class="hlFld-ContribAuthor ">Christian  LÃ¶fberg</span>, <span class="hlFld-ContribAuthor ">Madeleine  Antonsson</span>, <span class="hlFld-ContribAuthor ">Sverker  von Unge</span>, <span class="hlFld-ContribAuthor ">Martin A.  Hayes</span>, <span class="hlFld-ContribAuthor ">Robert  Judkins</span>, <span class="hlFld-ContribAuthor ">Karolina  Ploj</span>, <span class="hlFld-ContribAuthor ">Lambertus  Benthem</span>, <span class="hlFld-ContribAuthor ">Daniel  LindÃ©n</span>, <span class="hlFld-ContribAuthor ">Peter  Brodin</span>, <span class="hlFld-ContribAuthor ">Marie  Wennerberg</span>, <span class="hlFld-ContribAuthor ">MarlÃ©ne  Fredenwall</span>, <span class="hlFld-ContribAuthor ">Lanna  Li</span>, <span class="hlFld-ContribAuthor ">Joachim  Persson</span>, <span class="hlFld-ContribAuthor ">Rolf  Bergman</span>, <span class="hlFld-ContribAuthor ">Anna  Pettersen</span>, <span class="hlFld-ContribAuthor ">Peter  Gennemark</span>, and <span class="hlFld-ContribAuthor ">Anders  Hogner</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2497-2511. <a href="https://doi.org/10.1021/acs.jmedchem.5b01654" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01654</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01654%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525283-%2525284-%2525282-Oxa-6-azaspiro%25255B3.3%25255Dheptan-6-ylmethyl%252529phenoxy%252529azetidin-1-yl%252529%2525285-%2525284-methoxyphenyl%252529-1%25252C3%25252C4-oxadiazol-2-yl%252529methanone%252B%252528AZD1979%252529%25252C%252Ba%252BMelanin%252BConcentrating%252BHormone%252BReceptor%252B1%252B%252528MCHr1%252529%252BAntagonist%252Bwith%252BFavorable%252BPhysicochemical%252BProperties%26aulast%3DJohansson%26aufirst%3DAnders%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22102015%26date%3D05022016%26date%3D24032016%26date%3D07012016%26volume%3D59%26issue%3D6%26spage%3D2497%26epage%3D2511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideyuki  Igawa</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Keiko  Kakegawa</span>, <span class="hlFld-ContribAuthor ">Asato  Kina</span>, <span class="hlFld-ContribAuthor ">Minoru  Ikoma</span>, <span class="hlFld-ContribAuthor ">Jumpei  Aida</span>, <span class="hlFld-ContribAuthor ">Tsuneo  Yasuma</span>, <span class="hlFld-ContribAuthor ">Yayoi  Kawata</span>, <span class="hlFld-ContribAuthor ">Shuntaro  Ashina</span>, <span class="hlFld-ContribAuthor ">Syunsuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Mrinalkanti  Kundu</span>, <span class="hlFld-ContribAuthor ">Uttam  Khamrai</span>, <span class="hlFld-ContribAuthor ">Hideki  Hirabayashi</span>, <span class="hlFld-ContribAuthor ">Masaharu  Nakayama</span>, <span class="hlFld-ContribAuthor ">Yasutaka  Nagisa</span>, <span class="hlFld-ContribAuthor ">Shizuo  Kasai</span>, and <span class="hlFld-ContribAuthor ">Tsuyoshi  Maekawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and StructureâActivity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 1116-1139. <a href="https://doi.org/10.1021/acs.jmedchem.5b01704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMelanin-Concentrating%252BHormone%252BReceptor%252B1%252BAntagonists%252BLacking%252Ban%252BAliphatic%252BAmine%25253A%252BSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BNovel%252B1-%252528Imidazo%25255B1%25252C2-a%25255Dpyridin-6-yl%252529pyridin-2%2525281H%252529-one%252BDerivatives%26aulast%3DIgawa%26aufirst%3DHideyuki%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D01112015%26date%3D22012016%26date%3D11022016%26date%3D06012016%26volume%3D59%26issue%3D3%26spage%3D1116%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuntaro  Izawa</span>, <span class="hlFld-ContribAuthor ">Takeshi  Yoneshiro</span>, <span class="hlFld-ContribAuthor ">Kunio  Kondoh</span>, <span class="hlFld-ContribAuthor ">Shohei  Nakagiri</span>, <span class="hlFld-ContribAuthor ">Yuko  OkamatsuâOgura</span>, <span class="hlFld-ContribAuthor ">Akira  Terao</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Minokoshi</span>, <span class="hlFld-ContribAuthor ">Akihiro  Yamanaka</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Kimura</span>. </span><span class="cited-content_cbyCitation_article-title">Melaninâconcentrating hormoneâproducing neurons in the hypothalamus regulate brown adipose tissue and thus contribute to energy expenditure. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physiology</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1113/JP281241" title="DOI URL">https://doi.org/10.1113/JP281241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1113/JP281241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1113%2FJP281241%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physiology%26atitle%3DMelanin%2525E2%252580%252590concentrating%252Bhormone%2525E2%252580%252590producing%252Bneurons%252Bin%252Bthe%252Bhypothalamus%252Bregulate%252Bbrown%252Badipose%252Btissue%252Band%252Bthus%252Bcontribute%252Bto%252Benergy%252Bexpenditure%26aulast%3DIzawa%26aufirst%3DShuntaro%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salwa E. M.  El-Meligie</span>, <span class="hlFld-ContribAuthor ">Nadia A.  Khalil</span>, <span class="hlFld-ContribAuthor ">Hala B.  El-Nassan</span>, <span class="hlFld-ContribAuthor ">Ahmed A. M.  Ibraheem</span>. </span><span class="cited-content_cbyCitation_article-title">New synthetic approaches to thieno[3,2-d]pyrimidine and thieno[3,4-b]pyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2020,</strong> <em>74 </em>
                                    (8)
                                     , 2501-2514. <a href="https://doi.org/10.1007/s11696-020-01089-2" title="DOI URL">https://doi.org/10.1007/s11696-020-01089-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-020-01089-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-020-01089-2%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DNew%252Bsynthetic%252Bapproaches%252Bto%252Bthieno%25255B3%25252C2-d%25255Dpyrimidine%252Band%252Bthieno%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%26aulast%3DEl-Meligie%26aufirst%3DSalwa%2BE.%2BM.%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D8%26spage%3D2501%26epage%3D2514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yayoi  Kawata</span>, <span class="hlFld-ContribAuthor ">Shoki  Okuda</span>, <span class="hlFld-ContribAuthor ">Natsu  Hotta</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Igawa</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Minoru  Ikoma</span>, <span class="hlFld-ContribAuthor ">Shizuo  Kasai</span>, <span class="hlFld-ContribAuthor ">Ayumi  Ando</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Satomi</span>, <span class="hlFld-ContribAuthor ">Mayumi  Nishida</span>, <span class="hlFld-ContribAuthor ">Masaharu  Nakayama</span>, <span class="hlFld-ContribAuthor ">Syunsuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Yasutaka  Nagisa</span>, <span class="hlFld-ContribAuthor ">Shiro  Takekawa</span>. </span><span class="cited-content_cbyCitation_article-title">A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>796 </em>, 45-53. <a href="https://doi.org/10.1016/j.ejphar.2016.12.018" title="DOI URL">https://doi.org/10.1016/j.ejphar.2016.12.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2016.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2016.12.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bnovel%252Band%252Bselective%252Bmelanin-concentrating%252Bhormone%252Breceptor%252B1%252Bantagonist%252Bameliorates%252Bobesity%252Band%252Bhepatic%252Bsteatosis%252Bin%252Bdiet-induced%252Bobese%252Brodent%252Bmodels%26aulast%3DKawata%26aufirst%3DYayoi%26date%3D2017%26volume%3D796%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Tarrant</span>, <span class="hlFld-ContribAuthor ">K.J.  Hodgetts</span>, <span class="hlFld-ContribAuthor ">B.L.  Chenard</span>, <span class="hlFld-ContribAuthor ">J.E.  Krause</span>, <span class="hlFld-ContribAuthor ">D.  Doller</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of the MCH-1 Receptor Antagonist NGD-4715 for the Potential Treatment of Obesity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 488-515. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13785-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13785-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13785-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13785-0%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252Bthe%252BMCH-1%252BReceptor%252BAntagonist%252BNGD-4715%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BObesity%26aulast%3DTarrant%26aufirst%3DJ.%26date%3D2017%26spage%3D488%26epage%3D515%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">ViktÃ³ria  BÃ³dai</span>, <span class="hlFld-ContribAuthor ">LÃ¡szlÃ³  Nagy-GyÅr</span>, <span class="hlFld-ContribAuthor ">RÃ³bert  ÃrkÃ©nyi</span>, <span class="hlFld-ContribAuthor ">ZsÃ³fia  MolnÃ¡r</span>, <span class="hlFld-ContribAuthor ">Szabolcs  KohÃ¡ri</span>, <span class="hlFld-ContribAuthor ">BalÃ¡zs  ErdÃ©lyi</span>, <span class="hlFld-ContribAuthor ">Zsuzsanna  NagymÃ¡tÃ©</span>, <span class="hlFld-ContribAuthor ">Csaba  Romsics</span>, <span class="hlFld-ContribAuthor ">Csaba  Paizs</span>, <span class="hlFld-ContribAuthor ">LÃ¡szlÃ³  Poppe</span>, <span class="hlFld-ContribAuthor ">GÃ¡bor  HornyÃ¡nszky</span>. </span><span class="cited-content_cbyCitation_article-title">Wickerhamomyces subpelliculosus  as whole-cell biocatalyst for stereoselective bioreduction of ketones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Catalysis B: Enzymatic</span><span> <strong>2016,</strong> <em>134 </em>, 206-214. <a href="https://doi.org/10.1016/j.molcatb.2016.11.003" title="DOI URL">https://doi.org/10.1016/j.molcatb.2016.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcatb.2016.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcatb.2016.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Catalysis%2520B%253A%2520Enzymatic%26atitle%3DWickerhamomyces%252Bsubpelliculosus%252Bas%252Bwhole-cell%252Bbiocatalyst%252Bfor%252Bstereoselective%252Bbioreduction%252Bof%252Bketones%26aulast%3DB%25C3%25B3dai%26aufirst%3DVikt%25C3%25B3ria%26date%3D2016%26volume%3D134%26spage%3D206%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Johansson</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of physicochemical properties of melanin concentrating hormone receptor 1 (MCHr1) antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (19)
                                     , 4559-4564. <a href="https://doi.org/10.1016/j.bmcl.2016.08.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvolution%252Bof%252Bphysicochemical%252Bproperties%252Bof%252Bmelanin%252Bconcentrating%252Bhormone%252Breceptor%252B1%252B%252528MCHr1%252529%252Bantagonists%26aulast%3DJohansson%26aufirst%3DAnders%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4559%26epage%3D4564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Ploj</span>, <span class="hlFld-ContribAuthor ">Lambertus  Benthem</span>, <span class="hlFld-ContribAuthor ">Dorota  Kakol-Palm</span>, <span class="hlFld-ContribAuthor ">Peter  Gennemark</span>, <span class="hlFld-ContribAuthor ">Liselotte  Andersson</span>, <span class="hlFld-ContribAuthor ">Mikael  Bjursell</span>, <span class="hlFld-ContribAuthor ">Jenny  BÃ¶rjesson</span>, <span class="hlFld-ContribAuthor ">Lillevi  KÃ¤rrberg</span>, <span class="hlFld-ContribAuthor ">Marianne  MÃ¥nsson</span>, <span class="hlFld-ContribAuthor ">Madeleine  Antonsson</span>, <span class="hlFld-ContribAuthor ">Anders  Johansson</span>, <span class="hlFld-ContribAuthor ">Suzanne  Iverson</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  Carlsson</span>, <span class="hlFld-ContribAuthor ">Andrew  Turnbull</span>, <span class="hlFld-ContribAuthor ">Daniel  LindÃ©n</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of a novel potent melanin-concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2016,</strong> <em>173 </em>
                                    (18)
                                     , 2739-2751. <a href="https://doi.org/10.1111/bph.13548" title="DOI URL">https://doi.org/10.1111/bph.13548</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13548%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DEffects%252Bof%252Ba%252Bnovel%252Bpotent%252Bmelanin-concentrating%252Bhormone%252Breceptor%252B1%252Bantagonist%25252C%252BAZD1979%25252C%252Bon%252Bbody%252Bweight%252Bhomeostasis%252Bin%252Bmice%252Band%252Bdogs%26aulast%3DPloj%26aufirst%3DKarolina%26date%3D2016%26date%3D2016%26volume%3D173%26issue%3D18%26spage%3D2739%26epage%3D2751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideyuki  Igawa</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Minoru  Ikoma</span>, <span class="hlFld-ContribAuthor ">Hiromi  Kaku</span>, <span class="hlFld-ContribAuthor ">Keiko  Kakegawa</span>, <span class="hlFld-ContribAuthor ">Asato  Kina</span>, <span class="hlFld-ContribAuthor ">Jumpei  Aida</span>, <span class="hlFld-ContribAuthor ">Shoki  Okuda</span>, <span class="hlFld-ContribAuthor ">Yayoi  Kawata</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Noguchi</span>, <span class="hlFld-ContribAuthor ">Natsu  Hotta</span>, <span class="hlFld-ContribAuthor ">Syunsuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Masaharu  Nakayama</span>, <span class="hlFld-ContribAuthor ">Yasutaka  Nagisa</span>, <span class="hlFld-ContribAuthor ">Shizuo  Kasai</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Maekawa</span>. </span><span class="cited-content_cbyCitation_article-title">Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel non-basic 1-(2H-indazole-5-yl)pyridin-2(1H)-one derivatives and mitigation of mutagenicity in Ames test. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (11)
                                     , 2504-2518. <a href="https://doi.org/10.1016/j.bmc.2016.04.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAmine-free%252Bmelanin-concentrating%252Bhormone%252Breceptor%252B1%252Bantagonists%25253A%252BNovel%252Bnon-basic%252B1-%2525282H-indazole-5-yl%252529pyridin-2%2525281H%252529-one%252Bderivatives%252Band%252Bmitigation%252Bof%252Bmutagenicity%252Bin%252BAmes%252Btest%26aulast%3DIgawa%26aufirst%3DHideyuki%26date%3D2016%26volume%3D24%26issue%3D11%26spage%3D2504%26epage%3D2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratik  Devasthale</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">James  Mignone</span>, <span class="hlFld-ContribAuthor ">Kishore  Renduchintala</span>, <span class="hlFld-ContribAuthor ">Sridhar  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Jayanthi  Dhanapal</span>, <span class="hlFld-ContribAuthor ">Jagannath  Selvaraj</span>, <span class="hlFld-ContribAuthor ">Rajesh  Kuppusamy</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Pelleymounter</span>, <span class="hlFld-ContribAuthor ">Daniel  Longhi</span>, <span class="hlFld-ContribAuthor ">Ning  Huang</span>, <span class="hlFld-ContribAuthor ">Neil  Flynn</span>, <span class="hlFld-ContribAuthor ">Anthony V.  Azzara</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rohrbach</span>, <span class="hlFld-ContribAuthor ">James  Devenny</span>, <span class="hlFld-ContribAuthor ">Suzanne  Rooney</span>, <span class="hlFld-ContribAuthor ">Michael  Thomas</span>, <span class="hlFld-ContribAuthor ">Susan  Glick</span>, <span class="hlFld-ContribAuthor ">Helen  Godonis</span>, <span class="hlFld-ContribAuthor ">Susan  Harvey</span>, <span class="hlFld-ContribAuthor ">Mary Jane  Cullen</span>, <span class="hlFld-ContribAuthor ">Hongwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Christian  Caporuscio</span>, <span class="hlFld-ContribAuthor ">Paul  Stetsko</span>, <span class="hlFld-ContribAuthor ">Mary  Grubb</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa  Zhang</span>, <span class="hlFld-ContribAuthor ">Chris  Freeden</span>, <span class="hlFld-ContribAuthor ">Brian J.  Murphy</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">William N.  Washburn</span>. </span><span class="cited-content_cbyCitation_article-title">Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4412-4418. <a href="https://doi.org/10.1016/j.bmcl.2015.09.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNon-basic%252Bazolotriazinone%252BMCHR1%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%25253A%252BAn%252Bempirical%252Bbrain-exposures-driven%252Bcandidate%252Bselection%252Bfor%252Bin%252Bvivo%252Befficacy%252Bstudies%26aulast%3DDevasthale%26aufirst%3DPratik%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4412%26epage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratik  Devasthale</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Andres S.  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fang  Moore</span>, <span class="hlFld-ContribAuthor ">Kishore  Renduchintala</span>, <span class="hlFld-ContribAuthor ">Radhakrishnan  Sridhar</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Pelleymounter</span>, <span class="hlFld-ContribAuthor ">Daniel  Longhi</span>, <span class="hlFld-ContribAuthor ">Ning  Huang</span>, <span class="hlFld-ContribAuthor ">Neil  Flynn</span>, <span class="hlFld-ContribAuthor ">Anthony V.  Azzara</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rohrbach</span>, <span class="hlFld-ContribAuthor ">James  Devenny</span>, <span class="hlFld-ContribAuthor ">Suzanne  Rooney</span>, <span class="hlFld-ContribAuthor ">Michael  Thomas</span>, <span class="hlFld-ContribAuthor ">Susan  Glick</span>, <span class="hlFld-ContribAuthor ">Helen  Godonis</span>, <span class="hlFld-ContribAuthor ">Susan  Harvey</span>, <span class="hlFld-ContribAuthor ">Mary Jane  Cullen</span>, <span class="hlFld-ContribAuthor ">Hongwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Christian  Caporuscio</span>, <span class="hlFld-ContribAuthor ">Paul  Stetsko</span>, <span class="hlFld-ContribAuthor ">Mary  Grubb</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa  Zhang</span>, <span class="hlFld-ContribAuthor ">Chris  Freeden</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Li</span>, <span class="hlFld-ContribAuthor ">Brian J.  Murphy</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">William N.  Washburn</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setup. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (14)
                                     , 2793-2799. <a href="https://doi.org/10.1016/j.bmcl.2015.05.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDihydropyrrolopyrazol-6-one%252BMCHR1%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%25253A%252BInsights%252Bon%252Bin%252Bvivo%252Befficacy%252Bfrom%252Ba%252Bnovel%252BFLIPR%252Bassay%252Bsetup%26aulast%3DDevasthale%26aufirst%3DPratik%26date%3D2015%26volume%3D25%26issue%3D14%26spage%3D2793%26epage%3D2799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Johansson</span>, <span class="hlFld-ContribAuthor ">Christian  LÃ¶fberg</span>. </span><span class="cited-content_cbyCitation_article-title">Novel MCH
              1
              receptor antagonists: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (2)
                                     , 193-207. <a href="https://doi.org/10.1517/13543776.2014.993382" title="DOI URL">https://doi.org/10.1517/13543776.2014.993382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.993382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.993382%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252BMCH%252B1%252Breceptor%252Bantagonists%25253A%252Ba%252Bpatent%252Breview%26aulast%3DJohansson%26aufirst%3DAnders%26date%3D2015%26date%3D2014%26volume%3D25%26issue%3D2%26spage%3D193%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative MCHR1 antagonists and amide counterparts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Variation in exposure of <b>18</b> and <b>19</b> due to prodrug employed for oral administration to rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/medium/jm-2014-00026w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm500026w/20140919/images/large/jm-2014-00026w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500026w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, MeOH, 0 Â°C, 59%; (b) DMF, 80 Â°C, 90%; (c) NaBH<sub>4</sub>, EtOH, 96%; (d) chiral chromatography, 93%; (e) H<sub>2</sub>, Pd/C, 100%; (f) phenol, 130 Â°C, 74%; (g) (SEMO)<sub>2</sub>P(NiPr<sub>2</sub>); (h) H<sub>2</sub>O<sub>2</sub>, 95% (steps g and h combined yield); (i) TFA, 0 Â°C, 73%; (j) EtOH, 80 Â°C, 88%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24332" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24332" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>World Health Organization Global Health Observatory (GHO) Web site. <a href="http://www.who.int/gho/ncd/risk_factors/obesity_text/en/" class="extLink">http://www.who.int/gho/ncd/risk_factors/obesity_text/en/</a> (accessed Oct 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+Global+Health+Observatory+%28GHO%29+Web+site.+http%3A%2F%2Fwww.who.int%2Fgho%2Fncd%2Frisk_factors%2Fobesity_text%2Fen%2F+%28accessed+Oct+18%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Holes-Lewis, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeil, P. M.</span><span> </span><span class="NLM_article-title">Pharmacotherapy of obesity: clinical treatments and considerations</span> <span class="citation_source-journal">Am. J. Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=284-288&author=K.+A.+Holes-Lewisauthor=R.+Malcolmauthor=P.+M.+O%E2%80%99Neil&title=Pharmacotherapy+of+obesity%3A+clinical+treatments+and+considerations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoles-Lewis%26aufirst%3DK.%2BA.%26aulast%3DMalcolm%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DP.%2BM.%26atitle%3DPharmacotherapy%2520of%2520obesity%253A%2520clinical%2520treatments%2520and%2520considerations%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D2013%26volume%3D345%26spage%3D284%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schwartz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, J. P.</span><span> </span><span class="NLM_article-title">Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">â</span> <span class="NLM_lpage">629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1038%2Foby.2007.96" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=18239553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVOquro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=623-629&author=S.+M.+Schwartzauthor=V.+P.+Bansalauthor=C.+Haleauthor=M.+Rossiauthor=J.+P.+Engle&title=Compliance%2C+behavior+change%2C+and+weight+loss+with+orlistat+in+an+over-the-counter+setting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting</span></div><div class="casAuthors">Schwartz, Susan M.; Bansal, Vidhu P.; Hale, Cecilia; Rossi, Maureen; Engle, Janet P.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">623-629</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Objective: The study was conducted to provide information on how consumers would use orlistat 60 mg, esp. in terms of product dosing, in a setting without physician supervision.  Methods and Procedures: A 3-mo, open-label, naturalistic study was conducted in an over-the-counter (OTC) setting in 18 pharmacies.  Consumers â¥18 years were allowed to purchase orlistat packages contg. a bottle of orlistat 60 mg plus educational materials, which provided lifestyle information and tools to encourage successful wt. loss.  Data were collected at pharmacy visits and during telephone interviews at 14, 30, 60, and 90 days after enrollment.  Results: A total of 237 subjects purchased and used the product, and completed at least one interview.  Most subjects followed the dosing directions and took two to three capsules per day with meals throughout the study.  The majority of subjects took a daily multivitamin, as directed.  Approx., 80% of subjects used the educational materials and found them useful or very useful.  Over the study duration, most subjects reported following a diet and 51% of subjects reported more frequent or longer exercise than at enrollment.  Approx., 80% of subjects indicated they were satisfied or very satisfied with the wt. loss achieved; measured and self-reported relative median wt. loss was â¼5% after â¥60 days of using orlistat.  Most common adverse events were gastrointestinal (GI), and majority of subjects did not interrupt or discontinue orlistat due to these GI events.  Discussion: These results demonstrate that orlistat 60 mg can be used appropriately and safely and with high consumer satisfaction without physician supervision or dietary counseling.  Collectively, results indicate that orlistat 60 mg is an appropriate wt. loss therapy in the OTC environment.  Obesity (2008) 16 3, 623-629. doi:10.1038/oby.2007.96.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8S5zUdEeRq7Vg90H21EOLACvtfcHk0lh8MylhjuRnvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVOquro%253D&md5=921dc36a02aaa16c9fcf9c3722515d87</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Foby.2007.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2007.96%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DS.%2BM.%26aulast%3DBansal%26aufirst%3DV.%2BP.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DEngle%26aufirst%3DJ.%2BP.%26atitle%3DCompliance%252C%2520behavior%2520change%252C%2520and%2520weight%2520loss%2520with%2520orlistat%2520in%2520an%2520over-the-counter%2520setting%26jtitle%3DObesity%26date%3D2008%26volume%3D16%26spage%3D623%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Larsen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toubro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Baak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saris, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astrup, A.</span><span> </span><span class="NLM_article-title">Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">â</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=12324291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1eqsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2002&pages=780-788&author=T.+M.+Larsenauthor=S.+Toubroauthor=M.+A.+van+Baakauthor=K.+M.+Gottesdienerauthor=P.+Larsonauthor=W.+H.+Sarisauthor=A.+Astrup&title=Effect+of+a+28-d+treatment+with+L-796568%2C+a+novel+beta%283%29-adrenergic+receptor+agonist%2C+on+energy+expenditure+and+body+composition+in+obese+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a 28-d treatment with L-796568, a novel Î²3-adrenergic receptor agonist, on energy expenditure and body composition in obese men</span></div><div class="casAuthors">Larsen, Thomas M.; Toubro, Soren; van Baak, Marleen A.; Gottesdiener, Keith M.; Larson, Patrick; Saris, Wim H. M.; Astrup, Arne</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">780-788</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Nutrition</span>)
        </div><div class="casAbstract">Stimulation of energy expenditure (EE) with selective thermogenic Î²-adrenergic agonists may be a promising approach for treating obesity.  We analyzed the effects of the highly selective human Î²3-adrenergic agonist L-796568 on 24-h EE, substrate oxidn., and body compn. in obese, wt.-stable men.  In this 2-center, double-blind, randomized, parallel-group study, we measured 24-h EE before and after 28 d of treatment with L-796568 (375 mg/d) or placebo during wt. maintenance (ie, without dietary intervention) in nondiabetic, nonsmoking men aged 25-49 yr with body mass index (in kg/m2) of 28-35 (n = 10 subjects per treatment group).  The mean change in 24-h EE from before to after treatment did not differ significantly between groups (92Â±586 and 86Â±512 kJ/24 h for the L-796568 and placebo groups, resp.).  The change in 24-h nonprotein RQ from before to after treatment did not differ significantly between groups (0.009Â±0.021 and 0.009Â±0.029, resp.).  No changes in glucose tolerance were obsd., but triacylglycerol concns. decreased significantly with L-796568 treatment compared with placebo (-0.76Â±0.76 and 0.42Â±0.31 mmol/L, resp.; P < 0.002).  Overall, treatment-related changes in body compn. were not obsd., but higher plasma L-796568 concns. in the L-796568 group were assocd. with greater decreases in fat mass (r = -0.69, P < 0.03).  Treatment with L-796568 for 28 d had no major lipolytic or thermogenic effect but it lowered triacylglycerol concns.  This lack of chronic effect on energy balance is likely explained by insufficient recruitment of Î²3-responsive tissues in humans, down-regulation of the Î²3-adrenergic receptor-mediated effects with chronic dosing, or both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogKuqIefRBVbVg90H21EOLACvtfcHk0ljwFNKLvSEnkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1eqsLg%253D&md5=a1437ac79c034a5eb3ea710bb556b356</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DT.%2BM.%26aulast%3DToubro%26aufirst%3DS.%26aulast%3Dvan%2BBaak%26aufirst%3DM.%2BA.%26aulast%3DGottesdiener%26aufirst%3DK.%2BM.%26aulast%3DLarson%26aufirst%3DP.%26aulast%3DSaris%26aufirst%3DW.%2BH.%26aulast%3DAstrup%26aufirst%3DA.%26atitle%3DEffect%2520of%2520a%252028-d%2520treatment%2520with%2520L-796568%252C%2520a%2520novel%2520beta%25283%2529-adrenergic%2520receptor%2520agonist%252C%2520on%2520energy%2520expenditure%2520and%2520body%2520composition%2520in%2520obese%2520men%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2002%26volume%3D76%26spage%3D780%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Redman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenway, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravussin, E.</span><span> </span><span class="NLM_article-title">Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">â</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1210%2Fjc.2006-1740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=17118998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVaksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2007&pages=527-531&author=L.+M.+Redmanauthor=L.+de+Jongeauthor=X.+Fangauthor=B.+Gamlinauthor=D.+Reckerauthor=F.+L.+Greenwayauthor=S.+R.+Smithauthor=E.+Ravussin&title=Lack+of+an+effect+of+a+novel+beta3-adrenoceptor+agonist%2C+TAK-677%2C+on+energy+metabolism+in+obese+individuals%3A+a+double-blind%2C+placebo-controlled+randomized+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of an effect of a novel Î²3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study</span></div><div class="casAuthors">Redman, Leanne M.; de Jonge, Lilian; Fang, Xiaobing; Gamlin, Betsy; Recker, David; Greenway, Frank L.; Smith, Steven R.; Ravussin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">527-531</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Our objective was to test the safety and metabolic effects of a novel Î²3-adrenoreceptor agonist (TAK-677) in humans.  Design, Setting, and Participants: Sixty-five obese (body mass index = 33.9Â±2.1 kg/m2, mean Â± SE) men and women (31.4Â±0.9 yr) participated in a double-blind placebo-controlled study at an institutional research center.  Participants were randomized to 0.1 mg TAK-677 twice daily (BID) (n = 21), 0.5 mg TAK-677 BID (n = 22), or placebo BID (n = 22) for 29 days.  Drug safety, 24-h RQ (RQ), 24-h energy expenditure (EE), body compn., fat distribution, and fasting plasma concn. of substrates and hormones were assessed.  An acute-response study was also conducted.  The drug was well tolerated by all participants; however, heart rate was elevated (9Â±2 beats per min) with the 0.5-mg BID dose.  After 28 d of treatment and when compared with placebo, there was no change in 24-h RQ with either 0.1-mg BID (P = 0.1) or 0.5-mg BID (P = 1.0) doses of TAK-677.  However, TAK, 0.5 mg BID, resulted in a small increase in 24-h EE that was significantly different from placebo [change from baseline, 13 Â± 17 (0.5 mg BID) vs. -39 Â± 18 (placebo) kcal/d, P < 0.05].  Changes in wt., fat-free mass, and abdominal fat depots (visceral or s.c.) were not different between the three groups, nor were changes in fasting insulin, free fatty acid, or glucose concns.  TAK-677 has no effect on 24-h RQ or fat oxidn. but does slightly increase 24-h EE at the highest dose (0.5 mg BID).  The acute studies showed large interindividual variability in plasma concns. of TAK-677 indicating some possible problems with bioavailability and therefore efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObsRY4t2dobVg90H21EOLACvtfcHk0ljwFNKLvSEnkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVaksb4%253D&md5=903a6913c9f14fd88a967714a198a341</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1210%2Fjc.2006-1740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2006-1740%26sid%3Dliteratum%253Aachs%26aulast%3DRedman%26aufirst%3DL.%2BM.%26aulast%3Dde%2BJonge%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DGamlin%26aufirst%3DB.%26aulast%3DRecker%26aufirst%3DD.%26aulast%3DGreenway%26aufirst%3DF.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BR.%26aulast%3DRavussin%26aufirst%3DE.%26atitle%3DLack%2520of%2520an%2520effect%2520of%2520a%2520novel%2520beta3-adrenoceptor%2520agonist%252C%2520TAK-677%252C%2520on%2520energy%2520metabolism%2520in%2520obese%2520individuals%253A%2520a%2520double-blind%252C%2520placebo-controlled%2520randomized%2520study%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D92%26spage%3D527%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Christensen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartels, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliddal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astrup, A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x"> (</span><span class="NLM_issue">9600</span><span class="NLM_x">) </span> <span class="NLM_fpage">1706</span><span class="NLM_x">â</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1016%2FS0140-6736%2807%2961721-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=18022033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWrsb7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=1706-1713&issue=9600&author=R.+Christensenauthor=P.+K.+Kristensenauthor=E.+M.+Bartelsauthor=H.+Bliddalauthor=A.+Astrup&title=Efficacy+and+safety+of+the+weight-loss+drug+rimonabant%3A+a+meta-analysis+of+randomised+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomized trials</span></div><div class="casAuthors">Christensen, Robin; Kristensen, Pernelle Kruse; Bartels, Else Marie; Bliddal, Henning; Astrup, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">9600</span>),
    <span class="NLM_cas:pages">1706-1713</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Since the prevalence of obesity continues to increase, there is a demand for effective and safe anti-obesity agents that can produce and maintain wt. loss and improve comorbidity.  We did a meta-anal. of all published randomized controlled trials to assess the efficacy and safety of the newly approved anti-obesity agent rimonabant.  We searched The Cochrane database and Controlled Trials Register, Medline via Pubmed, Embase via WebSpirs, Web of Science, Scopus, and ref. lists up to July, 2007.  We collected data from four double-blind, randomized controlled trials (including 4105 participants) that compared 20 mg per day rimonabant with placebo.  Patients given rimonabant had a 4.7 kg (95% CI 4.1-5.3 kg; p < 0.0001) greater wt. redn. after 1 yr than did those given placebo.  Rimonabant caused significantly more adverse events than did placebo (OR = 1.4; p = 0.0007; no. needed to harm = 25 individuals [95% CI 17-58]), and 1.4 times more serious adverse events (OR = 1.4; p = 0.03; no. needed to harm = 59 [27-830]).  Patients given rimonabant were 2.5 times more likely to discontinue the treatment because of depressive mood disorders than were those given placebo (OR=2.5; p = 0.01; no. needed to harm = 49 [19-316]).  Furthermore, anxiety caused more patients to discontinue treatment in rimonabant groups than in placebo groups (OR = 3.0; p = 0.03; no. needed to harm = 166 [47-3716]).  The findings suggest that 20 mg per day rimonabant increases the risk of psychiatric adverse events-ie, depressed mood disorders and anxiety-despite depressed mood being an exclusion criterion in these trials.  Taken together with the recent US Food and Drug Administration finding of increased risk of suicide during treatment with rimonabant, we recommend increased alertness by physicians to these potentially severe psychiatric adverse reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH4_5WdwCLbbVg90H21EOLACvtfcHk0lh37bTbdWIN6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWrsb7E&md5=58bb31ac3b77690a60f1257462cf62f5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2961721-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252961721-8%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DR.%26aulast%3DKristensen%26aufirst%3DP.%2BK.%26aulast%3DBartels%26aufirst%3DE.%2BM.%26aulast%3DBliddal%26aufirst%3DH.%26aulast%3DAstrup%26aufirst%3DA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520the%2520weight-loss%2520drug%2520rimonabant%253A%2520a%2520meta-analysis%2520of%2520randomised%2520trials%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26issue%3D9600%26spage%3D1706%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pissios, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maratos-Flier, E.</span><span> </span><span class="NLM_article-title">Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological parameters</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">â</span> <span class="NLM_lpage">620</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1210%2Fer.2006-0021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=16788162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2gs7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=606-620&author=P.+Pissiosauthor=R.+L.+Bradleyauthor=E.+Maratos-Flier&title=Expanding+the+scales%3A+the+multiple+roles+of+MCH+in+regulating+energy+balance+and+other+biological+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions</span></div><div class="casAuthors">Pissios, Pavlos; Bradley, Richard L.; Maratos-Flier, Eleftheria</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">606-620</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Melanin-concg. hormone (MCH) is a cyclic peptide originally identified as a 17-amino-acid circulating hormone in teleost fish, where it is secreted by the pituitary in response to stress and environmental stimuli.  In fish, MCH lightens skin color by stimulating aggregation of melanosomes, pigment-contg. granules in melanophores, cells of neuroectodermal origin found in fish scales.  Although the peptide structure between fish and mammals is highly conserved, in mammals, MCH has no demonstrable effects on pigmentation; instead, based on a series of pharmacol. and genetic expts., MCH has emerged as a crit. hypothalamic regulator of energy homeostasis, having effects on both feeding behavior and energy expenditure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozEpay1iCpCrVg90H21EOLACvtfcHk0lh37bTbdWIN6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2gs7nK&md5=6e2445fe0bc9ad8709d717284dead386</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fer.2006-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2006-0021%26sid%3Dliteratum%253Aachs%26aulast%3DPissios%26aufirst%3DP.%26aulast%3DBradley%26aufirst%3DR.%2BL.%26aulast%3DMaratos-Flier%26aufirst%3DE.%26atitle%3DExpanding%2520the%2520scales%253A%2520the%2520multiple%2520roles%2520of%2520MCH%2520in%2520regulating%2520energy%2520balance%2520and%2520other%2520biological%2520parameters%26jtitle%3DEndocr.%2520Rev.%26date%3D2006%26volume%3D27%26spage%3D606%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Luthin, D. R.</span><span> </span><span class="NLM_article-title">Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">â</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=421-440&author=D.+R.+Luthin&title=Anti-obesity+effects+of+small+molecule+melanin-concentrating+hormone+receptor+1+%28MCHR1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuthin%26aufirst%3DD.%2BR.%26atitle%3DAnti-obesity%2520effects%2520of%2520small%2520molecule%2520melanin-concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonists%26jtitle%3DLife%2520Sci.%26date%3D2007%26volume%3D81%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Forray, C.</span><span> </span><span class="NLM_article-title">The MCH receptor family: feeding brain disorders?</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1016%2FS1471-4892%2802%2900013-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=12550747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=85-89&author=C.+Forray&title=The+MCH+receptor+family%3A+feeding+brain+disorders%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The MCH receptor family: feeding brain disorders?</span></div><div class="casAuthors">Forray, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of melanin concg. hormone (MCH) in the control of energy balance has been confirmed by findings of lean phenotypes of mice with targeted deletion of the melanin concg. hormone receptor 1 (MCH1-R).  The recent publications of anorectic and antiobesity effects of the first two selective MCH1-R antagonists have confirmed the notion that pharmacol. blockade of MCH1-R is a viable therapeutic approach for obesity.  In addn., MCH1-R antagonists have been found to have antidepressant and anxiolytic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUyIV7QZhsrVg90H21EOLACvtfcHk0lh37bTbdWIN6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtA%253D%253D&md5=1a06cc3f443091732ee8780c2c9e577d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2802%2900013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252802%252900013-9%26sid%3Dliteratum%253Aachs%26aulast%3DForray%26aufirst%3DC.%26atitle%3DThe%2520MCH%2520receptor%2520family%253A%2520feeding%2520brain%2520disorders%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1016%2FS0014-2999%2802%2901314-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500026w&amp;key=11909603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWktb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2002&pages=129-35&author=S.+Takekawaauthor=A.+Asamiauthor=Y.+Ishiharaauthor=J.+Terauchiauthor=K.+Katoauthor=Y.+Shimomuraauthor=M.+Moriauthor=H.+Murakoshiauthor=K.+Katoauthor=N.+Suzukiauthor=O.+Nishimuraauthor=M.+Fujino&title=T-226296%3A+a+novel%2C+orally+active+and+selective+melanin-concentrating+hormone+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist</span></div><div class="casAuthors">Takekawa, Shiro; Asami, Asano; Ishihara, Yuji; Terauchi, Jun; Kato, Kaneyoshi; Shimomura, Yukio; Mori, Masaaki; Murakoshi, Hitomi; Kato, Koki; Suzuki, Nobuhiro; Nishimura, Osamu; Fujino, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Screening of a chem. compd. library found a novel melanin-concg. hormone (MCH) receptor antagonist, T-226296, a (-) enantiomer of N-[6-(dimethylamino)methyl]-5,6,7,8-tetrahydro-2-naphthalenyl-4'-fluoro[1,1'-biphenyl]-4-carboxamide.  T-226296 exhibited high affinity for cloned human and rat MCH receptors (SLC-1) in receptor-binding assays (IC50 5.5 nM for human SLC-1; 8.6 nM for rat SLC-1).  T-226296 had high selectivity over other receptors, including the 2nd subtype of the MCH receptor, SLT (MCH2), transporters and ion channels.  In Chinese hamster ovary cells expressing human SLC-1, T-226296 reversed the MCH-mediated inhibition of forskolin-stimulated cAMP accumulation, inhibited MCH-induced intracellular Ca2+ increase, and also inhibited MCH-stimulated arachidonic acid release.  In rats, oral administration of T-226296 (30 mg/kg) almost completely suppressed the increase in food intake induced by intracerebroventricular injection of MCH.  These results indicate that T-226296 is a novel, orally active and selective MCH receptor antagonist that will be promising for further exploring the physiol. and pathophysiol. of MCH-SLC-1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqciwFzh1_XK7Vg90H21EOLACvtfcHk0lgyuCMXbUFEvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWktb4%253D&md5=5867fd50dbbc869b259fe669e5d064d5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901314-6%26sid%3Dliteratum%253Aachs%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DAsami%26aufirst%3DA.%26aulast%3DIshihara%26aufirst%3DY.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DShimomura%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DMurakoshi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DNishimura%26aufirst%3DO.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DT-226296%253A%2520a%2520novel%252C%2520orally%2520active%2520and%2520selective%2520melanin-concentrating%2520hormone%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D438%26spage%3D129%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, A. G.</span><span> </span><span class="NLM_article-title">A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3962</span><span class="NLM_x">â</span> <span class="NLM_lpage">3971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040762v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3962-3971&author=D.+E.+Clarkauthor=C.+Higgsauthor=S.+P.+Wrenauthor=H.+J.+Dykeauthor=M.+Wongauthor=D.+Normanauthor=P.+M.+Lockeyauthor=A.+G.+Roach&title=A+virtual+screening+approach+to+finding+novel+and+potent+antagonists+at+the+melanin-concentrating+hormone+1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm040762v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040762v%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DHiggs%26aufirst%3DC.%26aulast%3DWren%26aufirst%3DS.%2BP.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DNorman%26aufirst%3DD.%26aulast%3DLockey%26aufirst%3DP.%2BM.%26aulast%3DRoach%26aufirst%3DA.%2BG.%26atitle%3DA%2520virtual%2520screening%2520approach%2520to%2520finding%2520novel%2520and%2520potent%2520antagonists%2520at%2520the%2520melanin-concentrating%2520hormone%25201%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3962%26epage%3D3971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">McBriar, M. D.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of melanin-concentrating hormone receptor antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">â</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=496-508&author=M.+D.+McBriar&title=Recent+advances+in+the+discovery+of+melanin-concentrating+hormone+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcBriar%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520melanin-concentrating%2520hormone%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D496%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hertzog, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Barazanji, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigham, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizzle, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handlon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span> </span><span class="NLM_article-title">The discovery and optimization of pyrimidinone-containing MCH R1 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4723</span><span class="NLM_x">â</span> <span class="NLM_lpage">4727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4723-4727&author=D.+L.+Hertzogauthor=K.+A.+Al-Barazanjiauthor=E.+C.+Bighamauthor=M.+J.+Bishopauthor=C.+S.+Brittauthor=D.+L.+Carltonauthor=J.+P.+Cooperauthor=A.+J.+Danielsauthor=D.+M.+Garridoauthor=A.+S.+Goetzauthor=M.+K.+Grizzleauthor=Y.+C.+Guoauthor=A.+L.+Handlonauthor=D.+M.+Ignarauthor=R.+O.+Morganauthor=A.+J.+Peatauthor=F.+X.+Tavaresauthor=H.+Zhou&title=The+discovery+and+optimization+of+pyrimidinone-containing+MCH+R1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHertzog%26aufirst%3DD.%2BL.%26aulast%3DAl-Barazanji%26aufirst%3DK.%2BA.%26aulast%3DBigham%26aufirst%3DE.%2BC.%26aulast%3DBishop%26aufirst%3DM.%2BJ.%26aulast%3DBritt%26aufirst%3DC.%2BS.%26aulast%3DCarlton%26aufirst%3DD.%2BL.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DDaniels%26aufirst%3DA.%2BJ.%26aulast%3DGarrido%26aufirst%3DD.%2BM.%26aulast%3DGoetz%26aufirst%3DA.%2BS.%26aulast%3DGrizzle%26aufirst%3DM.%2BK.%26aulast%3DGuo%26aufirst%3DY.%2BC.%26aulast%3DHandlon%26aufirst%3DA.%2BL.%26aulast%3DIgnar%26aufirst%3DD.%2BM.%26aulast%3DMorgan%26aufirst%3DR.%2BO.%26aulast%3DPeat%26aufirst%3DA.%2BJ.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520and%2520optimization%2520of%2520pyrimidinone-containing%2520MCH%2520R1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4723%26epage%3D4727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ulven, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Receveur, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rist, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NÃ¸rregaard, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ¶gberg, T.</span><span> </span><span class="NLM_article-title">6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structureâactivity relationship, and investigation of binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5684</span><span class="NLM_x">â</span> <span class="NLM_lpage">5697</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050103y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5684-5697&author=T.+Ulvenauthor=T.+M.+Frimurerauthor=J.+M.+Receveurauthor=P.+B.+Littleauthor=O.+Ristauthor=P.+K.+N%C3%B8rregaardauthor=T.+H%C3%B6gberg&title=6-Acylamino-2-aminoquinolines+as+potent+melanin-concentrating+hormone+1+receptor+antagonists.+Identification%2C+structure%E2%80%93activity+relationship%2C+and+investigation+of+binding+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm050103y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050103y%26sid%3Dliteratum%253Aachs%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DReceveur%26aufirst%3DJ.%2BM.%26aulast%3DLittle%26aufirst%3DP.%2BB.%26aulast%3DRist%26aufirst%3DO.%26aulast%3DN%25C3%25B8rregaard%26aufirst%3DP.%2BK.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DT.%26atitle%3D6-Acylamino-2-aminoquinolines%2520as%2520potent%2520melanin-concentrating%2520hormone%25201%2520receptor%2520antagonists.%2520Identification%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520investigation%2520of%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5684%26epage%3D5697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhern, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodjian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kym, P. R.</span><span> </span><span class="NLM_article-title">Identification of 2-(4-benzyloxyphenyl)-<i>N</i>-[1-(2-pyrrolidin-1-yl-ethyl)-1<i>H</i>-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1318</span><span class="NLM_x">â</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0490890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1318-1321&author=A.+J.+Souersauthor=J.+Gaoauthor=M.+Bruneauthor=E.+Bushauthor=D.+Wodkaauthor=A.+Vasudevanauthor=A.+S.+Juddauthor=M.+Mulhernauthor=S.+Brodjianauthor=B.+Daytonauthor=R.+Shapiroauthor=L.+E.+Hernandezauthor=K.+C.+Marshauthor=H.+L.+Shamauthor=C.+A.+Collinsauthor=P.+R.+Kym&title=Identification+of+2-%284-benzyloxyphenyl%29-N-%5B1-%282-pyrrolidin-1-yl-ethyl%29-1H-indazol-6-yl%5Dacetamide%2C+an+orally+efficacious+melanin-concentrating+hormone+receptor+1+antagonist+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0490890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0490890%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBrune%26aufirst%3DM.%26aulast%3DBush%26aufirst%3DE.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DJudd%26aufirst%3DA.%2BS.%26aulast%3DMulhern%26aufirst%3DM.%26aulast%3DBrodjian%26aufirst%3DS.%26aulast%3DDayton%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DR.%26aulast%3DHernandez%26aufirst%3DL.%2BE.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DKym%26aufirst%3DP.%2BR.%26atitle%3DIdentification%2520of%25202-%25284-benzyloxyphenyl%2529-N-%255B1-%25282-pyrrolidin-1-yl-ethyl%2529-1H-indazol-6-yl%255Dacetamide%252C%2520an%2520orally%2520efficacious%2520melanin-concentrating%2520hormone%2520receptor%25201%2520antagonist%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1318%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Johansson, A.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists</span> <span class="citation_source-journal">Curr. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">â</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1517%2F13543776.2011.575063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500026w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmt1ymurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=905-925&author=A.+Johansson&title=Recent+progress+in+the+discovery+of+melanin-concentrating+hormone+1-receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists</span></div><div class="casAuthors">Johansson, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">905-925</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The appetite stimulating effects of melanin-concg. hormone (MCH) continues to be of high interest, and there is substantial support to investigate the use of MCH 1-receptor antagonists for the treatment of obesity.  Other areas of potential use for MCH 1-receptor antagonists include depression and anxiety.  There are, to date, no clin. proof of concept data, and efforts are ongoing for the discovery of novel MCH 1-receptor antagonists, as evidenced by the no. of patent applications published over the last 5 years.  Areas covered: This review covers the patent literature on MCH 1-receptor antagonists from Jan. 2006 to Nov. 2010.  The emphasis is on disclosed biol. data, esp. in vivo data, of exemplified compds.  Wherever possible, selectivity towards undesired pharmacol. is analyzed.  Expert opinion: Over the years, different approaches have been taken to overcome the undesired effects of MCH 1-receptor antagonists, such as interactions with the hERG channel.  Many programs have faced difficulties and, to date, only a few compds. have progressed into humans.  From this point of view, the MCH 1-receptor is regarded as a difficult target, and whether newer programs will be successful depends, to a large extent, on their selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2AqNTXpEOkbVg90H21EOLACvtfcHk0ljWhTyAmc4Iow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmt1ymurY%253D&md5=7df352cf7d1e33d0e245d09672c647fc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.575063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.575063%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520melanin-concentrating%2520hormone%25201-receptor%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D905%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rokosz, L. L.</span><span> </span><span class="NLM_article-title">Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">â</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1301-1327&author=L.+L.+Rokosz&title=Discovery+and+development+of+melanin-concentrating+hormone+receptor+1+antagonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRokosz%26aufirst%3DL.%2BL.%26atitle%3DDiscovery%2520and%2520development%2520of%2520melanin-concentrating%2520hormone%2520receptor%25201%2520antagonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D1301%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kowalski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=311-321&author=T.+J.+Kowalskiauthor=T.+Sasikumar&title=Melanin-concentrating+hormone+receptor-1+antagonists+as+antiobesity+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DT.%2BJ.%26aulast%3DSasikumar%26aufirst%3DT.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor-1%2520antagonists%2520as%2520antiobesity%2520therapeutics%26jtitle%3DBioDrugs%26date%3D2007%26volume%3D21%26spage%3D311%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Handlon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor-1 antagonists for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4017</span><span class="NLM_x">â</span> <span class="NLM_lpage">4022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058239j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4017-4022&author=A.+L.+Handlonauthor=H.+Zhou&title=Melanin-concentrating+hormone+receptor-1+antagonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm058239j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058239j%26sid%3Dliteratum%253Aachs%26aulast%3DHandlon%26aufirst%3DA.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor-1%2520antagonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4017%26epage%3D4022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mendez-Andino, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wos, J. A.</span><span> </span><span class="NLM_article-title">MCH-R1 antagonists: What is keeping most research programs away from the clinic?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">972</span><span class="NLM_x">â</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=972-979&author=J.+L.+Mendez-Andinoauthor=J.+A.+Wos&title=MCH-R1+antagonists%3A+What+is+keeping+most+research+programs+away+from+the+clinic%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendez-Andino%26aufirst%3DJ.%2BL.%26aulast%3DWos%26aufirst%3DJ.%2BA.%26atitle%3DMCH-R1%2520antagonists%253A%2520What%2520is%2520keeping%2520most%2520research%2520programs%2520away%2520from%2520the%2520clinic%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D972%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kamata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagisa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor-1 antagonists. Synthesis and structureâactivity relationships of novel 3-(aminomethyl)quinolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2353</span><span class="NLM_x">â</span> <span class="NLM_lpage">2366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201596h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2353-2366&author=M.+Kamataauthor=T.+Yamashitaauthor=T.+Imaedaauthor=S.+Masadaauthor=M.+Kamauraauthor=S.+Kasaiauthor=R.+Haraauthor=S.+Sasakiauthor=S.+Takekawaauthor=A.+Asamiauthor=T.+Kaishoauthor=N.+Suzukiauthor=S.+Ashinaauthor=H.+Oginoauthor=Y.+Nakanoauthor=Y.+Nagisaauthor=K.+Katoauthor=K.+Katoauthor=Y.+Ishihara&title=Melanin-concentrating+hormone+receptor-1+antagonists.+Synthesis+and+structure%E2%80%93activity+relationships+of+novel+3-%28aminomethyl%29quinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm201596h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201596h%26sid%3Dliteratum%253Aachs%26aulast%3DKamata%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DT.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DR.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DAsami%26aufirst%3DA.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DAshina%26aufirst%3DS.%26aulast%3DOgino%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DNagisa%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DY.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor-1%2520antagonists.%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%25203-%2528aminomethyl%2529quinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2353%26epage%3D2366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lim, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, K. Y.</span><span> </span><span class="NLM_article-title">Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2309</span><span class="NLM_x">â</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2309-2312&author=C.+J.+Limauthor=N.+Kimauthor=E.+K.+Leeauthor=B.+H.+Leeauthor=K.+S.+Ohauthor=S.+E.+Yooauthor=K.+Y.+Yi&title=Synthesis+and+SAR+investigations+of+novel+2-arylbenzimidazole+derivatives+as+melanin-concentrating+hormone+receptor+1+%28MCH-R1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DC.%2BJ.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DOh%26aufirst%3DK.%2BS.%26aulast%3DYoo%26aufirst%3DS.%2BE.%26aulast%3DYi%26aufirst%3DK.%2BY.%26atitle%3DSynthesis%2520and%2520SAR%2520investigations%2520of%2520novel%25202-arylbenzimidazole%2520derivatives%2520as%2520melanin-concentrating%2520hormone%2520receptor%25201%2520%2528MCH-R1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2309%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Berglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span> </span><span class="NLM_article-title">Discovery of 1,3-disubstituted-1<i>H</i>-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4859</span><span class="NLM_x">â</span> <span class="NLM_lpage">4863</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4859-4863&author=S.+Berglundauthor=B.+J.+Egnerauthor=H.+Gradenauthor=J.+Gradenauthor=D.+G.+Morganauthor=T.+Inghardtauthor=F.+Giordanetto&title=Discovery+of+1%2C3-disubstituted-1H-pyrrole+derivatives+as+potent+melanin-concentrating+hormone+receptor+1+%28MCH-R1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerglund%26aufirst%3DS.%26aulast%3DEgner%26aufirst%3DB.%2BJ.%26aulast%3DGraden%26aufirst%3DH.%26aulast%3DGraden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DInghardt%26aufirst%3DT.%26aulast%3DGiordanetto%26aufirst%3DF.%26atitle%3DDiscovery%2520of%25201%252C3-disubstituted-1H-pyrrole%2520derivatives%2520as%2520potent%2520melanin-concentrating%2520hormone%2520receptor%25201%2520%2528MCH-R1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4859%26epage%3D4863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kasai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagisa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span> </span><span class="NLM_article-title">Melanin-concentrating hormone receptor 1 antagonists: structureâactivity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1<i>H</i>-benzaxepine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6261</span><span class="NLM_x">â</span> <span class="NLM_lpage">6273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6261-6273&author=S.+Kasaiauthor=M.+Kamauraauthor=M.+Kamataauthor=K.+Asoauthor=H.+Oginoauthor=Y.+Nakanoauthor=K.+Watanabeauthor=T.+Kaishoauthor=M.+Tawadaauthor=Y.+Nagisaauthor=S.+Takekawaauthor=K.+Katoauthor=N.+Suzukiauthor=Y.+Ishihara&title=Melanin-concentrating+hormone+receptor+1+antagonists%3A+structure%E2%80%93activity+relationship%2C+docking+studies%2C+and+biological+evaluation+of+2%2C3%2C4%2C5-tetrahydro-1H-benzaxepine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DKamata%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DK.%26aulast%3DOgino%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DNagisa%26aufirst%3DY.%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIshihara%26aufirst%3DY.%26atitle%3DMelanin-concentrating%2520hormone%2520receptor%25201%2520antagonists%253A%2520structure%25E2%2580%2593activity%2520relationship%252C%2520docking%2520studies%252C%2520and%2520biological%2520evaluation%2520of%25202%252C3%252C4%252C5-tetrahydro-1H-benzaxepine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6261%26epage%3D6273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kasai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamaura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagisa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span> </span><span class="NLM_article-title">Synthesis, structureâactivity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether a-go-go-related gene (hERG) associated liabilities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4336</span><span class="NLM_x">â</span> <span class="NLM_lpage">4351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300167z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4336-4351&author=S.+Kasaiauthor=M.+Kamauraauthor=S.+Masadaauthor=J.+Kunitomoauthor=M.+Kamauraauthor=T.+Okawaauthor=K.+Takamiauthor=H.+Oginoauthor=Y.+Nakanoauthor=S.+Ashinaauthor=K.+Watanabeauthor=T.+Kaishoauthor=Y.+N.+Imaiauthor=S.+Ryuauthor=M.+Nakayamaauthor=Y.+Nagisaauthor=S.+Takekawaauthor=K.+Katoauthor=T.+Murataauthor=N.+Suzukiauthor=Y.+Ishihara&title=Synthesis%2C+structure%E2%80%93activity+relationship%2C+and+pharmacological+studies+of+novel+melanin-concentrating+hormone+receptor+1+antagonists+3-aminomethylquinolines%3A+reducing+human+ether+a-go-go-related+gene+%28hERG%29+associated+liabilities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm300167z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300167z%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DKamaura%26aufirst%3DM.%26aulast%3DOkawa%26aufirst%3DT.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOgino%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DAshina%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%2BN.%26aulast%3DRyu%26aufirst%3DS.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DNagisa%26aufirst%3DY.%26aulast%3DTakekawa%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIshihara%26aufirst%3DY.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520pharmacological%2520studies%2520of%2520novel%2520melanin-concentrating%2520hormone%2520receptor%25201%2520antagonists%25203-aminomethylquinolines%253A%2520reducing%2520human%2520ether%2520a-go-go-related%2520gene%2520%2528hERG%2529%2520associated%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4336%26epage%3D4351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sasmal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasmal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbineni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roshaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suresh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shashikuma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimure, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rist, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ¶gberg, T.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: focus to detune hERG inhibition</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">â</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=285-289&author=P.+K.+Sasmalauthor=S.+Sasmalauthor=C.+Abbineniauthor=B.+Venkateshamauthor=P.+T.+Raoauthor=M.+Roshaiahauthor=I.+Khannaauthor=V.+J.+Sebastianauthor=J.+Sureshauthor=M.+P.+Singhauthor=R.+Talwarauthor=D.+Shashikumaauthor=K.+H.+Reddyauthor=T.+M.+Frimureauthor=O.+Ristauthor=L.+Elsterauthor=T.+H%C3%B6gberg&title=Synthesis+and+SAR+studies+of+benzimidazole+derivatives+as+melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonists%3A+focus+to+detune+hERG+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasmal%26aufirst%3DP.%2BK.%26aulast%3DSasmal%26aufirst%3DS.%26aulast%3DAbbineni%26aufirst%3DC.%26aulast%3DVenkatesham%26aufirst%3DB.%26aulast%3DRao%26aufirst%3DP.%2BT.%26aulast%3DRoshaiah%26aufirst%3DM.%26aulast%3DKhanna%26aufirst%3DI.%26aulast%3DSebastian%26aufirst%3DV.%2BJ.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DM.%2BP.%26aulast%3DTalwar%26aufirst%3DR.%26aulast%3DShashikuma%26aufirst%3DD.%26aulast%3DReddy%26aufirst%3DK.%2BH.%26aulast%3DFrimure%26aufirst%3DT.%2BM.%26aulast%3DRist%26aufirst%3DO.%26aulast%3DElster%26aufirst%3DL.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520benzimidazole%2520derivatives%2520as%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonists%253A%2520focus%2520to%2520detune%2520hERG%2520inhibition%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D285%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hadden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deering, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khmelnitsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viggers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, P. R.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-aryl-(1-indazol-5-yl)pyridine-2(1<i>H</i>)ones as MCH-1 antagonists for the treatment of obesity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7020</span><span class="NLM_x">â</span> <span class="NLM_lpage">7023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7020-7023&author=M.+Haddenauthor=D.+M.+Deeringauthor=A.+J.+Hendersonauthor=M.+D.+Surmanauthor=M.+Lucheauthor=Y.+Khmelnitskyauthor=S.+Vickersauthor=J.+Viggersauthor=S.+Cheethamauthor=P.+R.+Guzzo&title=Synthesis+and+SAR+of+4-aryl-%281-indazol-5-yl%29pyridine-2%281H%29ones+as+MCH-1+antagonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadden%26aufirst%3DM.%26aulast%3DDeering%26aufirst%3DD.%2BM.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26aulast%3DSurman%26aufirst%3DM.%2BD.%26aulast%3DLuche%26aufirst%3DM.%26aulast%3DKhmelnitsky%26aufirst%3DY.%26aulast%3DVickers%26aufirst%3DS.%26aulast%3DViggers%26aufirst%3DJ.%26aulast%3DCheetham%26aufirst%3DS.%26aulast%3DGuzzo%26aufirst%3DP.%2BR.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-aryl-%25281-indazol-5-yl%2529pyridine-2%25281H%2529ones%2520as%2520MCH-1%2520antagonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7020%26epage%3D7023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mihalic, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">â</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3781-3785&author=J.+T.+Mihalicauthor=P.+Fanauthor=X.+Chenauthor=X.+Chenauthor=Y.+Fuauthor=A.+Motaniauthor=L.+Liangauthor=M.+Lindstromauthor=L.+Tangauthor=J.+L.+Chenauthor=J.+Jaenauthor=K.+Daiauthor=L.+Li&title=Discovery+of+a+novel+melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonist+with+reduced+hERG+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalic%26aufirst%3DJ.%2BT.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DMotani%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DJaen%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonist%2520with%2520reduced%2520hERG%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3781%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Devenny, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godonis, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelleymounter, M. A.</span><span> </span><span class="NLM_article-title">Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">â</span> <span class="NLM_lpage">45â1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500026w&amp;key=10.1038%2Foby.2012.59" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=16-45%E2%80%931652&author=J.+J.+Devennyauthor=H.+E.+Godonisauthor=S.+J.+Harveyauthor=S.+Rooneyauthor=M.+J.+Cullenauthor=M.+A.+Pelleymounter&title=Weight+loss+induced+by+chronic+dapagliflozin+treatment+is+attenuated+by+compensatory+hyperphagia+in+diet-induced+obese+%28DIO%29+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Foby.2012.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2012.59%26sid%3Dliteratum%253Aachs%26aulast%3DDevenny%26aufirst%3DJ.%2BJ.%26aulast%3DGodonis%26aufirst%3DH.%2BE.%26aulast%3DHarvey%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DS.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DPelleymounter%26aufirst%3DM.%2BA.%26atitle%3DWeight%2520loss%2520induced%2520by%2520chronic%2520dapagliflozin%2520treatment%2520is%2520attenuated%2520by%2520compensatory%2520hyperphagia%2520in%2520diet-induced%2520obese%2520%2528DIO%2529%2520rats%26jtitle%3DObesity%26date%3D2012%26volume%3D20%26spage%3D16%26epage%3D45%25E2%2580%25931652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Rat MCHR1 <i>K</i><sub>i</sub> values were also determined for all compounds prior to evaluation for in vivo efficacy. In all instances the rat MCHR1 <i>K</i><sub>i</sub> value was within a factor of 2 of the human MCHR1 <i>K</i><sub>i</sub> value.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">The chirality of <b>28</b> was assigned based on the coincident retention time of <b>28</b> using a chiral column with that of the product generated by alkylation of phenol <b>20</b> with the cyclopropanated product obtained by treatment of commercial (<i>S</i>)-2-hydroxybut-3-enyl 4-methylbenzenesulfonate with Et<sub>2</sub>Zn/CH<sub>2</sub>I<sub>2</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">Angiotensin, APJ, calcitonin gene related peptide, cholecystokinin A, cholecystokinin B, G-protein-coupled receptor 8, galanin 1, galanin 2, histamine H3, leptin, melanocortin 3, melanocortin 4, melatonin 1, melatonin 2, neuromedin U1, neuromedin U2, neurotensin 1, neurotensin nonselective, somatostatin, urotensin II.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">Despite aqueous solubility of <b>27</b> and related thienopyrimidinones analogs being <1 mg/mL, nephelometry studies confirmed that stable 40 Î¼M solutions required for in vitro profiling could be prepared by addition of a DMSO stock solution to aqueous buffer.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Calverley, M. J.</span><span> </span><span class="NLM_article-title">Synthesis of MC 903, a biologically active vitamin D metabolite analogue</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4609</span><span class="NLM_x">â</span> <span class="NLM_lpage">4619</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=4609-4619&author=M.+J.+Calverley&title=Synthesis+of+MC+903%2C+a+biologically+active+vitamin+D+metabolite+analogue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalverley%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520of%2520MC%2520903%252C%2520a%2520biologically%2520active%2520vitamin%2520D%2520metabolite%2520analogue%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D4609%26epage%3D4619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Leff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougall, I. G.</span><span> </span><span class="NLM_article-title">Further concerns over ChengâPrusoff analysis</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">â</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1993&pages=110-112&author=P.+Leffauthor=I.+G.+Dougall&title=Further+concerns+over+Cheng%E2%80%93Prusoff+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DDougall%26aufirst%3DI.%2BG.%26atitle%3DFurther%2520concerns%2520over%2520Cheng%25E2%2580%2593Prusoff%2520analysis%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1993%26volume%3D14%26spage%3D110%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500026w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm500026w%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500026w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                596KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994c6d3f48258d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
